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DEDICATION 
This dissertation is dedicated to dogs, creatures whose presence on earth 
immeasurably enriches the lives of their companion humans. It is dedicated to 
them in the hope that its content will contribute a tiny bit to the maintenance of 
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ABSTRACT 
This study of c anine hypoadrenocorticis m (canine Addison's disease ; adrena l 
insu fficiency ) used severa l techni ques to deter mine the incidence and p reva lence 
of the disease and to identi fy factors associated with its occu rrence. These 
techni ques were histo rica l; statist ica l, inc luding meta -ana lysis and logistic 
regression ; and epide mio logic , inc luding both case series and case contro l data. 
Data were gathered by : extract ing the detai ls of cases reported in the veterinary 
literature , a rudi mentary meta -ana lysis ; using data ob tained by Ciba Ani ma l  Hea lth 
in the c linical trial of the drug microcrysta lline deso xycorticosterone piva late 
(DOCP) ; using data obtained fro m the Vete rinary Medica l Data Base (VMDB) , 
a data reposito ry of c linica l infor mation fro m co lleges of vete rinary medicine in 
the United States -aug mented by direct ly querying VMDB non -participant co lleges 
of vete rina ry medicine in the Un ited States and Canada ; su rveying by mai l 
veterinarians enro lled in the Ciba Ani ma l  Hea lth c linica l tria l of DOCP; and 
su rveying by ma ill,OOO practicing s ma l l  ani ma l  veterinarians se lected rando mly 
fro m the ma iling list of the A merican Veterinary Medica l Association. 
The historical study focused on how hu mans first recogn ized the existence 
of the adrena l g lands , next unde rstood they were invo lved with disease in hu mans 
and other ani ma ls ,  and then deve lo ped methods for identi fying and treating 
hypoadrenocorticis m. The histo rica l study began with Ga len in the second centu ry 
A.D . ,  continued as hu man understanding expanded over the centuries , ended with 
vi 
th e cont empo ra ry und erstanding of hypoad renoco rticism , and p rovid ed a cont ext 
in which th e sp ecific r esults of th e s tudy b ecam e m eaningfu l. 
In cid enc e  es timat es for canin e ad renal insu ffici ency w ere, d ep ending on th e 
data s et us ed to obtain th e estimat e, 0. 1 3 /1 000 dogs /yr , 0. 34 /1 000 dogs /yr , and 
0 .6 /1 0 00  dogs /yr. A point estimat e was 0. 36 /1 000 dogs /yr. Preva lenc e esti mates 
w ere 3 .2 /1 000 dogs , 1 .7 /1 0 00  dogs , and 0. 6 /1 000 dogs. A point estimat e was 
1 .8 /1 000 dogs. 
Estimat es of th e av erag e ag e (yr) at diagnosis fo r dogs with 
hypoad renocorticis m w ere 4. 3 , 4.9 ,  and 5. 4 , again d ep ending on th e data s et. A 
point estimat e was 4.9 . Th e ag es of cas es and controls sugg est ed ,  bas ed on th e 
computation of ag e-sp ecific odds ratios (OR) and logistic r eg ression , that ag e was 
associated with th e occu rrenc e of dis eas e and that th e p robab ility of dis eas e 
inc reas ed with ag e. 
Fema le dogs w er e  mo re likely to b e  hypoadr enal than mal es , and n eut er ed 
dogs of eith er s ex w ere mo re li kely than intact on es.  Thes e conc lusions w ere bas ed 
on s ex-sp ecific incid enc e estimat es ,  s ex -s pecific OR, and logistic r egr ession. Th e 
latt er con firmed that s ex was a significant facto r associat ed with 
hypoadr enocorticis m in dogs. 
Br eed was , bas ed on b reed -s pe cific OR and logistic r egr ession , a significant 
facto r in wh eth er o r  not a dog d ev elop ed ad renal insu ffici ency. Ai redal e T er ri ers , 
Bass et Hounds , Beard ed Colli es ,  G erman Sh eph erds , G erman Sho rthair ed 
Point ers ,  Gr eat Dan es ,  Poodl es ,  Saint Bernards ,  Sp ring er Spa niels , and West 
Vll 
High land Whit e T erriers w ere at inc reas ed ris k of dis ease. Boston T erriers ,  
Box ers , Coc ker Spani els , Dalmatians , Lhasa Apsos , Pit Bu l l  T erri ers , 
Pomera nians ,  Sh etland Sh eepdogs , Shih Tzus , and Yo rkshi re T erriers w ere at 
dec reas ed risk. Th ere was l ess comp elling evid enc e that Lab rado r  Retri ev ers and 
Mi xed b reed dogs w ere at d ec reas ed  ris k. 
Av erag e  body w eight (kg ) es timat es fo r hypoad renal dogs w ere 23. 4 , 24.5 , 
and 19.7 , d ep ending on th e  data s et. A point estimat e w as  22. 5. The body w eights 
of cas es and cont rols sugg est ed ,  based on ag e-sp eci fic O R  and logist ic reg ression , 
that body w eight was associated with diseas e and that th e p robabi li ty of dis eas e 
inc reas ed with body w eight. 
Hypoad rena l dogs w ere charact eriz ed by hyponatr emia , h yperkalemia , and 
a d ec reas ed rat io of s erum sodium to potassium conc ent rations. Point esti mat es fo r 
s erum sodiu m concent ration , s erum potassium conc entration , and s erum sodiu m 
to potass iu m  conc en tration ratio w ere 1 3 2. 1  meq/L, 6. 6 meq/L, and 21 . 1 ,  
resp ectiv ely. Th ere was evid enc e that h ypoad renal dogs w ere s eldom no rmal fo r 
all three diagnostic indicato rs. 
Co mmon clinical findings among hypoad rena l dogs w ere ano rexia , vo miting , 
d ep ression , w eakn ess ,  w eight loss , azote mia ,  and di arrh ea. Though p robably 
a ffect ed by measu rement bias , the re was evid enc e that dogs with ad rena l 
insu ffici ency w ere mo re lik ely than dogs from th e  g en era l population to hav e 
an emia ,  arthritis , c ruciat e ligament ruptu re, diab et es mellitus , h epatitis , 
... 
v m  
hypothyroidis m, ke ratocon junctivitis s icca , megaesophagus , myasthenia gravis , 
nephritis , and thro mbocytopenia. 
The study conc luded that epide mio logic studies of canine 
hypoadrenocorticis m may use the practi cing veterin arian 's diagnosis as a case 
de finition rather than re qu ire a s trict c ase de fin ition based on the 
adrenocorticotropic hor mone sti mu lation test. This wou ld produce larger nu mbers 
of cases , be less co mp lex , more convenient , and less cost ly. 
Logistic regression of data fro m the ma il su rvey of veterinarians e nro led in 
the c linical tria l of DOC P indicated that age , breed , sex , and body weight were 
associated with canine hypoadrenocorticis m. The probabi lity of disease increased 
with age and body weight , was g reater in fema les than ma les , was greater in 
neutered than intact dogs , and va ried with breed. There was mode l-dependent 
evidence of higher order inte ractions , but the exact na ture of these interactions 
cou ld not be dete rmined. Models were prepa red which cou ld predict the relative 
probabi lity of hypoadrenocorticis m in different dogs. It was e mphas ized that these 
mode ls undoubted ly ove rlooked other unknown variab les. 
Data fro m the veterina ry litera ture , VMDB, c linica l t ria l of DOC P, and 
su rvey of veterin arians e nrol led in the DOC P c linica l tria l were all usefu l. The 
mai l su rvey methodo logy was va luab le ,  and shou ld be a usefu l too l in veterinary 
epide mio logic studies. The mai l su rvey of randomly se lected veterinarians was a 
poor method for studying an uncommon disease ; this de ficiency might be 




Th e Univ ersity of T enn ess ee (UT) awarded its first Ph .D. d eg ree in 1 886 in 
th e field of G en era l. Th e award of th e Ph.D. in G en era l har kens bac k to th e day 
wh en on e individua l cou ld legiti mat ely lay c lai m to at least a rudi ment ary grasp 
of a ll hu man know ledg e. That grasp , a fter all, was th e who le pu rpos e of th e 
d egr e . 
The Ph.D. in G en era l has sad ly disappeared in th e short 1 1 0 y ears sinc e 
1 886. (For t ime p erspectiv e, r ememb er that th er e  is a lady a liv e in Franc e--this is 
writt en in mid -Feb ruary 1996--who could hav e a ttended the 1 886 graduation as a 
s ma ll, but s ent ient , chi ld. ) Th e G en era l d egr e 's disapp earanc e, and its gradua l 
r ep lac ement by subs equ ent gen erations of ev er mor e  sp eci alized d egr ees , is a 
natura l, unavoidab le, and sa luta ry cons equ enc e of th e logarith mic growth of hu man 
know ledg e in th e last c entu ry. No san e p erson today wou ld c lai m ev en th e 
sha llow est , most t enuous grasp of al l hu man know led ge, and that is as it shou ld 
b e. A sing le hu man brain can co mpr eh end only so much. But th e in evitab le 
transition fro m G en era l to v ery ,  v ery s peci alized has co me at a pric e, in on e s ens e 
an unacc eptab ly high pric e. 
It s eems that th e i mpossibility today of mast er ing ev en a tiny part of hu man 
know led ge has b eco me a conv eni ent excus e for avoiding th e effort entir ely. Whil e 
mast ery is i mpossib le, and failur e to do so is not caus e for d espond ency or 
opprobriu m, making th e effo rt is n ev erth eless worthwhi le and ess ent ia l  to 
mean ingfu l scho larship. Whil e th e orig inal goal of th e Ph.D. d egr ee, i. e. ,  mast ery 
X 
of all human knowledge, may be unattainable, the goal's pursuit is not. Those who 
do not pursue the goal, and particularly those who are contemptuous of its pursuit, 
show disrespect for the very Ph.D. degree they have or covet. 
With the foregoing in mind, I feel very fortunate to be enrolled in the 
Comparative and Experimental Medicine program, a program specifically defined 
by its interdisciplinary character. Therefore, while I recognize that this thesis is 
and should be principally about science, I hope that it is a bit more. I hope I have 
not been guilty either of "scientific hubris"• or the "ignorant barbarism of 
scientific progress. nb I have tried to conduct and report good science, but to do 
so in an historical and interdisciplinary context. I hope that the thesis melds my 
admittedly limited knowledge of clinical veterinary practice, endocrinology, 
epidemiology, the philosophy of causality, the mail survey methodology of the 
social sciences, and statistics. I hope it demonstrates an effort, however inevitably 
unsuccessful, to achieve the original goal of the Ph.D. degree. 
•william F. Buckley, Jr., "Firing Line," November 1 2, 1995 , WSJK 
Television, Channel 2, Public Broadcasting System, Sneedville, Tennessee. 
bWilliam Hamilton, "Morning Edition," June 9 ,  1995 , WUOT Radio, 9 1 .9 
FM, National Public Radio, Knoxville, Tennessee . 
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A BRIEF IDSTORY OF HYPOADRENOCORTICISM 
Introduction 
Hypoadrenocort ic ism has almost certa inly a fflicted humans and other an imals 
s ince they first evolved , but the d isease was not w el l-defined unt il about 15 0 years 
ago , and the deta ils of its phys iology , d iagnos is ,  and therapy were not understood 
or developed unt il the 2 0th centu ry. In fact , defin itive therapy was not ava ilable 
unt il the 1 950s .  
The follow ing is a br ief h istory through the early 1950s of how understand ing 
o f  the d isease evolved over the decades. The h istory ends w ith the early 1950s 
because , though knowledge about the adrenal glands has ce rta inly advanced 
substant ially s ince then , the advances can generally be character ized as 
refinements , such as improved synthet ic co rticostero ids and improved cl in ical ca se 
management , rather than altogether new advances. c The art icles rev iewed and 
included in th is h istory , though ve ry numerous and qu ite comprehens ive , do not 
�e one area in wh ich substant ial new contribut ions have , in fact , been made 
s ince the early 1950s is understand ing the et iology of hypoadrenocort ic ism. Its 
pr inc iple cause appears to be immune -med iated des truct ion of the adrenal co rtex , 141 
and , s ince the field of immunology is so complex and has progressed so much 
s ince the 195 0s , a d iscuss ion of the h istory of progress in immunology is well 
beyond the sco pe of th is thes is .  Thus it has not been included. 
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p retend to be e xhaust ive-- i.e. , many , many a rt icles a re not included -but the 
lite ra tu re reviewed d oes paint a clear pictu re of the scienti fic p rog ress which 
resulted in our knowledge of the disease today. This chapte r focuses on the 
g radua l ,  stepwise unfolding of knowledge of hypoad renoco rticis m, and also , since 
many other diseases we re b eing si milarly characte ri zed du ring this pe riod , it se rves 
as a model fo r how " mode m medicine" studied disease p rocesses in gene ral. 
This chapte r d oes not focus on the disease in dogs since the following chapte r 
is a histo ry of clinical cases in the dog fro m the first reported cases in 1953 
th rough 199 4. Neve rtheless , dogs and oth er an ima ls are fre quen tly mentioned since 
they we re used extensively as labo rato ry an imals , and so me info rmation of inte rest 
to p racticing vete rin arians is included if it is not b rought ou t in the next chapte r. 
Early Period 
Galen , in about 177 A.D. ,  while describing the veins wh ich enter the caudal 
vena cava , refe rred to "A twig fro m th is not inconside rable vein [p robably the le ft 
ph renic ] joins and connects with the spongy flesh lying the re. "106 The "spongy 
flesh" is clearly the ad renal gland. Bartolo meo Eustacchio desc ribed the ad rena l 
glands in 1563 as "glandulae Ren ibus incu mbentes. "223 His work was first 
publ ished in 17 1 4  by the Italian clin ic ian Lanc isi , who added h is own notes. 223 
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Edward Tyson (165 0-17 08�, an Eng lish phys ic ian , stated that "Glandulae Renales 
in Emb ryos and Infants are greater , at least proport ionably , than in Adultis. "131 
These "Glandulae Renales" were , of course , the adrenal glands , and it is 
interest ing to note that Tyson recogn ized the d ifferent proport ions of the adrenals 
in adults and infants -i.e. , he recogn ized that an infant was not s imply a m in iature 
adult. 131 This could be viewed as an earl ier , adm ittedly very c rude , phys iolog ic 
obse rvat ion about the funct ion of the adrenal glands. With regard to domest ic 
an imals , August Chauveau (1827 -1917 ) desc ribed "The Supra-renal Capsules" in 
deta il. 21 Notably , Chauveau also used the word "adrenals" when refe rring to these 
organs , and he recogn ized the d ifference between "the cortical and the medullary 
substance."21 Two other early vete rinary anatomy books also descr ibed the gross 
anatomy of the adrenal g lands , both comment ing on the ir ductless nature. 198.241 One 
of these sources stated , interes tingly , but wrongly , that the adrenal glands are "sa id 
to be replaced if removed. "241 
First Descriptions of Disease 
Thomas Add ison , M.D. (1793 -186 0 ) , an Eng lishman educated in med ic ine 
in Scotland at the U Divers ity of Ed inburgh , was a d ist ingu ished phys ic ian of h is 
t ime w ith very eclect ic talents. He worked in surgery , dermatology , to xicology , 
dJul ian , not Gregor ian , calendar. 
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pathology , anatomy , and physiology. He wrote the first English language book on 
the actions of poisons on the l iving body in 1829 , was first to use sta tic electrici ty 
to treat convulsive disease in 1837 , and described ap pendicit is in 1 839. In 18 49 
he described a pe rnicious anemia and a disease of the suprarenal capsules (adrenal 
glands ) in a pa per to the South London Medical Socie ty. Addison felt that he had 
indeed described the disease for the first ti me ,  although he did so humbly , 
recogni zing that he could be fa lling prey to the "bias and pre judice inseparable 
from the hope or vani ty of an original discove ry. "  This "Addison's anemia" was 
described as "a state of gene ral ane mia incident to adult males. ne,I 
Six years later , in 1855 , Addison published a much more detailed account of 
the disease which included deta iled case repo rts ,  autopsy findings , and sketches of 
patients and their organs. He described clinical hypoadrenocorticism (not the term 
used then , of course ) with remarkable acumen , and (refreshingly ) the tone of his 
writing put the disease in the context of a "philoso phic" view of medicine and the 
pursuit of knowledge , not in a cold , steri le scientific context. Addison prefaced his 
paper as fo llows : 
�ough now recogn ized as more o ften a condition of females , Addison 's 
obse rvat ion that the disease occu rred more o ften in males may , specula tively , have 
resulted from chance alone , fro m males see king medical attent ion more o ften , or 
from occupat ional exposure by males , especially since tuberculosis was , though 
not recogni zed as such at the time ,  a p rincipal cause of the disease. Other 
explanations , of course , are possi ble. 
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If Pathology be to disease what Physiology is to health, it appears reasonable 
to conclude, that in any given structure or organ, the laws of the former will 
be as fixed and significant as those of the latter; and that the peculiar 
characters of any structure or organ may be as certainly recognized in the 
phenomena of disease as in the phenomena of health. . . . it is as a first and 
feeble step towards an inquiry into the functions and influence of these 
organs [the adrenal glands]. . . that I now put forth the following pages. r,2 
Addison described the condition with incredibly remarkable accuracy: 
The leading and characteristic features of the morbid state to which I would 
direct attention, are, anaemia, general languor and debility, remarkable 
feebleness of the heart's action, irritability of the stomach, and a peculiar 
change of colour in the skin, occurring in connexion with a diseased 
condition of the "supra-renal capsules.".  . . Notwithstanding these 
unequivocal signs of feeble circulation, anaemia, and general prostration, 
neither the most diligent inquiry, nor the most careful physical examination, 
tends to throw the slightest gleam of light upon the precise nature of the 
patient's malady: nor do we succeed in fixing upon any special lesion as the 
cause of this gradual and extraordinary constitutional change. 2 
Given some updating to a modem-day medical vocabulary, this could easily serve 
as a contemporary clinical description of hypoadrenocorticism. Addison's careful 
description of and observations on the 11 clinical cases reported in his article 
clearly qualify as classics in medical history. 
Forty-one years later, in 1896 , no lesser personage than William Osler added 
his imprimatur to Addison's findings. He said, "Recent studies render it very 
probable that the original view of Addison is correct--namely, that the symptoms 
of the disease are caused by loss of function of the adrenals. "144 Osler discussed 
six of his own cases of Addison's disease, and, importantly, put the disease in the 
Whatever happened to prose like this in the scientific literature? 
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context of other conditi ons ,  su ch as thyr oid mal fun cti ons , whi ch unders cored ' the 
imp ortan ce of the du ctless glands. "144 Notably , three of Osler 's six pa tients had 
tuber culosis , and five of the six died , but one was apparently cured by treatment 
with p or cine suprarenal extra cts . 144 
During the same era , a veterina ry physi ol ogy text stated , "The Renal 
Capsules [Bold in origina l] have been supp osed to be conne cted with the removal 
of wo rn-out pigment fr om the b ody , but their fun ction is involved in myste ry. " 199 
This p oints out a pr ominent hyp othesis of the time whi ch was that the adrenal 
glands were inv olved in s ome s ort of det oxifi cati on .  While m ore than a half ­
cen tury would pass bef ore a clini cal case was rep orted in the dog , 68 th is text 
re cognized that , "In d ogs and other animals , the effe ct of rem oving these glands 
has been the produ cti on of pr of ound degeneration in the central ne rvous system , 
f ollow ed by death . "199 
Adrenal Glands Recognized as Essential to Life and 
Early Anatomic and Physiologic Studies 
Th ough Addis on and Osler , as clini cians , felt that the adrena l glands were 
essential to life , this had st ill n ot been ascertained with s cientifi c certitude . 
Theref ore , resear chers studied whether or n ot these glands were essential , and , if 
s o, why , for about a qua rter- centu ry ,  from r oughly 1 900 until 1 925. The sear ch 
for definitive answers was made a pa rticularly difficult one because , in addition 
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to the crudity of physiologic and surgical studies of the day, the adrenal glands 
were, of course, comprised of two parts, the cortex and the medulla, with, 
unbeknownst to the researchers, completely different physiologic roles. Adding 
further to the complexity were the facts that the cortex itself, again unbeknownst 
to the researchers, had several different physiologically important products, and 
that some species, due to the presence of accessory adrenal tissue located 
elsewhere in the body, could occasionally survive bilateral adrenalectomy. 
Many studies demonstrated during this first quarter of the twentieth century 
that animals which were bilaterally adrenalectomized died. 39•102•132. 156-ISS,210.213.214.243 
One study, trying to experimentally mimic Addison's disease, showed that tying 
the adrenal veins in cats eventually led to death, but death ensued more slowly 
than in bilaterally adrenalectomized animals. 72 One study demonstrated that 
bilateral adrenalectomy in the goat was not necessarily fatal, 132 while another 
indicated that in cats bilateral adrenalectomy "practically always" led to death.39 
These survivals after bilateral adrenalectomy presumably resulted from the 
presence of accessory adrenal tissue elsewhere in the body, or possibly from 
incomplete surgical excision of the glands. One report documented the survival of 
a bilaterally adrenalectomized cat because of the presence of accessory adrenal 
tissue. 254 In any case, early in this period, the absolute biological requirement for 
functioning adrenal glands was still in question. By about 1925 , however, the issue 
was pretty well settled, and the conclusion was reached that adrenal glands were 
indeed necessary to life.15•82•209•254 
7 
Although it was clearly understood by the end of this quarter-century that the 
adrenal glands were necessary to life, why they were necessary was not understood 
at all. The hypotheses posited about why they were necessary included that they 
were related to some vaguely defined "nervous influences" associated with the 
glands, 214 that the glands were essential to the detoxification of certain substances 
in the body,61•118.213.214,243 that they produced a substance necessary to life,214 that 
they were involved in some essential way in muscle metabolism, 243 and that they 
played an active role in antibody production. 61 One quote from this period 
illustrates just how wrong a statement of scientific certitude can be. It said that the 
adrenals have two functions: " an antitoxic, protective function accomplished by the 
internal secretion of cholesterol of cortical origin, and the other the tonic effect of 
adrenalin of medullary origin. " 118 Regardless of this erroneous certainty, the life-
maintaining function of the adrenal glands was not defined during this period, and, 
as illustrated in the preceding quotation, the epinephrin produced by the adrenal 
medulla caused a good deal of confusion. 8 
The physiologic role of the adrenal glands was extraordinarily bewildering 
in large part because of the adrenal medulla and its physiologically powerful 
secretion epinephrin. Researchers, faced with this extremely powerful vasoactive 
'Ironically, though the author of the quotation was quite wrong about the life­
sustaining role of the adrenal glands, he was prescient in one sense-he did contend 
that the adrenal cortex and the adrenal medulla had separate functions. In that 
respect, he stumbled, perhaps accidentally, perhaps not, onto the truth. 
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hormone, quite naturally looked for years and years to discover how epinephrin 
from the adrenal glands was key to life. It was not, of course, so the research 
community was led astray for a long time. Several papers were published which 
indicated the (quite predictable and logical) focus on epinephrin.72,209.21l.242 
Eventually, researchers, still understanding of course the physiologic power of 
epinephrin, recognized that adrenal medullary epinephrin was not the key to 
survival. 103.212 One paper, after reviewing the assertions of others regarding the 
role of epinephrin in carbohydrate metabolism, said with forthright lucidity: 
Although not one of these statements is true, the theory has possessed a 
charm from which many have not been able to free themselves, and it has 
also been productive of work which has shown the matter in its proper light. 
. . . The theory that epinephrin causes a production of sugar from fat, 
decreases the power of the organism to oxidize glucose through inhibition of 
pancreatic function, and stimulates the thyroid so that protein metabolism is 
increased, is untenable in any of its particulars. h.103 
Researchers eventually realized that the adrenal cortex, rather than the adrenal 
medulla, was the part of the adrenal glands essential to life.i•15•82.212.243.254 
h Another example of the refreshing use of language in a scientific article. 
i'fwo fascinating historic notes from this period follow. First, a purportedly 
pathognomonic diagnostic test for hypoadrenocorticism was described in 1917 
which involved tracing a geometric pattern on the abdomen of the patient with a 
blunt object such as a fountain pen. If a pale white line appeared which became 
more distinct over a period of about one minute, and then disappeared in one to 
three minutes more, the patient was hypoadrenal. 191 Second, in 1919 in the wake 
of the influenza pandemic of 1918 , one paper claimed that dysfunctional adrenal 
glands were involved in influenza and influenza! pneumonia, and that, in fact, the 
severity of the influenza was proportional to the endocrine dysfunction. 25 
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The Fundamentals: Adrenal Cortex, 
Anterior Pituitary, and Hypothalamus 
Having concluded that the adrenal cortices, not the adrenal medullae, were 
necessary to sustain life, the research community next tried to determine 
specifically how the adrenal cortices helped maintain life. An obvious possibility 
was that some substance required for life was being secreted by the adrenal 
cortices. Pursuing this hypothesis, a bevy of researchers extracted various fractions 
from the adrenal glands, and used the extracts to attempt to maintain the lives of 
bilaterally adrenalectomized animals.j,73.Z19 Extracts of tissues other than the 
adrenal glands such as brain, testes, liver, spleen, and heart were used in attempts 
to extend the lives of experimental animals with adrenal insufficiency, 16 as were 
other physiologically active chemicals such as pituitrin, ergotamine, and 
ephedrine. 16 These extracts and chemicals all failed to sustain life in 
adrenalectomized animals. One paper, intriguingly, reported that the survival time 
of four bilaterally adrenalectomized female dogs was significantly extended 
because they were in heat. 160 This "adrenocortical effect" of the estrogenic 
hormones gave a hint, apparently unrecognized at the time, of the often 
jOne quotation from this period illustrates how very crude the surgical 
techniques being used at that time were: "It is never permissible for an 
experimenter with an inadequate [surgical] technique to assume that his operations 
will be of a uniform degree of badness [Italics added] in a control set of animals 
and in a set subjected to a certain procedure, the effect of which is to be tested, 
so that this factor can be considered as eliminating itself. " 161 
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overlapping physiologic effects of the steroid hormones. This result led these 
researchers to use only male dogs in the study of adrenocortical extracts. Another 
study confirmed that bitches in heat survived adrenalectomy longer than those not 
in heat, but also showed that luteal extracts did not similarly extend life. This same 
study demonstrated that in cats, but not in dogs, anterior pituitary extracts 
extended life in adrenalectomized animals (presumably, based on present-day 
knowledge, because of the presence of some accessory adrenocortical tissue), and 
that, in rats, growth hormone from the anterior pituitary did not.216 This began to 
show an acknowledgment of the interplay between the anterior pituitary and the 
adrenal cortices. Another study found that progesterone would maintain 
adrenalectomized ferrets in ''excellent health. "62 This contradicted (unless one 
posits a species difference) at least one other study which showed that progesterone 
did not extend the life of adrenalectomized cats. 216 The authors suggested that this 
apparent discrepancy probably resulted from the use of different dosages of 
progesterone.62 In any case, this clearly illustrated again that researchers were 
gradually realizing the often overlapping physiologic effects of the steroid 
hormones. 
Having established that adrenocortical extracts of one sort or another would 
sustain the life of adrenalectomized animals, the researchers naturally turned to the 
next issue, which was what specifically in the extracts sustained life. Several 
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papers discussed the isolation and efficacy of compounds isolated from 
adrenocortical extracts or their synthetic analogs. 122•196.207.228 These extracts or 
synthetics were then, of course, used to treat humans with adrenal insufficiency, 
sometimes successfully and sometimes not, and to maintain the life of 
adrenalectomized experimental animals. 22•48•94•126•197•227•236 
By 19 40 ,  as pointed out in a review article discussing the diagnosis and 
treatment of adrenal insufficiency, the synthetic crystalline corticosteroid 
desoxycorticosterone acetate (DOCA) was the most sophisticated therapeutic agent 
of the day. It was efficacious and available in large quantities at reasonable cost.224 
The DOCA could be injected intramuscularly or implanted subcutaneously as 
pellets. 7•230 Successful sublingual administration of DOCA dissolved in propylene 
glycol and alcohol was also reported.' 
Advances in knowledge in this area were fascinating. First, the determination 
that the adrenal cortices were required for life; second, the determination that 
extracts from the adrenal cortices and their synthetic analogs could sustain life in 
adrenalectomized animals; third, the purification in crystalline form of components 
of the extracts; and, last, the preparation of synthetic DOCA in large quantities at 
reasonable cost. While use was made of both the purified adrenal extracts and 
synthetic DOCA, as time went on more of the latter was used to treat human 
Addison's disease. 
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Despite these rapid advances in understanding and treating 
hypoadrenocorticism , therapeutic results were still not entirely satisfactory. Though 
DOCA , often combined with the administration of sodium chloride to help 
alleviate sodium loss , t was reasonably effective therapy , there were continuing 
problems related to an ill-defined failure in their "carbohydrate -regulating 
capability , "226.235 and some required treatment with cortical extracts in addition to 
DOCA. 172 Although unknown at the time , this resulted from the powerful 
mineralocorticoid effect , but very weak glucocorticoid effect , of DOCA. (The 
words "mineralocorticoid .. and 11 glucocorticoid 11 were not , of course , in use during 
this period. ) Gradually , however , researchers began to realize that the adrenal 
cortices produced two distinctly different types of corticosteroids , one with an 
electrolyte -regulating function Oater to be known as mineralocorticoids ) ,  and a 
second with a carbohydrate -regulating one Oater to be known as glucocorticoids ). 
A study in 1940 showed that Addison's disease patients with low normal fasting 
blood glucose values , an increased tolerance for hypoglycemia , and a low normal 
basic metabolic rate were non-responsive to DOCA , but responsive to 17 -hydroxy -
11 -dehydrocorticosterone and corticosterone. 238 Another study demonstrated the 
effects on carbohydrate metabolism in adrenalectomized dogs of crystalline 17 -
klJ se of this exogenous sodium chloride sometimes led to hypertension , edema , 
and even heart failure. These problems were occasionally attributed to the 
concomitant use of DOCA since the now well -known connection between 
hypertension and high salt intake was not well understood at the time. 247 
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hydroxy-1 1-dehydrocorticosterone isolated from an adrenal cortical extract. 96 These 
studies presaged the distinction between mineralocorticoids and glucocorticoids. 
By 1946 it was reasonably clear that both glucocorticoid and mineralocorticoid 
treatment (though, again, these words were still not in use) provided the best 
therapy for Addison's disease. Specifically, one article stated, 
In most patients [1 1-dehydrocorticosterone] therapy alone . . . failed to effect 
a significant change in the clinical condition. When . . . [11-
dehydrocorticosterone] was added to . . .  desoxycorticosterone acetate . . .  , 
a striking improvement over and above that observed with 
desoxycorticosterone acetate alone was observed. 57 
By 1949 the idea that treatment should consist of cortical extract for its 
glucocorticoid effect and DOCA for its mineralocorticoid effect had found its way 
into a medical textbook.206 Notably, this textbook also indicated the need for 
sodium chloride therapy as well, and commented that 1 1-dehydrocorticosterone 
(described as a "carbohydrate-active hormone") could also be used, but that there 
was still no source of it for general clinical use. This textbook also recognized that 
Addison's disease could sometimes be part of a multiglandular disease involving 
the pituitary, thyroid, gonads, pancreas, thymus, and, perhaps, parathyroid. The 
relationship between Addison's disease and other endocrinopathies had been 
1Sodium chloride could be given in normal food, per os as a supplement, 
intravenously, and even per rectum. One paper stated that "In a typical [Italics 
added] case of Addison's disease, the symptoms of severe adrenal insufficiency 
were relieved by treatment consisting of the administration of NaCl by mouth and 
by rectum. 101 
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reported earlier. One report of a man with concomitant Addison's disease and 
diabetes mellitus noted that these diseases had often been reported simultaneously 
in the same patient. 225 
The present-day terms glucocorticoid and mineralocorticoid were in use by 
1950. One review article of that year used both these terms, and also made several 
other important points. 181 It said that, although the exact active natural 
adrenocorticoids had still not been defined chemically, their physiologic roles, such 
as glucocorticoid and mineralocorticoid, had been. Further, the article said that, 
though the exact roles of the zona glomerulosa, zona fasciculata, and zona 
reticularis had not yet been defined, they might have distinctly different roles. This 
paper also recognized the physiologic interplay between the anterior hypophysis 
and the adrenal cortices. The idea that the adrenal cortices produced at least two 
distinctly different kinds of hormones, glucocorticoids and mineralocorticoids, was 
controversial. Some believed that only one corticosteroid, 17-
hydroxycorticosterone, was required. But a further study discussed the secretion 
of a salt-retaining hormone by the adrenal cortex. 195 
So, by the end of the 1940s, the idea was established that the adrenal cortices 
regulated electrolyte, carbohydrate, protein, and fat metabolism. The recognition 
by researchers and physicians of this functional duality was reflected in several 
publications. 66,231,232
.234 
One article even specifically identified the zona glomerulosa 
of the adrenal cortex as the source of desoxycorticosteroids which regulated fluid 
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and electrolyte balance, and the zona fasciculata as the source of 1 1-oxy­
corticosteroids which regulated gluconeogenesis . 66 Papers emphasized the 
physiologic effects of the "carbohydrate-regulating" corticosteroids5•ss,229 and the 
effects of "electrolyte-regulating" ones. 17•23•47•125•151.229.237 During the decade of the 
1940s, some elucidation of the physiologic interplay between the anterior pituitary 
and the adrenal cortices occurred. 
Two papers in 1943 described the isolation of pure adrenocorticotropic 
hormone (ACTH), one isolation from the anterior hypophyses of sheep, 97 and 
another from pigs. 182 The physiologic and therapeutic effects in humans of ACTH 
included those on blood and blood constituents, 58•76 electrolytes, 58 metabolism, 58 
androgens, 58 and urine, 58 as well as those on normal humans and those afflicted 
with Addison's disease, Cushing's disease, and hypothyroidism. 154 By the early 
1950s, adrenal cortical insufficiency had been clearly classified into primary and 
secondary disease. Thorn's article in 1951 reported, "Adrenal cortical insufficiency 
may occur as a result of disease of the adrenal gland itself (primary) or as a 
consequence of inadequate secretion of ACTH due to anterior pituitary or 
hypothalamic disease (secondary). "233 Therefore, by the early 1950s, 
hypoadrenocorticism was understood as a disease related directly to the adrenal 
cortices or indirectly to the anterior pituitary or hypothalamus. The control 
mechanism for the adrenocorticoids was shown, however, to be more complicated 
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than a simple feedback loop between the anterior hypophysis and the adrenal 
cortices. 
Steinbeck described three major mechanisms regulating ACTH and, hence, 
adrenocorticoid secretion.208 The three were negative feedback from 
adrenocorticoids, circadian rhythm, and stress; the latter two, significantly, were 
mediated through the hypothalamus. The hypothalamus released corticotropin­
releasing hormone which stimulated the anterior pituitary to release ACTH, the 
ACTH stimulated the release of adrenocorticoids from the adrenal cortices, and 
these adrenocorticoids then controlled further secretions by the hypothalamus and 
the anterior pituitary. 150 This relationship between the central nervous system and 
the adrenal cortices is one mechanism whereby altered emotional and psychologic 
states are translated into altered physiologic function. 223 Stresses such as pain, 
trauma, and anxiety could lead to this stimulation of adrenocorticoid release by the 
central nervous system. 37 
The historical treatment of Addison's disease138 pointed out that cortisol had 
been shown to be a major product of the adrenal cortex in man and dog, 139•140 that 
aldosterone was a major salt-retaining hormone secreted by the adrenal cortex, 195 
and that the adrenal gland produced androgenic substances.60 Consequently, "the 
three major types of adrenal hormones produced were [by 1952] represented by 
specific hormones: glucocorticoids-cortisol, mineralocorticoids-aldosterone, and 
the androgens, androstenedione and dehydroepiandrosterone, which are converted 
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to testosterone to produce their androgenic effects. " 138 By the early 1950s, the 
fundamental physiology and control of the adrenal cortices were understood. It 
involved the secretion of glucocorticoids, mineralocorticoids, and androgens by the 
adrenal cortices under the control of the anterior pituitary and the hypothalamus. 
Interestingly, just as these fundamentals were first clearly understood, the 




REVIEW OF 244 CASES OF NATURALLY OCCURRING 
CANINE HYPOADRENOCORTICISM REPORTED 
BETWEEN 1953 AND 1994 
Introduction 
Hypoadrenocorticism (Addison's disease, adrenal insufficiency, 
adrenocortical hypofunction) was first described in the dog in 1953 .68 It is thought 
to be an uncommon disease. 41•43 Clinical signs of disease include vomiting, 
anorexia, weakness, depression, weight loss, diarrhea, and dehydration. These 
signs result from a deficiency of mineralocorticoids, glucocorticoids, or both. 
Hypoadrenocorticism can be classified as primary or secondary. In primary 
hypoadrenocorticism, the adrenal glands fail to produce enough glucocorticoids, 
mineralocorticoids, or both. It may be caused by granulomatous diseases such as 
histoplasmosis and blastomycosis, hemorrhagic infarctions, cancer metastases, 
amyloidosis of the adrenals, intoxication, and treatment for hyperadrenocorticism 
withtheadrenocorticolyticdrug2,4'-dichlorodiphenyldichloroethane(o,p'-DDD).41 
Immune-mediated destruction of the adrenal glands occurs in human beings, and, 
though it has not been definitively demonstrated, it may also occur in dogs. 41 The 
cause of adrenal failure is usually not identified, so it is classified as idiopathic.41 
In secondary hypoadrenocorticism, decreased secretion of adrenocorticotropic 
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hormone (ACTH) by the pituitary or corticotropin releasing hormone by the 
hypothalamus leads to decreased glucocorticoid production. 41 It can be associated 
with neoplasia, inflammation, and trauma. 41 
The diagnosis ofhypoadrenocorticism is based on histopathology,9•13.27•36•59•68• 
83•92•133•134•163•171•176•184•194,222.246 either high serum potassium concentration or low 
serum sodium concentration or both 10,1 1,14,26,27 ,42,43,59, 10,75,86,87 ,104,105,n9,134,135,142,152,153, ' 
193'222,244•246 and a low plasma cortisol response to ACTH stimulation. 12•20•28•42•45•46• 
95,104·tos,t27,IS2,t5S,t71•183•184,244.246 Definitive diagnosis· is demonstrated by a lack of 
adequate plasma cortisol or aldosterone response to ACTH stimulation. 95•104•105 
Treatment consists of administration of glucocorticoids and mineralocorticoids as 
required to reestablish physiologic homeostasis. 
This chapter reviews 244 naturally occurring (non-iatrogenic) cases of canine 
hypoadrenocorticism reported in English language journals between 1953 and 
1994. 
Methods 
Forty-six reports (Table 2. 1 )  in the English language of naturally occurring 
canine hypoadrenocorticism were reviewed for ages, sexes, breeds, diagnostic 
methods, serum potassium and sodium concentrations, and clinical findings. One 
report was excluded from the review because the cases reported were biased by 
selection of only hypercalcemic cases from a larger pool of cases. 147 Thirty-five 
of 48 cases were excluded from another report because they were reportedly of 
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N ...... 
Table 2.1. Number of Cases Reported, Average Ages, Sexes, Breeds, Diagnostic Methods, and Mean Serum Sodium (Na +) and Polassium (K +) Concentrations of 244 Reported Cases of 
Naturally Occurring Canine Hypoadrcnocorticiam 
ACTH atim = ACTH stimulation test 
EKG = electrocardiogram 
F = female·inlact 
FS = female-spayed 




















Author of report• 
Had low" 
AMis' 
Marshak et al.119 
Ditchlield et a1.34 
Howell et al.'1 
Kelly91 
R.othenbacher et o.l.16' 
Siegel et al.'94 
Nimmons et al.141 
Siegel'" 
Theranm 
Morales et al.1:u 
Bonneau et al." 
Mulnix134 
Keeton et al.'' 
de Lahunta11 
MC = male-castrated 
Na + IK + "" diagnosis by serum sodium or polassium concentration, 
or the ratio or sodium to polassium 
NR = not reported 
Path = gross and/or microscopic pathology 
No. of Average 
cases ages 
reported (yr) Sexes (number) Breeds (number) 
3 3 .2 FS(2),M(1) NR (3) 
2 4 F(l) Welsh Corgi (1) 
1 3.1  FS(2) Cocker Spaniel (1); Mixed (1) 
1 4 FS(I) German Shepherd (1) 
1 6 M(1) Cocker Spaniel (1) 
1 6 F(l) Boxer (1) 
1 12 M(1) Mixed {1) 
1 3 F(1) Beagle (1) 
1 3 M(l) West Highland White Terrier(l) 
1 5 .5 M(1) Mixed (1) 
1 2 M(l) Saint Bernard (1) 
2 2.5 F(1),FS(1) German Shepherd (I); Gordon 
Setter (1) 
1 2 F(1) Poodle (1) 
8 4 .6 F(2),FS(5), Beagle {1); Irish Terrier (1); 
MC(1) Manchester Terrier (1); Mixed 
(1); Springer S�aniel (2); Poodle 
(1); West High and White Terrier 
(1) 
5 3 .2 F(3),FS(1),M(1) German Shepherd (1); Labrador 
Retriever {1); Mixed (1); Poodle 
(1); Saint Bernard (1) 
1 3 F(l) Mixed (1) 
Meao Na+ Meao K+ 
Diagnostic methods (number) (meq/L) (meq/L) 
Path (3) NR NR 
Eosinophilia(l);Na + IK + (1); 
urinary steroids(l) 
120 8.5 
Path (2) NR NR 
Path (1) NR NR 
Path (1) NR NR 
Path (1) NR NR 
Path(1) NR NR 
Path(1) NR NR 
Na+IK+(1); urinary chloride(1) 136 7.0 
Na+IK+(1); path(1); urinary NR NR 
ateroids (1) 
EKG (1); NA+IK+ (1); path (1) 130.5 8.2 
Path (2) NR NR 
Na+IK+ (I) 126 7.2 
EKG (3); Na+IK+ {8); path (3) 132.6 7.1 
EKG (2); hemogram (3); 1 19 .3 6.7 
Na+IK+ (S) 
EKG (I); Na+IK+ (1); path (1) 139 8.0 
Table 2.1 (continued) 
Year No. or Average 
of cases ages Mean Na+ Mean K+ 
report Author or report• reported (yr) Sexes (number) Breeds (number) Diagnostic: methods (number) (meq/L) (meq/L) 
1973 Fox et at." 2 4.3 FS(2) Brittany (I); Dalmatian (I) Eosino�ilia (2); Na+IK+ (I); 
path (1 ; urinary steroids (I) 
130.5 7.1 
1974 Sanger et at.'" I 2.5 M(l) German Shepherd (I) Path (I) NR NR 
1975 Musselman'� I 3 F(l) Mixed (I) EKG (I); urinary steroids (1); 
water-loading test (I) 
NR NR 
1975 O'Rourke10 2 4.5 FS(2) Mixed(2) Na+IK+ (2) 127 1.5 
1976 Harlton10 1 4 M(l) Poodle (1) Na+IK+ (1) 1 14 6.0 
1977 Feldman et al.'' I I  4.3 F(3),FS(4),M(4) German Shepherd (I); Golden 
Retriever (2); Great Dane (2); 
Mixed (I); Poodle (3); Samoyed 
ACI'H stim (1 1) 133.1t 6.8t 
(1); Schnauzer (1) 
19n Feldman et al.02 I 4 FS(1) Australian Terrier (I) ACI'H stim (I); EKG (1); 1 19 8.6 
N 
Na+IK+ (I); plasma ACI'H (1) 
N 1978 Bath et al.11 3 4.4 F(I),FS(2) Mixed (2); Welsh Corgi (I) H�oglycemia (I); Na+IK+ (3); 121.3 7.2 
pa (1); uremia (1) 
1978 Feldman et al.'" 8 4.1 F(1),FS(4),M(3) German Shepherd (I); Golden ACI'H stim (8) NR NR 
Retriever {1); Great Dane (1); 
Irish Setter (I); Mixed (2); 
Poodle (I); Samoyed (I) 
1978 Reimers et at • ..,, 2 8.5 F(1),FS(1) Cockapoo (1); Poodle (I) EKG (2); NA+IK+ (2) 120 8.8 
1979 Atwell et al.10 I 7 M(1) Mixed (1) EKG (1); eosinophilia (I); 132 9.3 
hemogram (1); NA+IK+ (1); 
uremia (I) 
1979 Crensbaw215 1 6 FS(I) Mixed (1) Na+IK+ (1); uremia (1) 133 7.4 
1979 Hil11' 5 4.5 F(I),FS(3),M(1) Kelpie (I); Mixed (3); Welsh 
Corgi {I) 
Na+IK+ (S) 121.6 7.4 
1980 DiBartola21 3 3.7 F(1),FS(1),M(I) Mixed (I); Poodle (1); 
Weimaraner (I) 
EKG (3); ACI'H atim (1) 122 9.5 
1980 Murrell'" I s F(l) Mixed (1) NA+IK+ (1) 124 6.4 
1980 Willard'" 1 6 FS(I) Mixed (1) ACTH atim (I); Na+/K+ (I) 126 5.0 
1981 Rogers et ai.U' 3 6.7 FS(I),M(2) Poodle (1); Pointer (I); Wheaten ACTH atim (3) 144.7 4.6 
Terrier (1) 
Table 2.1 (continued) 
Year No. of Average 
or cases ages Mean Na+ Mean K+ 
report Author or report• reported (yr) Sexes (number) Breecb (number) Diagnostic methods (number) (meq/L) (meq/L) 
1982 Willard et a1.244 37 4.2 F(6),FS(l9), NR (37) ACI'H atim (16); Na+IK+ (17); 129 7.4 
M(7),MC(5) path (4) 
1983 Schaer et at • .., 13 4.5 F(3),FS(3),M(7) Boston Terrier (I); Cocker ACI'H slim (13) 140,4 6.2 
Spaniel (I); Dachshund (I); 
Doberman Pinscher (3); German 
Shorthaired Pointer (I); Irish 
Setter (I); Mixed (I); Poodle (2); 
Schnauzer (I); Whippet (I) 
1984 Rakich ct at.1SJ 23 4.1 F(4),FS(12), 
M(4), MC(3) 
Mixed (5); NR (18) ACI'H stim (18); Na+IK+ (17) 131 7.0 
1985 Auge11 1 5 M(l) Poodle (I) EKG (I); Na+IK+ (I) 1 16 8.4 
1985 Ruben et at.171 I 0.2 F(l) Lhasa Apao (1) ACI'H atim (I); path (1) NR NR 
N 1986 Schaer et at.•M 3 3 .9 FS(l),M(l),MC Dachshund (I); Shar Pei (I); ACI'H slim (3); path (I) 1 14.5 6.6 IJ.J 
(I) Weimaraner (I) 
1987 Burrows"' I 0.8 M(l) Shar Pel (I) ACI'H atim (1) 123 6.4 
1989 Joaeph16 1 6 FS(l) Collie (I) Na+IK+ (I) 128 10.8 
1991 Lynn et al.100* 21 4.1 F(l),FS(l l), 
M(2), MC(7) 
Airedale Terrier (I); Cocker ACI'H atim (21); Na+IK+ (21) 131.2 7.3 
Spaniel (1); Dalmatian (1); 
German Shepherd (3); Golden 
Retriever (I); Kuvaaz (I); 
Labrador Retriever (3); Maltese 
(1); Mixed (1); Poodle (3); Rat 
Terrier (1); Rottweiler (2); 
Scottish Terrier (I); Welsh Coral 
(I) 
1992 Bartgea et al.12 1 5 FS(l )  Poodle (I) ACI'H slim (I); eosinophilia (I) ISO 4.8 
Table 2.1 (continued) 
Year No. or Average 
or cases ages Mean Na+ Mean K+ 
report Author of report• reported (yr) Sexes (number) Breeds (number) Diagnostic methods (number) (meqfL) (meqfL) 
1993 Lynn et al.10't 60 4.6 F(3),FS(34), Alaskan Malamute (I); Basset ACTH slim (60); Na+IK+ (60); 128.3 7.2 
M(S), MC(IS) Hound (2); Brittany (I); Cairn plasma ACTH (14) 
Terrier (I); Collie (1); 
Dachshund (2); Doberman 
Pinscher (4); German Shepherd 
(4); German Shorthaired Pointer 
(3); Golden Retriever (1); Great 
Pyrennea (I); Labrador Retriever 
(9); Mastiff (1); Mixed (1 1); 
Poodle (6); Pointer (I); 
Portuguese Water Dog (2); 
Rottweiler (3); Samoycd (I); 
Welsh Colli (1); West Hi,hland 
White Tomer (3); Yorkshtre 
Terrier (1) 
� 1993 Medinger et al • .u 3 4 F(l),FS(2) Chesapeake Bay Retriever (I); Fox Terrier (1); Great Pyrenncs 
(I) 
ACTH stlm (3) 123.3 6.4 
1994 Levy'' 1 6 F(l) Poodle (1) ACTH stim (I) 135 7.5 
� 
Table 2.1 (continued) 
Year 
or 






• Superscript indicates reference number. 








* Some breed information obtained by direct communication with the authors, 
Breeds (number) 
Airedale Terrier (1); Alaskan 
Malamute (1); Australian Terrier 
(1); Basset Hound (2); Beagle 
(2); Boston Terrier (1); Boxer 
(1); Brittany (2); Cairn Terrier 
(1 ); Chesapeake Bay Retriever 
(1); Coekapoo (1); Cocker 
Spaniel (4); Collie (2); 
Dachshund (4); Dalmatian (2); 
Doberman Pinscher (7); Fox 
Terrier (1); Oerman Shepherd 
(13); Oerman Shorthaired Pointer 
(4); Oolden Retriever (S); Oordon 
Setter (1); Oreal Dane (3); Oreal 
Pyrennes (2); Irish Setter (2); 
Irish Terrier (I); Kelpie (I); 
Kuvaaz (1); Lnbrador Retriever 
(13); IJ!osa Apso (1); Maltese 
(1); Manchester Temer (I); 
Mastiff (I); Mixed (40); NR (58); 
Pointer (2); Poodle (2S); 
Portuguese Water Dog (2); Rat 
Terrier (I); Rottweiler (S); Saint 
Bernard (2); Somoyed (3); 
Schnauzer (2); Scouish Terrier 
(1}; Shar Pei (2); Springer 
Spaniel (2); Weimaraner (2); 
Welsh Colli (5); West Highland 
White Temer (5); Wheaten 
Terrier (I); Whippet (I); 
Yorkshire Terrier (1) 
f Mean of 220 cases; normal sodium 136.0-150.0 meq/L;"1•41 normal potassium 3.5-S.O meq/L,••,., 
Diagnostic methods (number) 
ACTH slim (163); EKO (16); 
eosinophilia (5); hemogram (4); 
hypoglycemia (I); Na+IK+ 
(155); path (27); plasma ACTH 
(15); plasma c:ortJcoids (2); 
uremia (3); urinary chloride (I); 
urinary eteroids (5); water­







iatrogenic origin, seven due to treatment with o,p' -DDD and 28 due to treatment 
with glucocorticoids. 183 Similarly, three iatrogenic cases were excluded from 
another report. 45 One report was excluded because the cases all came from the 
same family of Standard Poodles. 192 Another was excluded because the endocrine 
characteristics of the reported case were confounded with those of canine 
distemper. 24 
Sex of the dog was classified as female, female-spayed, male, or male­
castrated. If an individual dog was reported as being "male," it was considered to 
be uncastrated. Similarly, "female" was considered to be unspayed. Two reports, 
Willard et al. (1982) and Rakich et al. (1984), reported 37 and 23 dogs, 
respectively, as all being either male or female. Since any group of 37 or 23 
clinically ill dogs is likely to have at least a few castrated or spayed individuals, 
it was assumed that these authors did not distinguish in their report between altered 
and intact patients. Therefore, these studies were not included in calculations 
regarding sex. 
One report was not included in the clinical findings data since it reported no 
clinical findings. 46 Another report did not separate clinical findings between 
naturally-occurring and iatrogenic cases, so the assumption was made that the 
number of cases with a particular clinical finding was distributed proportionally 
between naturally-occurring and iatrogenic cases. 45 
Since the reports generally did not distinguish among Toy, Miniature, and 
Standard Poodles, all Poodles have been reported as one breed. Similarly, since 
26 
the reports did not distinguish among Miniature, Standard, and Giant Schnauzers, 
all Schnauzers have been reported as one breed. Clinical signs and response to 
therapy were not included as methods of diagnosis because they were presumed 
to always be consistent with the diagnosis. 
Results, Discussion, and Conclusions 
Cases 
The year the report was published, author, number of cases reported, average 
ages, sexes, breeds, diagnostic methods, mean serum sodium concentration, and 
mean serum potassium concentrations are included in Table 2. 1 .  Two hundred 
forty-four cases from 46 reports were reviewed. Thirty-eight (82.6 %) of the 46 
reports described five or fewer cases each, for a total of 63 (25. 8 %) of the 244 
total cases. 9-14,20.26-28,36,42,43,59,68, 10, 75,83,86,87 ,92,95,1 19,127 ,133, 135,136,142,153,155, 163, 171,176, 184,193,194, 
222.244 Eight of the reports accounted for the remaining 181  (74.2%) 
cases.45•46•104•105•134•152•183•246 One hundred sixty-nine (69.3 %) cases were reported 
after 1980. 
Ages 
The average age was 4.3 yr for all dogs. The range of average ages for the 
46 studies was 0.2 yr to 12.0 yr, with a mean of 4.3 yr. This suggested that canine 
hypoadrenocorticism can occur in dogs of any age, with an average age between 
4 and 5 yr. 
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Sexes 
Sex was reported for 184 (75.4%) of the cases with 41 (22.3 %) male-intact, 
24 (13 .0%) male-castrated, 3 1  (16.8%) female-intact, and 88 (47.8 %) female­
spayed (Table 2.2) .  However, without data about the sex distribution in the entire 
dog population, the assertion that canine hypoadrenocorticism is typically a disease 
of the female dog41•43•189 remains to be proved. One report, which did include 
controls representing the entire dog population, concluded that females were more 
likely to develop this disease. 148 
Breeds 
Breed was reported for 186 (76.2%) of the cases, and 50 breeds were 
represented (Table 2.3). The most frequently reported purebreds (%) were Poodle 
(13.4), German Shepherd (7.0), Labrador Retriever (7.0) ,  Doberman Pinscher 
(3 .8), Golden Retriever (2.7), Rottweiler (2.7), Welsh Corgi (2.7) ,  and West 
Highland White Terrier (2.7) . The breed data established that canine 
hypoadrenocorticism can occur in many different breeds.  As with sex, however, 
without data about the proportion of each of these breeds in the entire dog 
population, any conclusions about breed predispositions need to be proved. 
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Table 2.2. Sexes of 184 Reported Cases of Naturally Occurring Canine 
Hypoadrenocorticism * 
Sex Number Percent 
Female-intact 3 1  16.8 
Female-spayed 88 47.8  
All females 1 19 64.7 
Male-intact 41 22.3 
Male-castrated 24 13.0 
All males 65 35.3 
All dogs 184 100.0 
*Two re�orts152.246 were excluded because they apparently did not distinguish 
neutered from intact dogs. 
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Table 2.3. Breeds of 186 RepoiUd Cues of Naturally Occurring Canine Hypoadn:nocorticism• 
Breed Number Pen:eot 
Airedale Terrier 0.5 
Alaskan Malamule 0.5 
Australian Terrier o.s 
Basset Hound 2 1.1 
Beagle 2 1.1 
Boston Terrier o.s 
Boxer o.s 
Brittany 2 1 . 1  
Cairn Terrier 0.5 
Chesapeake Bay Retriever o.s 
Cockspoo o.s 
Cocker Spaniel 4 2.2 
Collie 2 1 . 1  
Dachshund 4 2.2 
Dalmatian 2 1 . 1  
Doberman Pinscher 7 3.8 
Fox Terrier 0.5 
German Shepherd 13 7.0 
German Shorthaired Pointer 4 2.2 
Golden Retriever s 2.7 
Gordon Scuer 0.5 
Great Dane 3 1 .6 
Great Pyrenncs 2 1 . 1  
Irish Scaer 2 1.1 
Irish Terrier 0.5 
Kelpie o.s 
Kuvasz 0.5 
Labrador Retriever 13 7.0 
Lhasa Apso 0.5 
Maltese o.s 
Manchester Terrier 0.5 
Mastiff o.s 
Mixed 40 21.5 
Poineer 2 1 . 1  
Poodle 25 13.4 
Portuguese Water Dog 2 1.1  
Rat Terrier 0.5 
Rottweiler s 2.7 
30 







































Thirteen different diagnostic methods (in addition to clinical signs and 
response to therapy) were used to diagnose canine hypoadrenocorticism (Table 
2.4). The antemortem diagnostic acumen of veterinary practitioners who reported 
their results to professional publications, as well as the availability and accessibility 
of laboratory tests, has apparently improved with time. Diagnosis of the earliest 
reported cases was based largely on necropsy findings. With few 
exceptions, 11•86•152•246 all cases reported after 1980 were diagnosed using the ACTH 
stimulation test, the definitive test. 95•104•105 
Serum Sodium and Potassium Concentrations 
The mean sodium concentration was 129.4 meq/L with range from 1 14.0-
150.0 meq/L, and the mean potassium concentration was 7.2 meq/L with range 
from 4.6-10.8 meq/L. The mean sodium to potassium ratio (obtained by dividing 
129.4 by 7.2) was 18.0, well below the published diagnostic criterion of 27.0 or 
less suggested by two references,43•189 and also below the diagnostic criterion of 
25.0 or less suggested by another.129 So sodium to potassium ratio seemed a 
useful, though not definitive, diagnostic criterion. Other conditions such as 
chylothorax245 and gastrointestinal disease29 can produce hyponatremia and 
hyperkalemia. 
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Table 2.4. Methods Used to Diagnose 244 Reported Cases of Naturally Occurring 
Canine Hypoadrenocorticism* 
Method Number Percent 
ACTH stimulation test 163 66.8 
Electrocardiogram 16 6.6 
Eosinophilia 5 2.0 
Hemogram 4 1 .6 
Hypoglycemia 1 0.4 
Na+IK.+ ** 155 63.5 
Path*** 27 1 1 . 1  
Plasma ACTH 15 6 . 1  
Plasma corticoids 2 0.8 
Uremia 3 1 .2 
Urinary chloride 1 0.4 
Urinary steroids 5 2.0 
Water loading test 1 0.4 
*Excluding "clinical signs" and "response to therapy. "  
**Na + /K. + = Diagnosis by serum sodium or potassium concentration, or the 
ratio of sodium to potassium. 
***Path = Gross and/or microscopic pathology. 
33 
Clinical Findings 
Clinical findings frequently reported are tabulated in Table 2.5. The seven 
most frequently reported (%) were anorexia (73.7), vomiting (64.0), depression 
(61 .0) ,  weakness (54.2), weight loss (36.9), azotemia (25.8),  and diarrhea (25.0).  
Other less frequently observed clinical findings included changes in skin and hair, 
microcardia, muscle atrophy, limb stiffness, panting, and hematuria. Table 2.5 
should be useful to the veterinary clinician since it provides a picture of what 
clinical findings to expect from a hypoadrenal dog. 
Treatment 
Treatment may be on an emergency basis to deal with a hypoadrenal crisis, 
and maintenance to correct mineralocorticoid and glucocorticoid deficits on a long­
term basis. The following is a composite treatment plan gleaned from the review 
of the canine hypoadrenocorticism literature. 
Emergency treatment must be tailored to each individually evaluated patient. 
It generally consists of isotonic intravenous saline solution to correct hyponatremia, 
hyperkalemia, and hypovolemia, and the immediate initiation of glucocorticoid and 
mineralocorticoid therapy. 86 Intravenous sodium bicarbonate may be used to 
correct metabolic acidosis and to lower serum potassium levels.28 A simple lead 
II electrocardiogram can be used to monitor the patient's response to treatment for 
hyperkalemia.28•86 As hyperkalemia is reduced, peaked T waves become less 
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Table 2.5. Clinical Findings for 236 Reported Cases of Naturally 
Occurring Canine Hypoadrenocorticism* 
Clinical fmding Number Percent 
Anorexia 174 73 .7 
Vomiting 151 64.0 
Depression 144 61 .0 
Weakness 128 54.2 
Weight loss 87 36.9 
Azotemia 61 25.8  
Diarrhea 59 25.0 
Dehydration 51  21 .6 
Polyuria or polydipsia 34 14.4 
Shock or collapse 34 14.4 
Bradycardia or arrhythmia 3 1  13 . 1 
Shaking or trembling 25 10.6 
Ataxia or seizures 13 5.5 
Gastroenteritis or abdominal pain 12 5 . 1 
*Includes only 236 of 244 reported cases because one report46 of eight 
cases did not report any clinical findings. 
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apparent, the amplitude of P and R waves will increase, the PR and QT intervals 
will decrease, and bradycardia, if present, will subside.28 Intravenous 2.5 or 5.0% 
dextrose solution can carefully be used in the hypoglycemic patient, recognizing 
that the use of hypertonic solutions may cause or exacerbate dehydration. 86•95 
Maintenance therapy requires that the glucocorticoid and mineralocorticoid 
deficits be corrected. Mineralocorticoid activity may be obtained by administering 
fludrocortisone acetate orally daily or microcrystalline desoxycorticosterone 
pivalate (DOCP) intramuscularly about once a month. 28•95 The oral and parenteral 
routes each have obvious advantages and disadvantages to the clinician and client. 
Either drug may require additional glucocorticoid supplementation, such as 
prednisone, though fludrocortisone acetate has greater glucocorticoid activity. 95 
Some dogs do not respond adequately to fludrocortisone acetate and should be 
treated with DOCP, 95 which has near universal efficacy. 104•105 Maintenance therapy 
should be tailored to the individual patient's response, both general health and 
serum sodium and potassium concentrations, and to the convenience of the 
clinician and client. 
36 
CHAPfER 3 
DESCRIPI10N OF CASES OF CANINE 
HYPOADRENOCORTICISM ENROLLED IN THE 
CLINICAL TRIAL OF MICROCRYSTALLINE 
DESOXYCORTICOSTERONE PIVALATE 
Introduction 
This chapter has two purposes. First, it will review cases of canine 
hypoadrenocorticism which were enrolled in a clinical trial of microcrystalline 
desoxycorticosterone pivalate (DOCP), a mineralocorticoid drug used to treat the 
disease. This review will provide descriptive data about ages at diagnosis, breeds, 
sexes, body weights, serum sodium and potassium concentrations, and clinical 
findings for the hypoadrenal dogs in the clinical trial. Second, this chapter will 
compare two different case definitions, one which required a definitive 
adrenocorticotropic honnone (ACTH) stimulation test to confirm the diagnosis of 
hypoadrenocorticism, and a second unconfirmed diagnosis which required only that 
the veterinarian diagnosed the disease regardless of the diagnostic method. This 
chapter will examine the question whether for epidemiologic studies of canine 
hypoadrenocorticism it was necessary to use the definitive, confirmed, ACTH 
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stimulation testm as a case definition, or whether the less exacting, unconfirmed 
case definition using only the veterinarian's judgment was satisfactory. If the 
results were different or equivocal, depending on the definition, then clearly the 
confirmed ACTH stimulation test definition must be used, despite its expense, 
inconvenience, and fewer case numbers. If, on the other hand, the results were the 
same, or nearly so, regardless of case definition, then the unconfirmed definition 
using only the veterinarian's judgment could be used, thereby gaining in cost­
effectiveness, convenience, and the number of cases available for study. 
Methods 
Data on 506 cases of naturally occurring canine hypoadrenocorticism were 
compiled between April 18, 1989, and December 3 1 ,  1991 ,  in a clinical trial 
conducted by Ciba Animal Health to test the efficacy of DOCP. Three hundred 
ninety-four investigating veterinarians from 367 veterinary hospitals and clinics in 
the United States and Canada participated in the clinical trial. Veterinarians were 
enrolled if they requested DOCP to treat a patient from Ciba Animal Health, and 
were willing to participate in the clinical trial. The veterinarian's diagnosis of 
hypoadrenocorticism, regardless of the basis for the diagnosis, was satisfactory for 
entry in the clinical trial. Most of the diagnoses were made using either the ACTH 
mDemonstrating a lack of cortisol response to ACTH stimulation. 
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stimulation test or diagnostic serum sodium and potassium concentrations. The 
drug could not be obtained without enrollment in the clinical trial. Patient 
information obtained during the trial included age at diagnosis, sex, breed, 
diagnostic method, serum sodium and potassium concentrations, ACTH stimulation 
test results, and clinical findings. 
A subset of 262 (51 .7%) of these 506 cases had confirmed diagnoses using 
the ACTH stimulation test. These cases came from 239 investigating veterinarians 
from 200 veterinary hospitals and clinics in 39 different states in the United States. 
A subset of 244 (48.2%) of these 506 cases were unconfirmed by the ACTH 
stimulation test, and the diagnosis was therefore based on the veterinarian's 
judgment. These cases came from 203 investigating veterinarians from 198 
veterinary hospitals and clinics in 42 different states in the United States and one 
province of Canada. All the data came from the clinical records of practicing 
veterinarians, and were therefore dependent on the accuracy of these records. 
Since veterinarians often did not distinguish among different Poodle (Toy, 
Miniature, or Standard) or Schnauzer (Miniature, Standard, or Giant) breeds, 




The following results (and the discussion that follows), except as noted, were 
for the 262 cases which had confirmed diagnoses using the ACTH stimulation test. 
Ages at Diagnosis 
The average age at diagnosis (Figure 3 . 1) was 4.9 yr (SD 3 .0) (SEM0 0.2) 
(Range 0.3 - 13 .0) .  
Breeds 
The breeds of the 262 dogs (Table 3 . 1) demonstrated that canine 
hypoadrenocorticism can occur in many breeds. The seven most frequently 
represented breeds (%) were Mixed (12.2), Poodle (1 1 .8) ,  German Shepherd 
(8 .4), Labrador Retriever (8 .0),  West Highland White Terrier (6.5), Golden 
Retriever (3.8), and Great Dane (3.8). 
Sexes 
The sexes (%) (Table 3 .2) of the 262 dogs were 16  (6. 1) female-intact, 162 
(61 .8) female-spayed, 34 (13 .0) male-intact, and 50 (19. 1) male-castrated. 
0Standard error of the mean (SEM) equals the standard deviation (SD) divided 
















<1 >a1 ,<2 >=2,<3 >a3,<4 >=4,<5 >=5,<6 >=6,<7 >=7,<8 >=8,<9 >=9,<10 >=10,<1 1 >=11 ,<1 2  >=12,<13 >=13,<14 
Age (yr) at Diagnosis of Dogs 
Mean (All Dogs) 4.9 yr (SD 3.0) (SEM 0.2) (Range 0.3-1 3.0) 
*Age at diagnosis was unavailable for 30 of the 262 cases. 
Figure 3. 1 .  Ages at Diagnosis of 232* Dogs with Canine Hypoadrenocorticism Enrolled in Clinical Trial 
Table 3 . 1 .  Breeds of 262 Dogs with Canine Hypoadrenocorticism Enrolled in Clinical Trial 
by Breed Group 
Breed Number Percent 
Poodles (roy, Miniature, and Standard) 3 1  1 1 .8  
Schnauzers (Miniature, Standard, and Giant) 3 1 . 1  
Toy breeds 
Chihuahua 2 0.8 
Shih Tzu 3 1 . 1  
Bichon Prise 2 0.8 
Maltese 1 0.4 
Pomeranian 1 0.4 
All toy breeds 9 3 .4 
Sporting breeds 
Labrador Retriever 21  8.0 
Golden Retriever 10 3.8 
Springer Spaniel 6 2.3 
Cocker Spaniel 8 3 . 1  
German Shorthaired Pointer 5 1 .9 
Chesapeake Bay Retriever 1 0.4 
Irish Setter 1 0.4 
English Setter 1 0.4 
Nova Scotian Duck Tolling Retriever 1 0.4 
Pointer 1 0.4 
Portuguese Water Dog 1 0.4 
Vizsla 1 0.4 
All sporting breeds 57 21 .8 
Hound breeds 
Dachshund 8 3 . 1  
Beagle 4 1 .5 
Basset Hound 6 2.3 
Afghan Hound 1 0.4 
Norwegian Elkhound 1 0.4 
Rhodesian Ridgeback 1 0.4 
Saluki 1 "0.4 
All hound breeds 22 8.4 
Non-sporting breeds 
Chow Chow 2 0.8 
Shar Pei 3 1 . 1  
Keeshond 1 0.4 
Lhasa Apso 1 0.4 
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Table 3 . 1  (continued) 
All non-sporting breeds 7 2.7 
Herding breeds 
German Shepherd 22 8.4 
Collie 3 1 . 1  
Australian Shepherd 2 0.8 
Welsh Corgi 1 0.4 
Bouvier des Flanders 1 0.4 
Old English Sheepdog 1 0.4 
All herding breeds 30 1 1 .5 
Working breeds 
Great Dane 10 3.8 
Doberman Pinscher 7 2.7 
Rottweiler 6 2.3 
Siberian Husky 4 1 .5 
Alaskan Malamute 3 1 . 1  
Akita 4 1 .5 
Saint Bernard 2 0.8 
All working breeds 36 13.7 
Terrier breeds 
West Highland White Terrier 17 6.5 
Airedale Terrier 4 1 .5 
Scottish Terrier 2 0.8 
Bull Terrier 1 0.4 
Fox Terrier 1 0.4 
Pit Bull Terrier 1 0.4 
Wheaten Terrier 1 . 0.4 
All terrier breeds 27 10.3 
Miscellaneous breeds 
Bearded Collie 5 1 .9 
Border Collie 3 1 . 1  
All miscellaneous breeds 8 3 . 1  
Mixed 32 12.2 
Total dogs 262 100.0 
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Table 3 .2 .  Sexes of 262 Cases of Canine Hypoadrenocorticism Enrolled in Clinical Trial 
Sex Number Percent 
Female-intact 16 6. 1 
Female-spayed 162 61 .8 
All females 178 67.9 
Male-intact 34 13.0 
Male-castrated 50 19. 1 
All males 84 32. 1 
All dogs 262 100.0 
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Body Weights 
Body weights (Figure 3 .2) averaged 23.4 kg (SO 13 .6) (SEM 0.8) (Range 
2.7 - 72.7). 
Serum Sodium and Potassium Concentrations 
Two hundred forty-nine (95.0%) of the 262 cases had their serum sodium 
and potassium concentrations determined. Table 3.3 presents these results with the 
sodium to potassium ratio. The mean sodium concentration was 131 .8  meq!L (SO 
9.4) (SEM 0.6) (Range 104.0 - 174.0) (Normal 136.0 - 150.0'"•43}, the mean 
potassium concentration was 6.8 meq/L (SD 1 .3) (SEM 0. 1) (Range 3 .2 - 12.8) 
(Normal 3.5 - 5.041•43}, and the mean sodium to potassium ratio was 20.2 (SO 4.8) 
(SEM 0.3) (Range 10.5 - 38.8) (Normal ;;::27.041•43•189 or ;;::25.012�. 
Clinical Findings 
Clinical findings were tabulated for the 262 cases and are displayed in Table 
3 .4. The seven most frequently reported, in order of decreasing frequency, were 
vomiting (28.2%), anorexia (19.5 %), depression (18.3 %), weakness (14. 1 %), 
weight loss (1 1 . 1  %), diarrhea (9.2%}, and bradycardia or arrhythmia (6.5 %). 
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Figure 3 .2. Body Weights of 262 Dogs with Canine Hypoadrenocorticism Enrolled in Clinical Trial 
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Table 3.3.  Serum Sodium and Potassium Concentrations and Sodium/Potassium Ratios for 249* Dogs with Canine Hypoadrenocorticism 
Enrolled in Clinical Trial 
Sodium Potassium 
(meq/L) Number Percent (meq/L) Number Percent 
> 100, � 1 10 6 2.4 > 3, �4 5 2.0 
> 1 10, � 120 1 8  7.2 > 4, �5 1 5  6.0 
> 120, � 130 79 3 1 .7 > 5, �6 47 1 8.9 
> 130, � 140 106 42.6 > 6, �7 85 34. 1 
> 140, � 150 36 14.5 > 7, � 8  56 22.5 
< 150 4 1 .6 > 8, �9 29 1 1 .6 
> 9. � 10 1 1  4.4 
> 10  1 0.4 
I 
Mean 1 3 1 .8 Mean 6.8 
SD 9.4 SD 1 .3 
SEM 0.6 SEM 0. 1 
Range 104.0 - 174.0 
Normal 136.0 - 150.Q41•43 
Range 3.2 - 12.8 
Normal 3 .5 - 5 .Q41•43 
Number below normal 1 7 1  (68.7%) Number below normal 1 �.4%) 
Number normal 74 (29.7%) Number normal 19  (7.6% 
Number above normal 4 (1 .6%) Number above normal 22 
(92.0%) 
*Serum sodium and potassium concentrations were not reported for 13 of the 262 cases. 
Sodium 
potassium ratio•• Number Percent 
10. 1 - 15.0 2 1  
15. 1 - 20.0 123 
20. 1 - 25.0 76 
25. 1 - 30.0 15 
30. 1 - 35.0 10 




Range 10.5 - 38.8 
Normal � 27 .Q41•43•189 or � 25.0129 







(91 .6%)***; 2 19 �8.0%)**** 
Number normal 2 1  ( .4%)***; 30 
(12.0% )**** 
**Twenty-one (8.4%) of the sodium/potassium ratios exceeded 27 .0. A ratio below 27.0 is sometimes considered diagnostic of 
canine hypoadrenocorttcism. 41•43•189 Twenty-nine (1 1 .6%) of the ratios exceeded 25.0, the diagnostic criterion suggested by a 
commonly used reference. 129 
***A sodium to potassium ratio � 27.0 was considered normal. 41•43•189 
****A sodium to potassium ratio � 25.0 was considered normal.'29 
Table 3 .4. Clinical Findings* for 262 Cases of Canine Hypoadrenocorticism 
Enrolled in Clinical Trial 
Clinical f"mding Number Percent 
Vomiting 74 28.2 
Anorexia 51 19.5 
Depression 48 18.3 
Weakness 37 14. 1 
Weight loss 29 1 1 . 1  
Diarrhea 24 9.2 
Bradycardia or arrhythmia 17 6 .5 
Shock or collapse 15 5.7 
Shaking or trembling 1 1  4.2 
Azotemia 10 3 .8  
Gastroenteritis or abdominal pain 10 3 .8  
Polyuria or polydipsia 9 3 .4 
Dehydration 8 3 . 1  
*Includes those clinical findings reported for five or more cases. 
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Efficacy of Microcrystalline Desoxycorticosterone Pivalate 
When simply asked whether or not DOCP was effective, veterinarians 
responded yes for 260 (99.2%) of the 262 cases. 
Discussion 
Ages at Diagnosis 
The average age at diagnosis was 4.9 yr (SD 3 .0) (SEM 0.2) (Range 0.3 -
13.0) (Figure 3 . 1) .  These results suggested that the average age at diagnosis for 
canine hypoadrenocorticism was about five years, but, notably, could vary from 
very young to very old dogs. This was consistent with the estimate provided in a 
well-known veterinary reference. 43 
Breeds 
The seven most frequently reported breeds afflicted with canine 
hypoadrenocorticism were, in order of frequency from most to least frequent: 
Mixed, Poodle, German Shepherd, Labrador Retriever, West Highland White 
Terrier, Golden Retriever, and Great Dane {Table 3. 1). These results demonstrated 
that canine hypoadrenocorticism can occur in many different breeds. Without data 
about breed distribution in the entire dog population, whether or not these breeds 
are predisposed to adrenal insufficiency cannot be determined. 
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Sexes 
The sexes of dogs (percent) were female-intact (6. 1), female-spayed (61 . 8), 
male-intact (13.0),  and male-castrated (19. 1) (Table 3 .2) . Thus females, both intact 
and spayed, made up about 70% of the hypoadrenal patients . This was consistent 
with two veterinary references which found that 70%43 and 76%41 were female. 
However, without data about sex distribution in the entire dog population, the 
assertion that canine hypoadrenocorticism is typically a disease of the female 
dog41•43 remains to be proved. One report, which did consider the sex distribution 
in the entire dog pop:ulation, concluded that females were more likely to develop 
this disease. 148 (This will be discussed at some length in succeeding chapters.) 
Body Weights 
Body weights averaged 23.4 kg (SD 13.6) (SEM 0.8) (Range 2.7 - 72.7) . 
(Figure 3 .2). This established pretty convincingly that canine hypoadrenocorticism 
occurs in all sizes of dogs, and confirmed the previously reported assertion that 
the disease can affect dogs of any size. 41•43 
Serum Sodium and Potassium Concentrations 
The sodium, potassium, and sodium to potassium ratio were, respectively, 
131 .8 (SD 9.4) (SEM 0.6) (Range 104.0-174.0), 6.8 (SD 1 .3) (SEM 0 . 1) (Range 
3 .2 - 12.8), and 20.2 (SD 4.8) (SEM 0.3) (Range 10.5 - 38.8) (Table 3 .3). The 
normal values for sodium, potassium, and sodium to potassium ratio are, 
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respectively, 136.0 - 150.0,41•43 3.5 - 5.0,41•43 and �27.0'41•43•189 or �25.0. 129 So, 
the means of these diagnostic indicators were consistent with the hyponatremia and 
hyperkalemia expected in the hypoadrenal patient. 41•43•129 However, it is important 
to note that 74 (29.7 %) of the patients had normal sodium concentrations, 19 
(7.6%) had normal potassium concentrations, and 29 (1 1 .6%) (using diagnostic 
criterion �25.0) or 21 (8 .4%) (using diagnostic criterion �27.0) had normal 
sodium to potassium ratios. These results suggested that normal sodium and 
potassium values in a clinical patient do not eliminate the possibility that the dog 
suffers from an adrenal insufficiency. They also raised the interesting question as 
to how many dogs had normal electrolyte values for all three diagnostic indicators-
-sodium concentration, potassium concentration, and sodium to potassium ratio. 
The answer was 13 (5 .2%) of 249° were normal for all three diagnostic 
indicators, P suggesting that a veterinarian pondering a list of differential diagnoses 
can usually eliminate hypoadrenocorticism based on normal sodium and potassium 
results. It is important to recognize that the truth of the converse is unknown based 
on these data; i.e. , abnormal sodium and potassium results which are consistent 
with hypoadrenocorticism do not necessarily make the diagnosis. 
00f the 262 cases with valid ACTH stimulation test results, 249 also had 
sodium and potassium concentrations determined; therefore, 13/249 = 0.052 = 
5.2% is the meaningful datum. 
PUsing either the >25.0 or the �27.0 diagnostic criterion. 
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Clinical Findings 
The six most frequently reported clinical findings were vomiting, anorexia, 
depression, weakness, weight loss, and diarrhea (Table 3 .4) . Others included 
bradycardia or arrhythmia, shock or collapse, shaking or trembling, azotemia, 
gastroenteritis or abdominal pain, polyuria or polydipsia, and dehydration (Table 
3 .4) . This provided a reasonably comprehensive list of the clinical findings 
associated with adrenal insufficiency in the dog when compared to other accounts 
of the disease.44 
Efficacy of Microcrystalline Desoxycorticosterone Pivalate 
Since the veterinarians concluded that DOCP was effective in 99.2% of these 
cases, it seemed clear that the drug was efficacious . This has been reported before, 
but in much smaller groups of dogs. 104•105 
Case Definition in Epidemiologic Studies of Canine Hypoadrenocorticism 
To help answer the question if, for epidemiologic studies of canine 
hypoadrenocorticism, it matters whether the ACTH stimulation test (confirmed 
diagnosis) or the veterinarian's judgment (unconfirmed diagnosis) was used as a 
case definition, a side-by-side comparison of ages at diagnosis, breeds, sexes, body 
weights, serum sodium and potassium concentrations, and clinical findings is made 
in Table 3 .5. An examination of Table 3 .5 revealed that the results were virtually 
identical regardless of which definition was chosen. Age at diagnosis (yr) was 5. 1 
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Table 3.5. Comparison of Results Using Two Different Case Definitions for Cases of Canine Hypoadrenocorticism Enrolled in Clinical Trial 
Result 

















Unconfinned diagnosis* (n=244) Confinned diagnosis** (n=262) 
5. 1 *** (SO 2.9) (SEM 0.2) (Range 0.2 - 15.5) 
Poodle (22.5) 
Mixed (14.8) 
Labrador Retriever (10.2) 
Golden Retriever (6.6) 
West Highland White Terrier (6. 1) 
German Shepherd (4.5) 
Springer Spaniel (4. 1) 
Female-intact (7 .8) 
Female-spayed (67 .6) 
All females (75.4) 
Male-intact (8.6) 
Male-castrated (16.0) 
All males (24.6) 
21 .4 (SO 13.3) (SEM 0.9) (Range 2.7 - 75.0) 
Sodium (meq/L) 129.2 (SD 9.9) (SEM 0.7) (Range 104.0 - 159.0) 
Potassium (meq/L) 7.0 (SD 1 .3) (SEM 0.1)  (Range 4.0 - 1 1 .0) 





Diarrhea ( 12.3) . 
Bradrcardia or arrhythmia (6.6) 
Shakmg or trembling (6. 1) 
4.9*** (SO 3.0) (SEM 0.2) {Range 0.3 - 13.0) 
Mixed ( 12.2) 
Poodle (1 1 . 8) 
German Shepherd (8.4) 
Labrador Retriever (8.0) 
West Highland White Terrier (6.5) 
Golden Retriever (3.8) 
Great Dane (3.8) 
Female-intact (6. 1) 
Female-spayed (61 .8) 
All females (67 .9) 
Male-intact (13.0) 
Male-castrated (19. 1) 
All males (32. 1) 
23.4 (SD 13.6) (SEM 0.8) (Range 2.7 - 72.7) 
131 .8  (SO 9.4) (SEM 0.6) (Range 104.0 - 174.0) 
6.8 (SD 1 .3) (SEM 0. 1) (Range 3.2 - 12.8) 




Weakness ( 14. 1) 
Weight loss (1 1 . 1) 
Diarrhea (9.2) 
Bradycardia or arrhythmia (6.5) 
*A case was defmed as a dog which the veterinarian, for whatever reason, said bad bypoadrenocorticism. 
**A case was defmed as a dog which was diagnosed using the ACTH stimulation test. 
*"'*Not significantly different at p=0.05. 
*"'**Nonnal: sodium 136.0-150.0 meq/L;41•., potassium 3.5-5.0 meq/L;41•., sodium to potassium ratio :=:: 27.041•43•189 or :=: 25.0.129 
using the unconfirmed diagnosis, and 4.9 using the confirmed one; standard 
deviations, standard errors of the mean, and ranges were almost indistinguishable. 
Six of the seven most frequently afflicted breeds were the same. The sex 
distributions were very similar, and the sexes ranked from most to least frequently 
reported were identical for the unconfirmed and confirmed diagnosis: female­
spayed, male-castrated, male-intact, and female-intact. Average body weight (kg) 
differed by only two units, 23.4 using the confirmed diagnosis compared to 21 .4 
using the unconfirmed one; again, the standard deviations, standard errors of the 
mean, and ranges were virtually identical. Similarly, the results for serum sodium 
and potassium concentrations were, for all intents and purposes, the same. As with 
breeds, six of the seven most frequently reported clinical findings were the same, 
and the percentages of each clinical finding were quite consistent between the two 
definitions. Though the only way to definitively determine whether the 
veterinarians' diagnoses were accurate would be to test each dog individually with 
the ACTH stimulation test, these results suggested that, despite the probable 
presence of an inconsequential number of misdiagnoses when a less rigorous case 
definition is used, for epidemiologic studies of canine hypoadrenocorticism a 
rigorous case definition may be unnecessary. A less rigorous case definition would 
generally be more convenient and less costly. This recommendation cannot be 
generalized to other diseases . 
54 
Conclusions 
The following conclusions were based on all the cases reported, both 
confirmed and unconfirmed. 
1 .  Ages at Diagnosis. An estimated average age at diagnosis for hypoadrenal 
dogs was 5 yr, but the disease can occur in dogs of any age. 
2. Breeds. Poodle, Mixed, Labrador Retriever, German Shepherd, West 
Highland White Terrier, and Golden Retriever breeds seemed to have a propensity 
for developing hypoadrenocorticism. However, without data about the proportion 
of each of these breeds in the entire dog population, any conclusions about breed 
predispositions remain to be proved. (This issue will be explored in subsequent 
chapters.) 
3. Sexes. Females made up about 70% of hypoadrenal patients, and, of all 
females, about 90% of them were spayed. This was, again, consistent with the 
estimates that 70 %43 or 76 %41 of hypoadrenal patients are female, and with 
assertions that canine hypoadrenocorticism is typically a disease of the female 
dog. 41•43•93•148 Again, however, without data about the sex distribution in the entire 
dog population, these conclusions remain to be proved. (This issue will also be 
addressed in subsequent chapters .) 
4 .  Body Weights. An estimated average body weight for dogs with canine 
hypoadrenocorticism was 23 kg, but the disease can occur in dogs of any size. 
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5. Serum Sodium and Potassium Concentrations. Estimated average serum 
sodium and potassium concentrations (meq/L) were 130 and 7, respectively. An 
estimated average serum sodium to potassium ratio was 20. Nevertheless, 
hypoadrenal patients had abnormally low, normal, and abnormally high values for 
all three of these diagnostic indicators. Therefore, no single electrolyte indicator 
should be used for diagnosis. However, only about 5 %  of hypoadrenal patients 
were normal for all three diagnostic criteria, so a dog normal for all three is 
unlikely to be hypoadrenal. Conversely, sodium and potassium results consistent 
with adrenal insufficiency do not necessarily make the diagnosis. 
6.  Clinical Findings. The most common clinical findings in hypoadrenal dogs 
were vomiting, anorexia, weakness, depression, diarrhea, weight loss, shaking or 
trembling, and bradycardia or arrhythmia. 
7 .Efficacy of Microczystalline Desoxycorticosterone Pivalate. Based on 
reports from veterinarians, DOCP was very effective in the treatment of canine 
hypoadrenocorticism. 
8. Case Definition in Epidemiologic Studies of Canine Hypoadrenocorticism. 
Epidemiologic studies of canine hypoadrenocorticism may be conducted using the 
case definition that, if the veterinarian says a dog has adrenal insufficiency, then 
the diagnosis is made and the case definition satisfied. This will increase the 
number of cases included in epidemiologic studies, and make them less 
complicated, more convenient, and less costly. 
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CHAPfER 4 
THREE HUNDRED SEVENTY-SIX CASES DIAGNOSED 
BY VETERINARY COLLEGES AND A REFERRAL INSTITUTION 
Introduction 
Colleges of veterinary medicine and other veterinary referral hospitals 
typically maintain detailed case records. About two thirds of the colleges of 
veterinary medicine in the United States and Canada contribute case data to the 
Veterinary Medical Data Base (VMDB) at Purdue University, West Lafayette, 
Indiana. The remaining third of the colleges and the referral hospitals maintain 
their case data independently. These data are a rich source of information about 
canine hypoadrenocorticism, and this source was used to estimate the incidence 
and prevalence of canine hypoadrenocorticism; to describe the patients afflicted 
with the disease as to ages at diagnosis, sexes, breeds, serum sodium and 
potassium concentrations, and treatment; and to identify factors associated with the 
disease. 
Methods 
The VMDB was queried for all the data on hypoadrenal dogs submitted by 
participating universities during 1989, 1990, and 1991 . The data available included 
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university, patient identification number, discharge date, length of hospitalization, 
clinician, patient sex, species, breed� age, weight, diagnoses, and surgical 
procedures. Since information not available from the VMDB was needed, a 
collection form (Case Data Abstract Form, Appendix AI) was developed. 
Additional data obtained using this form included adrenocorticotropic hormone 
(ACTH) stimulation test results, serum sodium and potassium concentrations, other 
diagnoses, and whether the dogs had been treated with fludrocortisone acetate or 
microcrystalline desoxycorticosterone pivalate (DOCP). These forms were sent 
with a cover letter explaining the purpose of the request to the 20 universities in 
the United States and Canada known to have submitted cases of canine 
hypoadrenocorticism to the VMDB in 1989, 1990, or 1991 . 
Six universities and two veterinary referral hospitals which did not submit 
data to the VMDB during the years of interest were also queried. A Population 
Data Abstract Form (Appendix A2) and a modified Case Data Abstract Form 
(Appendix A3) were developed to obtain the data. Data requested included number 
of dogs seen during 1989, 1990, and 1991 by sex and breed if available, date of 
diagnosis, age .at diagnosis, sex, breed, ACTH stimulation test results, other 
diagnoses, and whether or not the dogs had been treated with fludrocortisone 
acetate or DOCP. These forms were sent with a cover letter explaining the purpose 
of the request. 
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Only data from institutions responding with data forms were included in the 
study. Non-responders were included for incidence and prevalence calculations if 
they had contributed valid case and population data to the VMDB, but failed to 
return data forms. 
Confidence intervals for odds ratios (OR) were calculated using Cornfield's 
approximation. 49 If Cornfield confidence limits were inexact, exact confidence 
limits were calculated. 128 Uncorrected chi-square statistics were reported.40 Fisher 
exact probability calculations for the 2x2 contingency tables were calculated when 
the expected value of a cell was less than five (Appendix B). 162 
The selected clinical findings were chosen either because of their anecdotal 
association with canine hypoadrenocorticism (they seemed from clinical experience 
to be associated with canine hypoadrenocorticism), or, since canine 
hypoadrenocorticism may be an autoimmune disease, 41 because of their putative 
autoimmune etiology. They were selected to investigate whether or not they were 
actually associated with hypoadrenocorticism in the dog. The list of selected 
clinical findings requested was not exhaustive. 
The VMDB coded ages into eight categories, zero through seven, rather than 
the specific age of each patient. Each category represented an age range. The 
midpoint of each range (yr) was used as the dog's age for this study. Table 4. 1 
includes the VMDB age codes, age code ranges, and the midrange ages used for 
this study. 
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Table 4. 1 .  Veterinary Medical Data Base (VMDB) Age Codes and Corresponding 
Midrange Ages Used in Veterinary College and Referral Institution Study of 
Canine Hypoadrenocorticism 
VMDB age code Age code range Midrange age used in 
study (yr) 
0 0 - 2 wk 0.019 
1 2 wk - 2 mo 0. 103 
2 2 - 6  mo 0.333 
3 6 - 12 mo 0.750 
4 1 - 2 yr 1 .500 
5 2 - 4  yr 3 .000 
6 4 - 7  yr 5.500 
7 7 - 10 yr 8 .500 
8 10 - 15 yr 12.500 
9 15  yr and older 15.000 
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Although the VMDB data distinguished among Toy, Miniature, and Standard 
Poodles, and among Miniature, Standard, and Giant Schnauzers, other data sets 
reported in subsequent chapters did not. Dogs were, for example, frequently 
reported as simply "Poodle" or "Schnauzer" without size specification. Therefore, 
to maintain consistency among data sets, all Poodles in each data set have been 
reported as one breed, and all Schnauzers have been reported as one breed. 
The VMDB was queried a second time for the years 1989, 1990, and 1991 
to gather data on seven diseases or other reasons for being taken to veterinary 
referral hospitals in dogs both with and without hypoadrenocorticism (natural or 
iatrogenic) . These seven--cataracts, dental tartar, fleas, heartworm infection, mitral 
insufficiency, rabies vaccination, and squamous cell carcinoma-were specifically 
chosen because they were, in the judgment of several veterinarians, probably not 
associated with hypoadrenocorticism. The data were collected as a check on 
methodology, since, hypothetically, these seven reasons for presentation of dogs 
should not have been related to hypoadrenocorticism. 
Results 
General 
Unless noted otherwise, all results are for naturally occurring cases (as 
opposed to iatrogenic). 
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Institutional Participants 
Nineteen of the 20 universities (Table 4.2) which submitted canine 
hypoadrenocorticism case data to the VMDB for 1989, 1990, or 1991  returned 
Case Data Abstract Forms. All six universities (Table 4.2) which did not submit 
data to the VMDB for 1989, 1990, or 1991 provided Case Data Abstract Forms, 
and five provided Population Data Abstract Forms. The Angell Memorial Animal 
Hospital provided Case Data Abstract Forms, but not a Population Data Abstract 
Form. Therefore, all English-speaking colleges of veterinary medicine in the 
United States and Canada, except one, which reported cases of canine 
hypoadrenocorticism in 1989, 1990, or 1991 ,  submitted data. 
Cases 
Three hundred seventy-six cases of canine hypoadrenocorticism were 
reported (Table 4.2). Two hundred ninety-one (77.4%) were from universities 
participating in the VMDB, and 85 (22.6%) were from non-participants. The total 
number of canine patients seen at each institution during 1989, 1990, and 1991,  
were available for 346 of the 376 cases. Three hundred forty-one of the cases were 
naturally occurring hypoadrenocorticism. Thirty-five were iatrogenically produced 
cases, virtually all of which were produced by treating hyperadrenocorticism 
(Cushing's disease) with 2,4'-dichlorodiphenyldichloroethane (o,p·-DDD). 
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Table 4.2. Universities and Veterinary Referral Hospitals in the United States and 
Canada Responding with Canine Hypoadrenocorticism Case Data for 1989-1991 
and Number of Cases Contributed* 
Participants in the Veterinary Medical Data 
Base 
Auburn University 
Colorado State University 
Florida, University of 
Georgia, University of 
lllinois, University of 
Iowa State University 
Kansas State University 
Michigan State University 
Minnesota, University of 
Missouri, University of 
Ohio State University 
Ontario Veterinary College 
Pennsylvania, University of 
Purdue U Diversity 
Saskatchewan, University of 
Tennessee, University of 
Texas A&M University 
Virginia Tech and University of Maryland 
W. • u . . f JSCODSJO, ntve[SJty 0 
Subtotal 
Non-narticipants in the Veterinary Medical 
Data Base 
Angell Memorial Animal Hospital 
California, University of 
Mississippi State University 
North Carolina State University 
Prince Edward Island, University of 
Tufts University 
Washington State University 
Subtotal 
Total 



































*Non-responders: Cornell University; Animal Medical Center, New York 
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Incidence and Prevalence Estimates 
Incidence and prevalence were estimated because measures of disease 
frequency are fundamental to the study of any disease, and because Ciba Animal 
Health requested the estimates in return for project support. Since incidence can 
only be determined prospectively, and since a prospective study of canine 
hypoadrenocorticism would be too costly, incidence was estimated retrospectively. 
Because the date of initial diagnosis could be easily retrieved from the VMDB, the 
strategy was to estimate incidence and then estimate prevalence using the incidence 
estimate and an estimate of average disease duration. Underlying the estimates is 
the understanding that the focus is on the population of dogs seen by veterinarians, 
not all dogs. The estimates are also based on the assumption that a dog with 
hypoadrenocorticism will be presented to a veterinarian since it will not recover 
spontaneously. 
Incidence was estimated using the total number of dogs initially diagnosed 
with hypoadrenocorticism during 1989, 1990, and 1991 divided by the total 
number of dogs seen by all the institutions in 1989, 1990, and 1991 .  Institutions 
which responded with case data, but not population data, were excluded. Cornell 
University, which had 39 cases but did not respond with data forms, was included 
in this computation because its number of cases and underlying population were 
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reported to VMDB. Since the VMDB does not distinguish between natural and 
iatrogenic cases, the assumption was made that the 39 Cornell cases were divided 
between natural and iatrogenic in the same proportions, 90.2% and 9.8 % ,  
respectively, as were the rest of the cases. This led to the computations below. 
Incidence estimate (natural cases) = 
Number of cases diagnosed + Number of cases diagnosed 
(all institutions except (Cornell University) 
Cornell University) 
Total dogs seen in 1989, 1990, 1991 (all institutions) 
312 + (.902) (39) 
- = 0.001674 = 0. 1674% 
207,388 
= 1 .7 cases/1 ,000 dogs/3 yr 
Adding iatrogenic cases yielded an incidence estimate (natural and iatrogenic cases) 
of 1 .9 cases/1000 dogs/3 yr. 
These incidence estimates were used with an estimate of average disease 
duration of 4.9 yr (see Chapter 5 for computation of this estimate). Prevalence 
estimates were computed using the following formula: 
Prevalence = (Incidence) (Average disease duration) 
This formula is well established in the epidemiologic literature as a method for 
estimating the prevalence of diseases which have a low prevalence and a stable 
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endemic rate of occurrence. 3•98•120•123•168.200.215.239 This led to the computation below. 
Prevalence estimate (natural cases) = 
[Incidence estimate (natural cases)] [Average disease duration] 
- (1 .7 cases/1000 dogs/3 yr) (4.9 yr) 
- 2.8 cases /1000 dogs 
The prevalence estimate (natural and iatrogenic cases) was 3 . 1  cases/1000 dogs. 
Sex-specific incidence estimates were calculated for naturally occurring cases. 
These incidence estimates were (number of cases of the particular sex/1000 dogs 
of that sex/3 yr) female-intact 1 .0, female-spayed 3.0, all females 2. 1 ,  male-intact 
0.7, male-castrated 1 .9, and all males 1 . 1  (Table 4.3).  The computation for 
female-intact follows to illustrate the computation method. 
Female-intact incidence estimate = 
Number of female-intact cases diagnosed 
Total female-intact dogs seen in 1989, 1990, 1991 (all institutions) 
43 = 0.000994 = 0.0994% 
43,249 
1 .0 case/1000 female-intact dogs/ 3 yr 
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Table 4.3. Sex-Specific Incidence Estimates of Naturally Occurring Canine 
Hypoadrenocorticism Seen in Veterinary Referral Hospitals in 1989-1991,  United 
States and Canada 
Number Sex-specific incidence 
Sex of cases estimate* 
Female-intact 43 1 .0 
Female-spayed 159 3 .0 
All females 202 2. 1 
Male-intact 40 0.7 
Male-castrated 55 1 .9 
All males 95 1 . 1  
*Expressed as number of cases of the particular sex with hypoadrenocorticism/ 
1000 dogs of that sex/3 yr. 
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Breed-specific incidence estimates were calculated for naturally occurring 
cases reported by 19 institutions which participated in the VMDB. These incidence 
estimates were calculated for the seven breeds most frequently affected with canine 
hypoadrenocorticism (see Breeds section which follows) . Incidence estimates were 
(number of diseased dogs of the particular breed/1 000 dogs of that breed/3 yr), in 
decreasing order, West Highland White Terrier 12.0, Great Dane 7.6, Poodle 4.9, 
Rottweiler 2.2, Mixed 1 .  7, German Shepherd 1 .2, and Labrador Retriever 0.9; the 
incidence estimate for all other breeds combined was 1 .4 (Table 4.4). 
Ages at Diagnosis 
Age at diagnosis (yr) was reported for 329 (96.5 %) of the 341 naturally 
occurring cases . It averaged 5.4 (SD 3 .2) (SEMq 0.2) (Range 0. 1 - 15.0).  Age is 
stratified by sex in Table 4.5. 
Age-specific OR were calculated for age at diagnosis (Table 4.6). These OR 
are based on all the cases submitted to the VMDB, except those from Cornell 
University, during 1989, 1990, and 1991 . 
qStandard error of the mean (SEM) equals the standard deviation (SD) divided 
by the square root of the sample size. 
68 
Table 4.4. Breed-Specific Incidence Estimates of Naturally Occurring Canine 
Hypoadrenocorticism Seen in Veterinary Referral Hospitals in 1989-1991,  United 
States and Canada 
Number Breed-specific 
Breed of cases incidence estimate* 
German Shepherd 9 1 .2 
Great Dane 10 7.6 
Labrador Retriever 9 0.9 
Mixed 58 1 .7 
Poodle 35 4.9 
Rottweiler 7 2.2 
West Highland White Terrier 12 12.0 
All other breeds 1 18  1 .4 
*Expressed as number of cases of a particular breed with hypoadrenocorticism/ 
1000 dogs of that breed/3 yr. 
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Table 4.5. Average Age at Diagnosis for 329 Naturally Occurring Cases of Canine 
Hypoadrenocorticism Seen in Veterinary Referral Hospitals in 1989-1991 , United 
States and Canada 
Average age at diagnosis 
Sexes of cases Number of cases (yr) (SD) (SEM) (Range) 
Female-intact 46 3.9 (2.5) (0.4) (0. 1  - 10.2) 
Female-spayed 176 5.9 (3 .2) (0.2) (1 .3 - 15.0) 
All females 222 5 .4 (3 .2) (0.2) (0. 1  - 15.0) 
Male-intact 40 5.2 (3 .6) (0.6) (0.8  - 15.0) 
Male-castrated 62 5.3 (3 . 1) (0.4) (0.7 - 12.5) 
All males 102 5.2 (3 .3) (0.3) (0. 7 - 15.0) 
All sexes* 329 5.4 (3 .2) (0.2) (0. 1  - 15.0) 
*Includes five dogs of unknown sex. 
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Table 4.6. Age-Specific Odds Ratios (OR) for Age at Diagnosis of Dogs with Naturally Occurring and Iatrogenic Hypoadrenocorticism Seen in Veterinary 
Referral Hospitals in 1989-1991,  United States and Canada 
x2 statistic (p value) 
Number of cases Total number of dogs 95 % confidence 
Age interval (yr)* n=330 n= l47,037 OR interval for OR49 Uncorrected40 
0 < age < 1 l l  32,790 0. 12 0.06 - 0.22 68.45 ( < 0.0001) 
1 � age < 4 92 40,829 1 .01 0.78 - 1 .29 0.00 (0.9641) 
4 � age < 7 101 27,688 1 .90 1 .49 - 2.42 29.84 ( < 0.0001) 
7 � age < 10 73 23,238 1 .5 1  1 . 16 - 1.98 9.87 (0.0017) 
age � 10 53 22,492 1 .06 0.78 - 1 .43 0. 15 (0.7002) 
* The comparison group is all other dogs. 
Sexes 
Sex was reported for 329 (96.5 %) of the 341 naturally occurring cases . The 
number (%) of each sex is reported in Table 4.7, and sex-specific OR in Table 
4.8. 
Breeds 
Breed was reported for 333 (97.7 %) of the 341 naturally occurring cases 
(Table 4.9). The seven most frequently reported breeds with number (%) were: 
Mixed 68 (20.4); Poodle 46 (13 .8); Labrador Retriever 16 (4.8); Gennan 
Shepherd 15 (4.5); Great Dane 12 (3.6); Rottweiler 12 (3 .6); and West Highland 
White Terrier 12 (3 .6).  Breed-specific OR were calculated for these seven breeds 
(Table 4. 10).  
Serum Sodium and Potassium Concentrations 
Serum sodium and potassium concentrations were reported for 250 (75. 1 %) 
of the 341 naturally occurring cases (Figures 4. 1 and 4.2, respectively). The 
sodium to potassium ratios are reported in Figure 4.3 . One hundred forty (56.0%) 
of the ratios were 25.0 or less, the diagnostic indicator suggested by one 
reference, 129 and 151 (60.4%) were 27.0 or less, the diagnostic indicator suggested 
by two others. 43•189 
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Table 4. 7. Sexes of 329 Naturally Occurring Cases of Canine 
Hypoadrenocorticism Seen in Veterinary Referral Hospitals in 1989-1991 ,  United 
States and Canada 
Sexes Number Percent 
Female-intact 46 14.0 
Female-spayed 177 53. 8  
All females 223 67.8 
Male-intact 43 13 . 1  
Male-castrated 63 19. 1  
All males 106 32.2 
All sexes 329 100.0 
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Table 4.8. Sex-Specific Odds Ratios (OR) for Dogs with Naturally Occurring Hypoadrenocorticism Seen in Veterinary Referral Hospitals in 1 989-199 1 ,  
United States and Canada 
X: statistic (p value) 
Total number 
Number of cases of dogs OR 95 % confidence 
Sex* n=297 n= 18S,026 interval for OR49 Uncorrected40 
Female-intact 43 43,206 0.56 0.40 - 0.78 13.05 (0.0003) 
Female-spayed 159 52,839 2.88 2.28 - 3.64 90.60 ( < 0.0001) 
Female-spayed*"' 159 52,839 3.02 2 . 13 - 4.30 45.75 ( < 0.0001) 
Female (intact and spayed) 202 96,045 1 .97 1 . 53 - 2.53 30. 8 1  ( < 0.000 1) 
Male-intact 40 60,484 0.32 0.23 - 0.45 49.81  ( < 0.0001) 
Male-castrated ss 28,497 1 .25 0.92 - 1 .69 2.21 (0. 1371)  
Male-castrated*** 55 28,497 2.92 1 .9 1  - 4.47 29. 16  ( <  0.0001) 
Neutered (either sex) 2 14 8 1 ,336 3.29 2.53 - 4.27 94.99 ( < 0.0001) 
* Except as noted, the comparison group is all other dogs. 
*"' Female-spayed compared to female-intact. 
"'"'* Male-castrated compared to male-intact. 
Table 4.9. Breeds of 333 Naturally Occurring Cases of Canine Hypoadrenocorticism Seen in VeteriDary 
Referral Hospitals in 1989-1991, United States and Canada 
Breed Number Percent 
Afghan Hound 1 0.3 
Airedale Terrier 3 0.9 
Alaskan Malamute 1 0.3 
Junerican Foxhound 1 0.3 
Australian Heeler 1 0.3 
Australian Shepherd 4 1.2 
Australian Terrier 1 0.3 
Basset Hound 9 2.7 
Beagle 3 0.9 
Bearded Collie 3 0.9 
Bedlington Terrier 1 0.3 
Bichon Frise 2 0.6 
Border Collie 3 0.9 
Boston Terrier 1 0.3 
Bouvier des Flandres 1 0.3 
Brittany 1 0.3 
Bull Terrier 1 0.3 
Cairn Terrier 3 0.9 
Chesapeake Bay Retriever 2 0.6 
Chihuahua 4 1.2 
Chow Chow 2 0.6 
Cocker Spaniel 6 1 .8  
Collie 1 0.3 
Dachshund 5 1.5 
Dandie Dinmont Terrier 1 0.3 
Doberman Pinscher 8 2.4 
English Bulldog 1 0.3 
English Setter 1 0.3 
Fox Terrier 2 0.6 
French Bulldog 1 0.3 
German Shepherd 15 4.5 
German Shorthaired Pointer 2 0.6 
Golden Retriever 8 2.4 
Gordon Setter 1 0.3 
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Table 4.9 (continued) 
Breed Number Percent 
Great Dane 12 3.6 
Great Pyrennes 2 0.6 
Greyhound 1 0.3 
Irish Setter 1 0.3 
Irish Wolfhound 1 0.3 
Keeshond 1 0.3 
Kuvasz 1 0.3 
Labrador Retriever 16 4.8 
Mixed 68 20.4 
Newfoundland 2 0.6 
Nova Scotian Duck Tolling Retriever 1 0.3 
Pit Bull Terrier 4 1.2 
Pointer 4 1.2 
Pomeranian 1 0.3 
Poodle 46 13.8 
Rottweiler 12 3.6 
Saint Bernard 2 0.6 
Samoyed 4 1 .2 
Schipperke 1 0.3 
Schnauzer 7 2.1 
Scottish Terrier 3 0.9 
Shar Pei 2 0.6 
Shetland Sheepdog 2 0.6 
Shih Tzu 2 0.6 
Siberian Husky 3 0.9 
Silky Terrier 1 0.3 
Springer Spaniel 9 2.7 
Vizsla 2 0.6 
Weimaraner 1 0.3 
Welsh Corgi 2 0.6 
Welsh Terrier 1 0.3 
West Highland White Terrier 12 3.6 
Wheaten Terrier 3 0.9 
Whippet 2 0.6 
Yorkshire Terrier 1 0.3 
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Table 4. 10. Selected Breed-Specific Odds Ratios (OR) for Dogs with Naturally Occurring Hypoadrenocorticism Seen in Veterinary Referral Hospitals in 
1989-1991 ,  United States and Canada 




Labrador Retriever 9 
German Shepherd 9 
Great Dane 10 
Rottweiler 7 
West Highland White 12 
Terrier 
"' The comparison group is all other dogs. 
Number of controls 95 % confidence 
n =  149,208 OR interval for OR49 
34,697 0.96 0.71 - 1 .29 
1,045 3. 17 2. 18 . 4.58 
10,255 0.49 0.24 . 0.98 
7,229 0.71 0.34 . 1 .42 
1 ,309 4.56 2.28 . 8.83 
3, 154 1 .29 0.56 . 2.83••• 
986 7.33 3.90 . 13.46 
*"' Calculated only if an expected cell value is < S; the preferred p value for this OR. 
••• Inaccurate; exact calculation of confidence interval beyond computing ability. 
X: statistic (p 
value} 
Uncorrected40 
0.09 (0. 7689) 
44.65 ( < 0.0001) 
4.61 (0.0317) 
1 .03 (0.3 105) 
26.48 ( < 0.0001) 
0.45 (0.5038) 
61 .83 ( < 0.0001) 

















<1 10.1 1 10.1-120.0 1 20.1-130.0 130.1-140.0 140.1-150.0 150.1-160.0 
Serum Sodium Concentration (meq/L) 
Mean 1 35.2 (SO 1 0.6) (SEM 0.7) (Range 97.0-160.0) Nonnal 1 36.0-150.0 
Figure 4. 1 .  Serum Sodium Concentrations for 250 Naturally Occurring Cases of Canine Hypoadrenocorticism Seen 
in Veterinary Referral Hospitals in 1989-1991 ,  United States and Canada 
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<3.1 3.1-4.0 4.1 -5.0 5.1-6.0 8.1-7.0 7.1-8.0 
Serum Potassium Concentration (meq/L) 
Mean 5.9 (SO 1 .7) (SEM 0.1 ) (Range 2.9-1 1 .7) 
Nonnal 3.5-5.0 
8.1-9.0 >9.0 
Figure 4.2. Serum Potassium Concentrations for 250 Naturally Occurring Cases of Canine Hypoadrenocorticism 
Seen in Veterinary Referral Hospitals in 1989-199 1 ,  United States and Canada 
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10.1-15.0 15.1-20.0 20.1-25.0 25.1-30.0 30.1-35.0 35.1-40.0 
Serum Sodium to Potassium Ratios 
Mean 25.2 (SO 8.3) (SEM 0.5) (Range 11 .1-46.6) 
Normal >=27 .o or >=25.0 
40.1-45.0 45.1-50.0 
Figure 4.3 . Serum Sodium to Potassium Ratios for 250 Naturally Occurring Cases of Canine Hypoadrenocorticism 
Seen in Veterinary Referral Hospitals in 1989-1991 ,  United States and Canada 
One hundred fifteen (46.0%) of the sodium results were normal. Eighty-four 
(33.6%) of the potassium results were normal. Fifty-eight (23 .2%) were normal 
for both sodium and potassium. Forty-four percent were normal using the 
diagnostic criterion for disease of a sodium to potassium ratio of 25.0 or less, and 
39.6 %  were normal using the 27.0 or less criterion. No case was normal for 
sodium, potassium, and sodium to potassium ratio (using either the 25.0 or the 
27.0 criterion). 
Occurrence of Selected Clinical Findings 
The most frequently reported (%) of the selected clinical findings among the 
341 naturally occurring cases were anemia (6.7), hypothyroidism (5.9), 
thrombocytopenia (3 .5), and megaesophagus (2.9). A complete list of frequencies 
is included as Table 4. 1 1 .  
Treatment 
Of the reports for the 341 naturally occurring cases, 312 indicated whether 
or not fludrocortisone acetate was used to treat the disease, and 285 indicated 
whether DOCP was used. Of those, 235 (75.3 %) and 36 (12.6%) used, 
respectively, fludrocortisone acetate and DOCP (Table 4. 12).  
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Table 4. 1 1 .  Frequency of Occurrence of Selected Clinical Findings* for 341 
Naturally Occurring Cases of Canine Hypoadrenocorticism Seen in Veterinary 
Referral Hospitals in 1989-1991, United States and Canada 
Clinical f"mdiog Number Percent 
Anemia 23 6.7 
Arthritis 3 0.9 
Cruciate ligament rupture 2 0.6 
Diabetes mellitus 2 0.6 
Hepatitis 4 1 .2 
Hypothyroidism 20 5.9 
Keratoconjunctivitis sicca 4 1 .2 
Megaesophagus 10 2.9 
Myasthenia gravis 4 1 .2 
Nephritis 3 0.9 
Thrombocytopenia 12 3 .5 
*Clinical findings were chosen either because of their anecdotal association with 
canine hypoadrenocorticism, or their putative autoimmune etiology. 
82 
Table 4.12. Treatment of 341 Naturally Occurring Cases of Canine Hypoadrenocorticism Seen 








Number of dogs 






*Indicates the number of dogs of the 341 naturally occurring cases where reports indicated 
whether or not the drug was used for treatment. 
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Odds Ratios for Diseases (or Other Reasons for Presentation of Dogs to 
Veterinary Referral Hospitals) Hypothetically Not Associated with 
Hypoadrenocorticism 
The OR for these diseases are included in Table 4. 13 .  When case information 
was requested the second time from the VMDB, information on 434 cases was 
received. This number of cases differed from the 376 reported earlier for two 
reasons. First, the VMDB is constantly being updated. Second, to be included in 
the 376, a Case Data Abstract Form had to be provided by the institution. In 
contrast, diseases or other reasons for presentation that were coincident with cases 
of canine hypoadrenocorticism could be extracted directly from the VMDB. 
Discussion 
Institutional Participants 
Virtually all the colleges of veterinary medicine in the United States and 
Canada submitted data, and data were very complete. A weakness of the study was 
that colleges of veterinary medicine are referral hospitals which do not represent 
all veterinary hospitals. A corollary was that colleges of veterinary medicine are 
a particular kind of referral hospital which do not necessarily represent all 




Table 4. 13. Odds Ratios (OR) for Diseases or Other Reasons for Presentation to Veterinary Referral Hospitals for Dogs with Naturally Occurring or 
Iatrogenic Hypoadrenocorticism in 1989-1991 ,  United States and Canada 
Disease or reason Number of cases Number of controls 95% confidence 
for presentation* n=434 n= 189,909 OR interval for OR49 
Cataracts 6 5,6 15 0.46 0. 19-1 .06*"'"' 
Dental tartar 20 4,284 2.09 1 .30-3.34 
Fleas 5 2,428 0.90 0.33-2.25*"'"' 
Heartworm infection 0 1 ,472 0.00 0.00-1.42"'"'"' 
Mitral insufficiency 7 1 ,394 2.22 0.96-4. 83"'"'"' 
Rabies vaccination 24 25,447 0.38 0.24-0.58 
Squamous cell carcinoma 0 653 0.00 0.00-3.21"'"'"' 
"' The comparison group is all other dogs. 
•• Calculated only if an expected cell value is < 5; the preferred p value for this OR. 
"'"'"' Inaccurate; exact calculation of confidence interval beyond computing ability. 
X: statistic (p 
value) 
Uncorrected40 





23. 14 ( < 0.0001) 
1 .50 (0.221 1) 






The large numbers of cases, 341 naturally occurring and 35 iatrogenically 
produced, provided, at least for summary calculations for the entire population, 
reasonable confidence in the results. This confidence diminished as the overall 
population was subdivided by variables such as sex and breed. 
Incidence and Prevalence Estimates 
A discussion of the incidence and prevalence estimates must be prefaced with 
an understanding of the method underlying their calculation. Most fundamental are 
the definitions of incidence and prevalence. Incidence was defined as the number 
of new cases diagnosed during this time period divided by the population at risk. 
This definition 1s consistent with several textbook definitions of 
incidence. 50•123•188•190 The population at risk was defined as all dogs (individual 
dogs, not dog visits) which were presented to veterinary referral hospitals during 
these years for any reason. Since all dogs can develop hypoadrenocorticism, the 
only dogs which should have been excluded from the population at risk were those 
which already had the disease. But, since the disease is so uncommon, these cases 
were ignored; i.e. , the denominator would not change substantially whether or not 
they were included. 
The incidence estimates of 1 .  7 cases/1000 dogs/3 yr (0.6 cases/1000 dogs/yr) 
for naturally occurring disease provide useful information to veterinary 
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practitioners who need to know roughly how many cases they might expect to see 
in their practices. For example, if a practice sees 5,000 dogs a year, it would 
expect to see (5000) (0.6) = 3 dogs with hypoadrenocorticism. Chance will dictate 
a good deal of variation among practices, but if the practice did not diagnose any 
cases (or, conversely, diagnosed two dozen), the veterinarians in the practice might 
want to reevaluate their approach to hypoadrenocorticism. Similarly, with the 
prevalence estimates of 2.8 cases/1000 dogs for naturally occurring disease, the 
veterinarians might look askance at their diagnostic acumen if they had 10,000 
patient records and no cases of hypoadrenocorticism (or, conversely, 100 cases). 
So, both the incidence and prevalence estimates should be useful to the 
veterinarian. This logic must be cautiously considered since the data extant came 
from veterinary referral hospitals and the interpretation has been extended to 
private veterinary practitioners. Since veterinarians may be more likely to refer 
cases of canine hypoadrenocorticism, this logic is more sound for veterinarians in 
referral hospitals than for those in private practice. 
The prevalence estimate for naturally occurring and iatrogenically produced 
canine hypoadrenocorticism should be useful to producers of drugs used to treat 
the disease. The prevalence estimate would help the producers plan for the 
manufacture, marketing, and distribution of their drugs as illustrated below. 
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Microcrystalline DOCP is used as a mineralocorticoid to treat hypoadrenal 
dogs. The dosage of the drug used therapeutically varies among dogs, but averages 
about 1 mg/4.5kg/25da. Using an estimate of the United States dog population of 
52.5 million, 6 and an estimate of 22.4 kg for the average weight of a hypoadrenal 
dog (see Chapter 3), the following computation is straightforward. 
Potential amount of DOCP (mg) 
which could be used in one = Dog population • Prevalence (diseased dogs) • Average weight (kg) • 
yr in United States (dogs) (dogs) diseased dog 
dose (mg/kg/da) • 365 da 
yr = 52,500,000 • 3. 1 diseased dogs • 22.4 kg • 
total dogs 1000 dogs diseased dog 
1 mg/4.5 kg/25 da • 365 da • 1 1,830,000 mg/yr 
yr 
This computation assumes that DOCP is the only drug used to treat canine 
hypoadrenocorticism, which it is not. The computation does, however, indicate the 
potential market for the drug, and can be adapted to accommodate a market 
penetration of whatever percent seems reasonable. For example, a 20% market 
penetration would require 20% of the above amount of DOCP per yr. 
The sex-specific incidence estimates {Table 4.3) suggested that female dogs 
are more likely to be hypoadrenal than males. This was indicated by the incidence 
estimate of0.7 case/1000 female dogs/yr compared to 0.4 case/1000 male dogs/yr. 
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The data also suggested the possibility that neutering either a female or a male 
leads to an increased probability of disease. The incidence estimate for female­
spayed was 1 .0 case/1000 female-spayed dogs/yr, three times the incidence 
estimate for female-intact dogs, which was 0.3 case/1000 female-intact dogs/yr. 
Similarly, the incidence estimate for male-castrated dogs was 0.6 case/1000 male­
castrated dogs/yr, compared to the incidence estimate for male-intact of 0.2 
case/1000 male-intact dogs/yr. There may be variables such as age which mitigate 
this seeming predilection of the neutered dog for hypoadrenocorticism. Increased 
age (Table 4.6) and neutering (Table 4.8) led to a predilection for the disease. This 
possibility will be explored by stratified data analysis in Chapter 5 .  
The breed-specific incidence estimates (Table 4.4) suggested that Great Danes 
(7.6 cases/1000 dogs/3 yr), Poodles (4.9 cases/1000 dogs/3 yr), and West 
Highland White Terriers (12.0 cases/1000 dogs/3 yr) were at increased risk. Other 
variables may account for this effect, but none is an obvious possibility. 
Using 1989, 1990, and 1991 registration statistics for the American Kennel 
Club,11.s.117 the same years included in this study, Great Danes comprised 0.7% of 
total registrations, Poodles 5.9%,  and West Highland White Terriers 0.9 % .  In this 
89 
study (using Table 4.9 and calculating breed percentages of pure-bred dogs only, 
i.e. , excluding Mixed dogs), Great Danes comprised 4.5 % of total cases, Poodles 
17.4%,  and West Highland White Terriers 4.5 % .  These percentages were all 
substantially higher than for the general population. Recognizing that American 
Kennel Club registrations do not represent all pure-bred dogs, this was further 
evidence that these breeds were more likely to be hypoadrenal. r 
Ages at Diagnosis 
The average ages at diagnosis (Table 4.5) were unremarkable with the 
possible exception of the difference between the average age for female-intact dogs 
of 3 .9 yr compared to female-spayed dogs of 5.9 yr. Older dogs may be more 
likely to be spayed than younger ones, but a similar disparity might be expected 
between male-intact and male-castrated. But this difference did not exist between 
the 5.2 yr and 5.3 yr ages of male-intact and male-castrated dogs, respectively. 
Perhaps owners who eventually spay their females delay the procedure for some 
reason, while owners who castrate their males are less likely to delay. (Data on 
r To ensure that the 1989, 1990, and 1991 American Kennel Club registrations 
represented American Kennel Club registrations over a longer time period, and 
that the percentages of these breeds in the general population were relatively stable 
over time; percentages of total registrations for Great Danes, Poodles, and West 
Highland White Terriers were calculated for the years 1981 through 1988. These 
were: Great Danes 1 .  0%,  Poodles 7. 9%,  and West Highland White Terriers 0. 8 % .  
These were all consistent with the percentages for 1989, 1990, and 1991 ,  and 
fHPPOrted the conclusion that these breeds were more likely to be hypoadrenal. 
107-
90 
average age at the time of spaying or castrating, as well as proportion of males 
and females neutered, would be useful in addressing this issue.) In any case, the 
age disparity between female-intact and female-spayed was interesting, but 
unexplained. 
Regarding age-specific OR in Table 4.6, dogs in the 0-1 yr age range were 
less likely to be diseased (OR = 0. 12), though dogs as young as 0. 1 yr were 
diagnosed. Dogs in the 1-4 yr age range had neither an increased nor decreased 
probability of disease (OR = 1 .01), but age beyond 4 yr seemed to predispose to 
disease. Significant OR for the 4-7 yr and 7-10 yr age groups were 1 .90 and 1 .51 ,  
respectively. Variables other than age were possibly involved, but an age effect 
seemed clear. The age effect seemed to disappear in very elderly dogs--the OR for 
the over 10 yr age group was not significant. Nevertheless, three 15 yr old dogs 
were diagnosed as hypoadrenal. While recognizing the necessarily arbitrary 
selection of the age categories above, the probability of onset of 
hypoadrenocorticism in dogs increased with age, significantly between 4 and 10 
yr. 
Sexes 
Females (intact and spayed) made up 5 1 .9 %  of dogs in the 1989, 1990, and 
1991 VMDB data base; males (intact and castrated) made up the remaining 48. 1 % .  
Among the hypoadrenal dogs, 67.8 %  were females (intact and spayed) and 32.2% 
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were males (intact and castrated) (Table 4. 7). The predisposition of females to the 
disease has been reported previously. 41•43•93•148•189 This study confirmed this effect 
by the sex-specific incidence of hypoadrenocorticism among females (intact and 
spayed) of2. 1 cases/1000 female dogs/3 yr compared to 1 . 1  cases/1000 dogs/3 yr 
for males (intact and castrated) (Table 4.3). 
Since female-spayed comprised 53 .8% (Table 4.7) of all the hypoadrenal 
patients in this study, it seemed that female-spayeds were at increased risk of 
having adrenal insufficiency. This could have resulted from an overrepresentation 
of female-spayeds in the overall population. However, the overall population of 
dogs reported to the VMDB in 1989, 1990, and 1991  included only 27.7% female­
spayed dogs. Though other variables may be at work, it seemed likely that the 
large percentage of female-spayeds in the diseased population resulted from a real 
predisposition of female-spayeds to the disease. This was consistent with the 
discussion above of sex-specific incidence estimates. 
Interestingly, female-intact dogs comprised 14.0% of the hypoadrenal 
patients, and 24.3 % of the general VMDB population. This suggested that an 
unspayed female may be less likely to be hypoadrenal. This was consistent with 
the sex-specific incidence estimates. It was inconsistent, however, with one report 
that female-intacts had a higher risk than female-spayeds.148 
Male-castrates were 15. 1 % of the overall population, but were 19. 1 % of the 
diseased group. This suggested that being neutered might increase the likelihood 
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of disease. This was consistent with the sex-specific incidence estimates since 
male-castrates had a substantially higher incidence of disease than male-intact 
dogs. However, the overall incidence estimate for male-castrates (Table 4.3) was 
exactly the same as the incidence estimate for all dogs of all sexes of 1 .9 
cases/1000 dogs (all sexes)/3 yr. 
The results for male-intact dogs were striking. They comprised 33.0% of the 
general VMDB population, but only 13 . 1  % of the diseased population. This 
suggested that male-intact dogs were less likely to be hypoadrenal than castrated 
ones, and this was supported by the sex-specific incidence estimate of 0.7 
case/1000 male-intact dogs/3 yr compared to the incidence estimate for all dogs 
of all sexes of 1 .9 cases/1000 dogs (all sexes)/3 yr. 
The sex-specific OR reported in Table 4.8 reinforced these conclusions. 
Females (intact and spayed) were more likely to be diseased than males (intact and 
castrated). Female-spayeds were more likely to be hypoadrenal compared to all 
other dogs and female-intact dogs. Male-castrates were (OR 1 .25 compared to all 
other dogs, and OR 2.92 compared to male-intact dogs) more likely to be 
diseased.s Female-intact dogs (OR 0.56) and male-intact dogs (OR 0.32) were less 
likely to be affected. 
1All the OR reported here were highly significant (p < 0.001) except the OR 
1 .25 (p = 0. 15) for male-castrates compared to all other dogs. 
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Since female-spayed and male-castrated dogs seem predisposed to 
hypoadrenocorticism, a neutering effect may be at work. This was reinforced by 
the OR of 3 .29 (p < 0.0001) for neutered animals of either sex compared to intact 
animals of either sex (Table 4.8). This may have been affected to some extent by 
the age effects discussed above. 
Breeds 
Sixty-nine breeds were reported among the 333 naturally occurring cases 
which reported breed (Table 4.9) .  This established that hypoadrenocorticism can 
occur in many breeds. 
The OR for the seven most frequently reported breeds (Table 4. 10) indicated 
. 
a predisposition for hypoadrenocorticism among the following breeds: Poodle (OR 
3 . 17, p < 0.0001); Great Dane (OR 4.56, p = 0.0001); and West Highland 
White Terrier (OR 7.33, p < 0.0001). Another paper reported breed predilections 
in the Standard Poodle, Great Dane, and West Highland White Terrier. 148 The OR 
for the Labrador Retriever was 0.49 (p < 0.05), indicating that Labrador 
Retrievers were less likely to be diseased. Possible familial predispositions for 
hypoadrenocorticism have been reported in this breed.69 
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Serum Sodium and Potassium Concentrations 
Of the 250 naturally occurring cases for which serum sodium and potassium 
concentrations were available, 1 15 (46.0%) had normal sodium concentrations, 84 
(33 .6%) had normal potassium concentrations, and 58 (23.2%) had both normal 
sodium and potassium concentrations. These results differed from others which 
showed that only 18 .7% and 4.4% of hypoadrenal dogs had normal serum sodium 
and potassium concentrations, respectively. 148 Forty-four percent had normal 
sodium to potassium ratios using the 25.0 or less diagnostic criterion, 129 and 39.6 % 
had normal ratios using the 27.0 or less criterion.43•189 The remarkable result was 
that no one case of the 250 was normal for all three diagnostic criteria--sodium 
concentration, potassium concentration, and sodium to potassium ratio (regardless 
of whether the less than 25.0 or the less than 27.0 criterion was used) . This 
suggested that a dog diagnosed with hypoadrenocorticism will usually have an 
electrolyte abnormality. This could mean that most veterinarians are already not 
diagnosing hypoadrenocorticism in dogs normal by all three criteria. If they are 
not, it means they should seldom go to the time, trouble, and expense of the 
ACTH stimulation test. 
Occurrence of Selected Clinical Findings 
The frequency (%) of occurrence of anemia (6.7), hypothyroidism (5.9), 
thrombocytopenia (3.5), and megaesophagus (2.9) suggested that these conditions 
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were associated with canine hypoadrenocorticism (Table 4. 1 1) .  However, since 
this study contained no data about the frequency of these clinical findings in the 
entire study population, these results must be viewed as anecdotal. 
Treatment 
Fludrocortisone acetate and DOCP were used in 75.3 %  and 12.6% of the 
patients, respectively. The more common use of fludrocortisone acetate may result 
from its advantages: oral administration, glucocorticoid and mineralocorticoid 
activity,69 and its easy availability since it is currently approved by the United 
States Food and Drug Administration (FDA). It has some disadvantages as well: 
cost in large dogs, difficulty of use in animals resistant to taking oral medication, 
large doses sometimes required, 69 occurrence of significant polyuria and polydipsia 
in some patients, 69 and the failure of some dogs to respond to it. 69 Microcrystalline 
DOCP has the advantages of nearly universally favorable response in dogs, and 
its use obviates the need for daily administration since it is given by intramuscular 
injection about every 25 da. Its disadvantages are: the need to visit the veterinarian 
for an injection every 3 to 4 wk; it often requires supplemental administration of 
glucocorticoids;69 and it is more difficult to obtain since it is not approved by the 
FDA. Though both drugs will have therapeutic niches, the test of which drug is 
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preferred by owners and veterinarians will have to wait until both drugs are readily 
available to the veterinary practitioner. 
Odds Ratios for Diseases (or Other Reasons for Presentation of Dogs to 
Veterinary Referral Hospitals) Hypothetically Not Associated with 
Hypoadrenocorticism 
Data on seven diseases not believed to be associated with canine 
hypoadrenocorticism were obtained from the VMDB as a methodology check. Of 
the seven items included in Table 4. 13,  four-cataracts, fleas, heartworm infection, 
and squamous cell carcinoma--were not statistically related to 
hypoadrenocorticism. This was expected since these diseases were intuitively not 
related to hypoadrenocorticism. 
Two of the items--dental tartar and rabies vaccination--were positively and 
negatively associated, respectively, with hypoadrenocorticism. These results were 
unexplained, but dental tartar and hypoadrenocorticism may have been associated 
because each was associated with older age. Conversely, younger dogs may have 
had a lesser tendency to be hypoadrenal and a greater tendency to be vaccinated 
for rabies; therefore, adrenal insufficiency and rabies vaccination were negatively 
associated. 
The results for mitral insufficiency were equivocal in that the Cornfield's 
approximate 95 % confidence interval included one, but the 2-tailed Fisher exact 
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p value was 0.0435. Since the Cornfield's approximation could be considered 
inaccurate in this case, and an exact computation of the confidence interval was 
beyond the computer's capability, the 2-tailed Fisher exact p value should be 
considered definitive, thus leading to the conclusion that mitral insufficiency and 
hypoadrenocorticism were positively associated. If so, they may have been 
associated through age, as may be the case with hypoadrenocorticism and dental 
tartar. 
Conclusions 
1 .  Incidence and Prevalence Estimates. The incidence (0.6 case/1000 
dogs/yr for naturally occurring, and 0.6 case/1000 dogs/yr for naturally occurring 
and iatrogenic) and prevalence (2.8 cases/1000 dogs for naturally occurring and 
3 .2 cases/1000 dogs for naturally occurring and iatrogenic) estimates from this 
study can serve as baselines for the expected caseload of canine 
hypoadrenocorticism for referral hospitals. They could be used by pharmaceutical 
companies for marketing decisions. 
2.  Sex-Specific Incidence Estimates and Sex Predispositions. Sex-specific 
incidence estimates suggested that female dogs were more likely than males to 
develop hypoadrenocorticism. Further, the data suggested that neutering either 
females or males increased the incidence of disease. This effect may have been 
exacerbated by other variables, possibly age. 
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The overrepresentation of females, particularly female-spayeds, in the 
diseased population compared to the entire VMDB population suggested that 
females, especially those spayed, were at increased risk for hypoadrenocorticism. 
It also appeared that intact animals of either sex were less likely to develop disease 
than their neutered counterparts. These conclusions were supported by both sex­
specific OR and incidence rates. 
3 .  Breed-Specific Incidence Estimates and Breed Predispositions. Breed­
specific incidence estimates suggested that Great Danes, Poodles, and West 
Highland White Terriers were at increased risk of developing 
hypoadrenocorticism. Other variables may be involved. These breed 
predispositions were supported by a pronounced overrepresentation of these 
breeds in the study population of diseased dogs compared to American Kennel 
Club breed registrations for the same years. Labrador Retrievers were less likely 
to have the disease. 
4. Age-Specific Odds Ratios. Age-specific OR indicated that increasing age 
was associated with an increased risk of developing disease. This effect was 
particularly profound between the ages of 4 and 10 yr. 
5.  Serum Sodium and Potassium Concentrations. No dog with 
hypoadrenocorticism was normal for serum concentrations of sodium and 
potassium and the sodium to potassium ratio. This suggested that dogs with this 
disease seldom are normal for all three diagnostic criteria. As a practical matter, 
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this means that veterinarians considering hypoadrenocorticism in a canine patient 
can usually remove hypoadrenocorticism from the list of differential diagnoses if 
all three diagnostic tests are within normal limits. 
6.  Associated Conditions. Anemia, hypothyroidism, thrombocytopenia, and 
megaesophagus were positively associated with canine hypoadrenocorticism. This 
conclusion was based on anecdotal data, and must be viewed skeptically. These 
associations warrant further investigation. 
7. Treatment. Fludrocortisone acetate was much more frequently used than 
DOCP to treat hypoadrenocorticism. This probably resulted from several factors, 
but the principal reason was probably that fludrocortisone acetate was more easily 
available to veterinarians. 
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CHAPfER 5 
CASE CONTROL STUDY USING PATIENTS OF 
VETERINARIANS ENROLLED IN THE CLINICAL TRIAL OF 
MICROCRYSTALLINE DESOXYCORTICOSTERONE PIV ALATE 
Introduction 
To this point the study has focused almost exclusively on cases of 
hypoadrenocorticism: cases from the literature (Chapter 2), cases enrolled in the 
clinical trial of microcrystalline desoxycorticosterone pivalate (DOCP) (Chapter 
3), and cases from veterinary referral hospitals (Chapter 4). The cases have, with 
a few exceptions for data gathered from veterinary referral hospitals, been without 
controls. This limits the utility of any result. For example, if a certain percent of 
cases are Poodles, and the percent seems to be inordinately high, does this 
represent a breed predisposition for hypoadrenocorticism or not? Therefore, 
controls needed to be obtained with cases as described in this chapter. 
Methods 
The veterinarians enrolled in the Ciba Animal Health clinical trial of DOCP 
provided an ideal source of controls to compare with the hypoadrenal dogs. 
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Detailed information was already known about the veterinarians and their patients, 
and the veterinarians were accustomed to providing data. Therefore, a case control 
study was designed using these veterinarians as respondents. The cases were the 
dogs enrolled in the clinical trial. The two controls for each case were the next 
dog in the veterinarian's patient record file which was owned by a different client, 
and the fifth dog owned by a different client after the first control dog (see 
Appendices A6 and A 7). Whether the control dogs were sick or well wa8 not 
considered. 
A questionnaire (Appendices A4 and A5) with instructions (Appendices A6 
and A7) was designed and used to query veterinarians enrolled in the clinical trial. 
Veterinary hospitals known by Ciba Animal Health personnel to be referral 
hospitals were not queried. The method of Dillman, 35 slightly abbreviated, was 
used for the mail survey. This involved mailing the questionnaire with instructions 
and cover letter to 571 veterinarians who had diagnosed 767 cases of canine 
hypoadrenocorticism. A follow-up reminder letter was sent to all the veterinarians 
approximately 1 wk after the initial mailing, and subsequent mailings with 
additional questionnaires and cover letters were made to those not known to have 
responded approximately 4 and 7 wk after the initial mailing. 
The questionnaire requested the number of dogs (not dog visits) seen in the 
veterinary practice in 1993, and the age, breed, sex, body weight, and other 
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diseases diagnosed for cases and controls selected randomly from the hospital's 
patient files. These data were used to calculate odds ratios (OR). 
Confidence intetvals for OR were calculated using Cornfield's 
approximation. 49 If Cornfield confidence limits were inexact, exact confidence 
limits were calculated. 128 Uncorrected chi-square statistics were reported.40 Fisher 
exact probability calculations for the 2x2 contingency tables were calculated when 
the expected value of a cell was less than five. 162 Appendix B contains further 
details regarding these calculations. Body weights for cases and controls were 
compared using a technique for comparing means of unequal variances. 130 
Logistic regression was done using JMp® statistical software. 177 Breeds were 
specifically included in the logistic regression if they met two sequential criteria. 
First, if the breed was represented in the study by either five cases or five 
controls, an OR was calculated for the breed. Second, if the 95 % confidence 
interval for the breed's OR did not include one, the breed was included in the 
logistic regression. If the breed had neither five cases nor five controls in the 
study, or if the 95 % confidence interval for its OR did include one, then it was 
categorized as "Other11 in the logistic regression. Sexes were categorized as 
female-intact, female-spayed, male-intact, and male-castrated. The units were yr 
for age and kg for body weight. 
Logistic regression models were developed generally using the method 
advocated by Hosmer and Lemeshow. 80 This method calls for variable selection 
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first by a univariate analysis of each variable; second, by the selection from the 
univariate analysis of variables to be included in a multivariate analysis; third, by 
a verification of the importance of each variable included in the multivariate 
model; and, last, by consideration of whether or not to include variable interaction 
terms in the model. This was done with the following admonition about the 
pwpose of logistic regression: 
Before beginning a study of logistic regression it is important to understand 
that the goal of an analysis using this method is the same as that of any 
model-building technique used in statistics: To find the best fitting and most 
parsimonious, yet biologically reasonable model to describe the relationship 
between an outcome (dependent or response variable) and a set of 
independent (predictor or explanatory) variables. 78 
Dogs were frequently reported as simply "Poodle" or 11 Schnauzer'' without 
size specification. Therefore, all Poodles (Standard, Miniature, and Toy) have 
been reported as one breed, and all Schnauzers (Giant, Standard, and Toy) have, 
similarly, been reported as one breed. 
The selected clinical findings were chosen for inclusion in the questionnaire 
either because of their anecdotal association with canine hypoadrenocorticism, or 




Questionnaire Responses and Description of Veterinary Clinics 
Five hundred nineteen (90.9%) of the 571 veterinarians from 494 separate 
veterinary clinics in the United States returned questionnaires on 720 cases and 
1 , 192 controls. One case was not included in the computations in this chapter 
(except for Figure 5. 1) because the computations were completed before the 
response was received. The first response was received 7 da after the first mailing, 
and the last response was received 240 da after. Figure 5. 1 graphs number of 
responses received vs. time after initial mailing. 
Four hundred fifty-nine veterinarians reported a total of 1 ,208 full-time 
veterinarians in the 459 clinics for an average of 2. 6 per clinic (SD 1 .  7) (SEM' 
0 . 1) (Range 1 .0 - 13 .0). Figure 5.2 plots the number of full-time veterinarians in 
the clinics vs. the percent of clinics employing that number of veterinarians. 
Four hundred two of the veterinary clinics reported the number of dogs 
diagnosed with canine hypoadrenocorticism in 1993 and the estimated number of 
active dog patientsu seen in the practice in 1993. The estimated number of dogs 
diagnosed for 1993 was 495.5 by the 402 veterinary clinics for a mean of 1 .23 
'Standard error of the mean (SEM) equals the standard deviation (SD) 
divided by the square root of the sample size. 
uAn active dog patient was a dog seen in the practice in 1993 . Dogs were 
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Figure 5 .2. Number of Veterinarians Per Clinic from 1994 Survey in the United States of Veterinaria,-ts Enrolled in 
Clinical Trial 
dogs newly diagnosed per clinic (SD 1 .9) (SEM 0. 1) (Range 0.0 - 21 .0) .  These 
402 clinics estimated that they saw 1 ,472,081 active dog patients during 1993. 
Four hundred one clinics reported the number of dogs diagnosed in 1993 and the 
number of full-time veterinarians employed in these clinics. The average annual 
number of dogs diagnosed per full-time veterinarian was 0.53 (SD 0.92) (SEM 
0.05) (Range 0.00 - 10.50). Four hundred six clinics reported the number of active 
dog patients seen in the practice in 1993 and the number of full-time veterinarians 
employed in these clinics. The average annual number of active dog patients seen 
per full-time veterinarian was 1504.7v (SD 929.5) (SEM 46. 1) (Range 86.0 -
7000.0).  
Incidence and Prevalence Estimates 
Incidence was estimated at 0.34 case/1000 dogs/yr by dividing 495.5 
estimated cases in 1993 by 1 ,472,081 estimated dogs seen in practices in 1993. 
This incidence estimate led to a prevalence estimate of 1 .  7 cases/1000 dogs by 
multiplying the incidence estimate by the average disease duration estimate of 4.9 
yr (see Ages below). 3.98.t20.123.t68.200.21S,239 
Prevalence = (Incidence) (Average disease duration) 
vnis was similar to the estimate of 1 ,600 dogs seen per veterinarian per yr 
obtained on July 29, 1996 from personal communication with Dr. J. Karl Wise, 
Center for Information Management, American Veterinary Medical Association. 
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Ages 
The ages reported in this survey were current age or age at death or age 
when lost to follow-up, depending on which age applied to the particular patient. 
This was a different definition of age from the ages at diagnosis reported in 
Chapter 4, and was used so that the ages of cases and controls could be compared. 
There were 666 (92.6%) of the 719 hypoadrenal cases which reported age. 
The mean age was 8 .7 yr (SD 3.2) (SEM 0. 1) (Range 1 .0 - 18 .0).  These ages are 
displayed in Figure 5.3 .  Of these 666 cases, 405 (60.8 %) were alive, 23 1 (34.7%) 
were dead, 20 (3 .0%) were lost to follow-up, and 10 (1 .5 %) were of unknown 
status. The average current age was 8 . 1  yr (SD 3 .0) (SEM 0. 1) (Range 1 .5 - 18.0) 
compared to average age at death of 9.8 yr (SD 3 .4) (SEM 0.2) (Range 1 .0 -
17.2) ,  and average age when lost to follow-up of 8.6 yr (SD 3 . 1) (SEM 0.7) 
(Range 4.0 - 13 .0) .  These data were combined and displayed in Figure 5.3 .  
Age was reported for 1 , 163 (97.6 %) of the 1 , 192 controls. The mean age 
was 6.2 yr (SD 4. 1) (SEM 0. 1) (Range 0. 1 - 19 .0) as displayed in Figure 5.4. Of 
these 1 , 163 controls, 954 (82.0%) were alive, 44 (3 .8%) were dead, 98 (8 .4%) 
were lost to follow-up, and 67 (5.8%) were of unknown status. The average age 
of the live dogs was 6 .1  yr (SD 3 .9) (SEM 0. 1) (Range 0. 1 - 19.0) .  The average 
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Figure 5.3 . Ages* of 666 Dogs with Hypoadrenocorticism from 1994 Survey in the United States of Veterinarians 
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Figure 5.4. Ages* of 1 , 163 Control Dogs from 1994 Survey in the United States of Veterinarians Enrolled in 
Clinical Trial 
The average age of the dogs lost to follow-up was 5.7 yr (SD 4.3) (SEM 0.4) 
(Range 0.2 - 16.0) . 
Age-specific OR and relevant statistics are presented in Table 5 . 1 .  
Average disease duration was estimated as 4.9 yr by subtracting the estimated 
average age at diagnosis (4.9 yr) from the average age at death (9.8  yr) . Average 
age at death was likely influenced by euthanasia of dogs whose owners chose not 
to treat their dog. This average age at diagnosis was estimated with a weighted 
average of 4.3 yr for 244 1iterature review cases (Chapter 2), 4.9 yr for 232 cases 
enrolled in the clinical trial of DOCP (Chapter 3), and 5.4 yr for 329 cases from 
veterinary referral hospitals (Chapter 4). 
Sexes 
Sex was reported for 711  (98.9%) of the 719 cases and 1 , 152 (96.6%) of the 
1 , 192 controls (Table 5 .2) . Sex-specific OR are presented in Table 5 .3 .  Age 
stratified sex-specific OR were calculated for the age intervals (yr) 0 < age < 5, 




Table S. l .  Age*-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 Survey in the United States of Veterinarians Enrolled 
in Clinical Trial 
Number of cases Number of controls 
Age interval (yr)** n=666 n= 1 , 163 
0 < age < 1 0 52 
1 � age < 2 3 89 
2 � age < 3  6 129 
3 � age < 4  21 1 19 
4 � age < S  51 108 
5 � age < 6 52 92 
6 � age < 7 54 88 
7 � age < 8 75 78 
8 � age < 9 74 69 
9 � age < 10 70 77 
10 � age < 1 1  69 68 
1 1  � age < 12 46 41  
12  � age < 13 56 49 
13 � age < 14 40 41  
14  � age < 15 28 30 
age � IS 21 33 
* Current age or age at death or age when lost to follow-up. 
** The comparison group is all other dogs. 
*** Exact confidence limits. lltl 
x.2 statistic (p value) 
95% confidence 
OR interval for OR'" Uncorrected40 
0.00 0.00 - 0. 12*** 30.65 ( < 0.0001) 
0.05 0.01 - 0. 17*** 45.98 ( < 0.0001) 
0.07 0.03 - 0. 16*** 64.34 ( < 0.0001) 
0.29 0.17 - 0.47 30.02 ( < 0.0001) 
0.81 0.56 - 1 . 16 1 .42 (0.2342) 
0.99 0.68 - 1 .42 0.01 (0.9374) 
1 .08 0.75 - 1 .56 0. 17 (0.6771) 
1 .77 1 .25 - 2.49 1 1 .46 (0.0007) 
1 .98 1.39 - 2.83 15.16 (0.0001) 
1 .66 1 . 16 - 2.36 8.67 (0.0032) 
1.86 1.29 - 2.68 12.45 (0.0004) 
2.03 1 .29 - 3.20 10.69 (0.001 1) 
2.09 1 .38 - 3. 16 13.77 (0.0002) 
1 .75 1 .09 - 2.80 6. 16 (0.0131) 
1 .66 0.95 - 2.88 3.64 (0.0564) 
1 . 1 1  0.62 - 2.01 0. 15 (0.7012) 
Table 5.2. Sexes of71 1 Cases of Canine Hypoadrenocorticism and 1 , 152 Controls 
from 1994 Survey in the United States of Veterinarians Enrolled in Clinical Trial 
Cases Controls 
Sexes Number Percent Number Percent 
Female-intact 37 5.2 157 13.6 
Female-spayed 454 63.9 474 41 . 1  
All females 491 69. 1  631 54.8 
Male-intact 73 10.3 272 23 .6 
Male-castrated 147 20.7 249 21 .6 
All males 220 30.9 521 45.2 





Table 5.3. Sex-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 Survey in the United States of Veterinarians Enrolled 
in Clinical Trial 
X: statistic (p value) 
Number of cases Number of controls 95% confidence 
Sex* n=7 1 1  n= 1 , 152 OR interval for OR49 Uncorrected40 
Female-intact 37 157 0.35 0.24 - 0.51 33.45 ( < 0.0001) 
Female-spayed 454 474 2.52 2.07 - 3.08 90.68 ( < 0.0001) 
Female-spayed** 454 474 4.06 2.74 - 6.06 57.88 ( < 0.0001) 
Female (intact and spayed) 491 63 1 1 .84 1 .51 - 2.25 37. 18 (<  0.0001) 
Male-intact 73 272 0.37 0.28 - 0.49 51 .10 (< 0.0001) 
Male-castrated 147 249 0.95 0.75 - 1 .20 0.22 (0.6410) 
Male-castrated*"'* 147 249 2.20 1 .56 - 3. 10 22.50 ( < 0.0001) 
Neutered (either sex) 601 723 3.24 2.54 - 4. 13 101 .00 ( < 0.0001) 
"' Except as noted, the comparison group is all other dogs. 
"'"' Female-spayed compared to female-intact. 




Table 5.4. Sex-Specific Odds Ratios (OR) for Dogs (0 yr < Age < 5 yr) with Hypoadrenocorticism from 1994 Survey in the United States of 
Veterinarians Enrolled in Clinical Trial 
Number of cases Number of controls 
Sex• n = 8 1  n=478 
Female-intact 6 108 
Female-spayed 38 134 
Female-spayed••• 38 134 
Female (intact and spayed) 44 242 
Male-intact 1 1  141 
Male-castrated 26 95 
Male-castrated•••• 26 95 
Neutered (either sex) 64 229 
• Except as noted, the comparison group is all other dogs. 
,..,.. Exact confidence limits. •28 
••• Female-spayed compared to female-intact. 











interval for OR49 
0.09 - 0.65•• 
1 .37 - 3.77 
2.03 - 15.26*"' 
0.70 - 1 .91 
0. 18 - 0.76 
1 . 10 - 3 .29 
1 .57 - 7.97 
2.26 - 7.50 
X: statistic {p value) 
Uncorrected40 
9.84 (0.0017) 





1 1.68 (0.0006) 




Table 5.5. Sex-Specific Odds Ratios (OR) for Dogs (5 yr � Age < 10 yr) with Hypoadrenocorticism from 1994 Survey in the United States 
of Veterinarians Enrolled in Clinical Trial 
x? statistic (p value) 
Number of cases Number of controls 95% confidence 
Sex"' n=323 n=393 OR interval for OR4� Uncorrected• 
Female-intact 15 32 o.ss 0.28 - 1 .07 3.54 (0.0600) 
Female-spayed 202 190 1 .78 1 .31 - 2.44 14.41 (0.0001) 
Female-spayed"'"' 202 190 2.27 1 . 14 - 4.55 6.46 (0.01 10) 
Female (intact and spayed) 217 222 1 .58 1 . 15 - 2. 17 8.55 (0.0035) 
Male-intact 36 73 0.55 0.35 - 0.86 7.58 (0.0059) 
Male-castrated 70 98 0.83 0.58 - 1 .20 1 .05 (0.3050) 
Male-castrated"'"'"' 70 98 1.45 0.85 - 2.47 2.09 (0. 1484) 
Neutered (either sex) 272 288 1 .94 1 .32 - 2.87 12.42 (0.0004) 
"' Except as noted, the comparison group is all other dogs. 
"'"' Female-spayed compared to female-intact. 




Table 5.6. Sex·Specific Odds Ratios (OR) for Dogs (Age &;::: 10 yr) with Hypoadrenocorticism from 1994 Survey in the United States of Veterinarians 
Enrolled in Clinical Trial 
X: statistic (p value) 
Number of cases Number of controls 95% confidence 
Sex• n=259 n=255 OR interval for OR49 Uncorrected40 
Female·intact 1 1  15 0.7 1 0.30 - 1 .68 0.72 (0.3976) 
Female·spayed 183 140 1 .98 1 .35 - 2.89 13.66 (0.0002) 
Female·spayed** 183 140 1.78 0.74 - 4.30 2.01 (0. 1566) 
Female (intact and spayed) 194 ISS 1.93 1 .30 - 2.86 1 1 .75 (0.0006) 
Male·intact 21 48 0.38 0.21 - 0.68 12.69 (0.0004) 
Male�astrated 44 52 0.80 0.50 . 1 .28 0.98 (0.3222) 
Male-castrated••• 44 52 1 .93 0.96 . 3.91 3.99 (0.0459) 
Neutered (either sex) 227 192 2.33 1.42 . 3 .81  13.01 (0.0003) 
• Except as noted, the comparison group is all other dogs. 
•• Female-spayed compared to femal�intact. 
••• Male�trated compared to male·intact. 
Breeds 
Breeds were reported for 714 (99.3 %) of the 719 cases (Table 5.7). The 
seven most frequently reported case breeds with number (%) were: Poodle 122 
(17. 1); Mixed 72 (10. 1); Labrador Retriever 71  (9.9); German Shepherd 40 (5.6); 
Golden Retriever 32 (4.5) ;  West Highland White Terrier 3 1  (4.3) ;  and Rottweiler 
24 (3.4). 
Breeds were reported for 1 , 184 (99.3 %) of the 1 , 192 controls (Table 5.7). 
The seven most frequently reported control breeds with number (%) were: Mixed 
152 (12.8) ;  Labrador Retriever 1 18 (10.0); German Shepherd 86 (7.3); Golden 
Retriever 68 (5.7); Cocker Spaniel 67 (5.7); Poodle 65 (5.5) ;  and Shetland 
Sheepdog 33 (2.8).  The number (%) of the seven most frequently reported case 
breeds among controls was (in the same order as listed above for cases): Poodle 
65 (5.5); Mixed 152 (12.8); Labrador Retriever 1 1 8  (10.0); German Shepherd 86 
(7.3); Golden Retriever 68 (5.7); West Highland White Terrier 9 (0.8) ;  and 
Rottweiler 32 (2. 7). 
Breed-specific OR were calculated for all breeds for which there were at least 
five cases or five controls of ihe breed reported in the survey (Table 5 .8). 
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Table 5.7. Breeds of 7 14 Cases of Hypoadrenocorticism and 1.184 Controls from 1994 Survey in the 
United States of Veterinarians Enrolled in Clinical Trial* 
Cases Controls 
Breed Nwnber Percent Nwnber Percent 
Airedale Terrier 14 2.0 9 0.8 
Akita 5 0.7 4 0.3 
Alaskan Malamute 7 1.0 6 o.s 
Australian Shepherd 7 1.0 20 1.7 
Basset Hound 20 2.8 10 0.8 
Beagle 1 1  1.5 30 2.5 
Bearded Collie 10 1 .4 4 0.3 
Bichon Frise 3 0.4 9 0.8 
Border Collie 7 1 .0 6 o.s 
Boston Terrier 0 0.0 7 0.6 
Boxer 1 0. 1 14 1 .2 
Brittany 4 0.6 7 0.6 
Chihuahua 5 0.7 10 0.8 
Chow Chow 7 1.0 22 1 .9 
Cocker Spaniel 21 2.9 67 5.7 
Collie 10 1.4 19 1 .6 
Dachshund 1 1  1.5 23 1.9 
Dalmatian 0 0.0 14 1 .2 
Doberman Pinscher 8 1 .1  25 2. 1 
English Bulldog 0 0.0 6 0.5 
German Shepherd 40 5.6 86 7.3 
German Shorthaired Pointer 15 2. 1 10 0.8 
Golden Retriever 32 4.5 68 5.1 
Great Dane 18  2.5 4 0.3 
Irish Setter 4 0.6 7 0.6 
Jack Russell Terrier 0 0.0 5 0.4 
Labrador Retriever 71 9.9 1 18 10.0 
Lhasa Apso 3 0.4 22 1.9 
120 
Table 5. 7 (continued) 
Cases Controls 
Breed Nmnber Percent Nmnber Percent 
Malte$e 5 0.7 19 1 .6 
Mixed 72 10. 1 152 12.8 
Pekingese 3 0.4 7 0.6 
Pit Bull Terrier 0 0.0 9 0.8 
Pomeranian 1 0. 1 14 1 .2 
Poodle 122 17. 1 65 5.5 
Pug 0 0.0 6 0.5 
Rottweiler 24 3.4 32 2.7 
Saint Bernard 5 0.7 0 0.0 
Schnauzer 1 1  1 .5 2S 2. 1 
Scottish Terrier 8 1 . 1  6 0.5 
Shar Pei 2 0.3 8 0.7 
Shetland Sheepdog 3 0.4 33 2.8 
Shih Tzu 3 0.4 20 1 .7 
Siberian Husky 6 0.8 10 0.8 
Spitz (American Eskimo) 1 0. 1 1 1  0.9 
Springer Spaniel 24 3.4 16 1 .4 
West Highland White Terrier 3 1  4.3 9 0.8 
Yorkshire Terrier 2 0.3 23 1.9 
* Breeds are included only if there were at least five cases or five controls of the breed reported in the 
survey. 
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Table 5.8. Breed-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 Survey in the United States of Veterinarians Enrolled 
in Clinical Trial* 
X: statistic (p value) 
Number of cases Number of controls 95% confidence Fisher exact 
Breed** n=714 n= l . l 84 OR interval for OR49 Uncorrected40 (2-tailed p 
value)***102 
Airedale Terrier 14 9 2.61 1 .06 - 6.56 5.36 (0.0206) 
Akita 5 4 2.08 0.45 - 10.52**"'"' 1 .24 (0.2655) 0.3098 
Alaskan Malamute 7 6 1.94 0.56 - 7.03**"'"' 1 .47 (0.2255) 0.2567 
Australian Shepherd 7 20 0.58 0.20 - 1 .43*"'"'"' 1 .60 (0.2065) 
Basset Hound 20 10 3.38 1 .50 - 7.79 10.96 (0.0009) -
[:j Beagle 1 1  30 0.60 0.28 - 1 .26 2.08 (0. 1494) 
Bearded Collie 10 4 4.19 1 .20 - 1 8.36**"'"' 6.87 (0.0088) 
Bichon Prise 3 9 0.55 0. 10 - 2.22**** 0.82 (0.3654) 0.5520 
Border Collie 7 6 1 .94 0.56 - 7.03**** 1 .47 (0.2255) 0.2567 
Boston Terrier 0 7 0.00 0.00 - 1 . 15**** 4.24 (0.0396) 0.0498 
Boxer 1 14 0. 12 0.00 - 0.77**** 6.17 (0.0130) 
Brittany 4 7 0.95 0.20 - 3. 74**""1' 0.01 (0.93 13) 1 .0000 
Chihuahua 5 10 0.83 0.22 - 2.67•••• 0. 12  (0.7309) 
Chow Chow 7 22 0.52 0. 19 - 1 .28**** 2.28 (0. 1310) 
Cocker Spaniel 21  67 0.51 0.30 - 0.85 7.44 (0.0064) 
Collie 10 19 0.87 0.38 - 1 .98 0. 12 (0.7254) 
Dachshund 1 1  23 0.79 0.36 - 1 .7 1  0.41 (0.5225) 
Dalmatian 0 14 0.00 o.oo - o.5o•••• 8.51 (0.0035) 
Table 5.8 (continued) 
X: statistic (p value) 
Number of cases Number of controls 95% confidence Fisher exact 
Breed''"" n=714 n= 1 , 184 OR interval for OR49 Uncorrected40 (2-tailed p 
value)**"'162 
Doberman Pinscher 8 25 0.53 0.22 - 1 .23 2.56 (0. 1096) 
English Bulldog 0 6 0.00 0.00 - 1.4 1"'"'"'"' 3.63 (0.0568) 0.0895 
German Shepherd 40 86 0.76 0.50 - 1 . 13 1 .98 (0. 1590) 
German Shorthaired 15 10 2.52 1 .06 - 6.06 5.41 (0.0200) 
Pointer 
Golden Retriever 32 68 0.77 0.49 - 1.21 1 .42 (0.2334) 
-� Great Dane 18  4 7.63 2.50 - 31 .09"'"'"'"' 18.53 ( <  0.0001)  
Irish Setter 4 7 0.95 0.20 - 3.74"'"'"'"' 0.01 (0.93 13) 1.0000 
Jack Russell Terrier 0 5 0.00 0.00 - 1.81"'"'"'"' 3.02 (0.0821) 0. 1639 
Labrador Retriever 71  1 18 1 .00 0.72 - 1.38 0.00 (0.9875) 
Lhasa Apso 3 22 0.22 0.04 - 0.75"'"'"'"' 7.09 (0.0078) 
Maltese 5 19 0.43 0. 13 - 1 .20"'"'"'"' 2.92 (0.0876) 
Mixed 72 152 0.76 0.56 - 1 .04 3.24 (0.0716) 
Pekingese 3 7 0.71 0.12 - 3. 12"'"'"'"' 0.25 (0.6180) 0.75 15 
Pit Bull Terrier 0 9 0.00 0.00 - 0.84*"'"'"' 5.45 (0.0195) 0.0165 
Pomeranian 1 14 0. 12 0.00 - 0.77"'"'"'"' 6. 17 (0.0130) 
Poodle 122 65 3.55 2.55 - 4.93 67.44 ( <  0.0001)  
Pug 0 6 0.00 0.00 - 1.4 1"'"'"'"' 3.63 (0.0568) 0.0895 
Rottweiler 24 32 1 .25 0.71 - 2.21 0.67 (0.41 14) 
-
� 
Table 5.8 (continued) 
,(- statistic (p value) 
Number of cases Number of controls 95% confidence 
Breed•• n=714 n= 1 , 1 84 OR interval for OR49 Uncom:cted40 
Saint Bernard 5 0 ............... ... ............ 8.3 1  (0.0039) 
Schnauzer 1 1  2S 0.73 0.33 • 1 .55 0.78 (0.3771) 
Scottish Terrier 8 6 2.22 0.67 . 7.81•••• 2.29 (0. 1301) 
Sbar Pei 2 8 0.41 0.04 . 2.08•••• 1 .33 (0.2488) 
Shetland Sheepdog 3 33 0.15 0.03 . 0.47""""'"' 13.41 (0.0003) 
Shih Tzu 3 20 0.25 0.05 . 0.83•••• 5.99 (0.0144) 
Siberian Husky 6 10 0.99 0.30 . 3.04•••• 0.00 (0.9922) 
Spitz (American Eskimo) I 1 1  0.15 0.00 . 1 .03•••• 4.4 1 (0.0357) 
Springer Spaniel 24 16 2.54 1 .29 . 5.04 8.72 (0.003 1) 
West Highland White 3 1  9 5.93 2.69 . 13.46 27.69 (< 0.0001) 
Terrier 
Yorkshire Terrier 2 23 0. 14 o.o2 - o.58•••• 9.47 (0.0021) 
• Breeds are included only if there were at )east five cases or five controls of the breed reported in the survey. 
•• The comparison group is all other dogs. 
••• Calculated only if an expected cell value is < 5; the preferred p value for this OR. 









Body weights were reported for 657 (91 .4%) of the 719 cases (Figure 5.5).w 
The average body weight (kg) for cases was 24.5 (SD 14.5) (SEM 0.6) (Range 2.3 
- 8 1 .8) .  Body weights were reported for 1 , 1 1 1  (93.2%) of the 1 , 192 controls 
(Figure 5.6). The average body weight (kg) for controls was 19.7 (SD 12.7) (SEM 
0.4) (Range 1 .4 - 68.2). Body weight-specific OR were calculated for 5 kg body 
weight increments (Table 5.9). 
Selected Clinical Findings Hypothetically Associated with Canine 
Hypoadrenocorticism 
Odds ratios were calculated for clinical findings which were either 
anecdotally linked to hypoadrenocorticism or had a putative autoimmune etiology. 
Table 5 . 10 tabulates these results and relevant statistics. Since aging may affect the 
occurrence of many of these clinical findings, OR for clinical findings were 
calculated after stratifying the ages into five-year intervals (Tables 5 . 1 1-5. 13). 
"The questionnaire simply asked the veterinarian to report "body weight, " so 
the weight reported was, presumably, the most recently recorded body weight in 















































Figure 5.5. Body Weights of 657 Dogs with Hypoadrenocorticism from 1994 Survey in the United States of 









































Figure 5.6. Body Weights of 1 , 1 1 1  Control Dogs from 1994 Survey in the United States of Veterinarians Enrolled 




Table 5.9. Body Weight-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 Survey in the United States of Veterinarians 
Enrolled in Clinical Trial 
'Jf statistic (p value) 
Body weight Number of cases Number of controls 95% confidence 
interval (kg)* n=657 n= l , 1 1 1  OR interval for OR49 Uncorrected40 
0 < weight :S: S 29 122 0.37 0.24 - 0.58 22.79 (< 0.0001) 
S < weight :S: 10 1 19 224 0.88 0.68 - 1 . 13 1 . 1 1  (0.2923) 
10 < weight :s: IS 56 ISS O.S7 0.4 1 - 0.80 1 1 .57 (0.0007) 
IS < weight :S: 20 53 125 0.69 0.49 - 0.98 4.62 (0.0315) 
20 < weight :S: 25 107 1 14 1 .70 1 .27 - 2.28 13.70 (0.0002) 
2S < weight :S: 30 75 1 16 1 . 1 1  0.80 - 1 .52 0.41 (O.S236) 
30 < weight :S: 35 74 109 1 . 17 0.84 - 1.61 0.94 (0.3327) 
35 < weight :S: 40 62 66 1 .6S 1 . 13 - 2.40 7.51 (0.0061) 
40 < weight :s: 45 3 1  41  1 .29 0.78 - 2. 13  1 . 12 (0.2906) 
45 < weight :S: SO 17  26 1 . 1 1  0.57 - 2. 14 0. 1 1  (0.7443) 
SO < weight :S: 55 1 1  6 3. 14 1 .06 - 10.37** 5.58 (0.0182) 
weight > SS 23 7 5.72 2.36 - 15.86"'"' 20.40 ( < 0.0001) 
"' The comparison group is all other dogs. 
*"' Exact confidence limits.128 
-
Table 5. 10. Odds Ratios (OR) for Clinical Findings Associated with Hypoadrenocorticism in Dogs from 1994 Survey in the United States of Veterinarians 
Enrolled in Clinical Trial 
X: statistic (p 
value) 
Number of cases Number of controls 95% confidence Fisher exact 
Clinical finding"' n=666 n= 1 , 147 OR interval for OR49 Uncorrected40 (2-tailed p value)"'"'162 
Anemia 68 7 18.52 8.43 - 48.03"'"'"' 97.92 ( < 0.0001) 
Arthritis lOS 80 2.50 1 .81  - 3.44 35.54 ( < 0.0001) 
Cruciate ligament rupture 17 13 2.28 1.05 - 5.02 5.21 (0.0224) 
Diabetes mellitus s 4 2. 16 0.46 - 10.93**"' 1 .38 (0.2403) 0.3023 
Hepatitis 29 7 7.41 3 . 15 - 20. 14 30.35 ( < 0.0001) 
� Hypothyroidism 85 35 4.65 3.04 - 7. 12 64.29 ( < 0.0001) 
Keratoconjunctivitis sicca 18 9 3.51 1 .49 - 8.49 10.57 (0.0012) 
Megaesophagus 3 1 5 . 19 0.41 - 272.46••• 2.53 (0. 1 120) 0. 1434 
Myasthenia gravis 3 0 ... ...... ... ......... 5. 18  (0.0229) 0.0494 
Nephritis 41  1 1  6.77 3.33 - 14.08 40.85 ( < 0.0001) 
Thrombocytopenia 9 3 5.22 1 .30 - 30.07"'"'"' 7.61 (0.0058) 0.01 19 
"' Clinical findings either anecdotally linked to hypoadrenocorticism or with a putative autoimmune etiology; comparison group is all other dogs. 
•• Calculated only if an expected cell value is < S; the preferred p value for this OR. 




Table 5. 1 1 .  Odds Ratios (OR) for Clinical Findings Associated with Hypoadrenocorticism in Dogs (0 yr < Age < 5 yr) from 1994 Survey in the 
United States of Veterinarians Enrolled in Clinical Trial 
r statistic (p 
value) 
Number of cases Number of controls 95% confidence Fisher exact 
Clinical fmding* n=79 n=477 OR interval for OR49 Uncorrected40 (2-tailed p 
value)**162 
Anemia 6 2 19.52 3.38 - 199.41 "'"'"' 24.61 ( < 0.0001) 0.0002 
Arthritis 5 8 3.96 0.99 - 14. 12"'"'"' 6.42 (0.01 13) 0.0260 
Cruciate ligament rupture 0 1 0.00 0.00 - 235.48"'"'"' 0. 17 (0.6838) 1 .0000 
Hepatitis 0 1 0.00 0.00 - 235.48••• 0. 17 (0.6838) 1 .000  
Hypothyroidism 6 6 6.45 1 .67 - 24.7 1••• 12.89 (0.0003) 0.0031 
Keratoconjunctivitis sicca 1 0 •••• •••• 6.05 (0.0139) 0. 142 1  
Megaesophagus 1 1 6. 10 0.08 - 479.99••• 2. 1 1  (0. 1464) 0.2642 
Myasthenia gravis 1 0 •••• •••• 6.05 (0.0139) 0. 1421 
Nephritis 2 1 12.36 0.63 - 730. 86••• 6.81 (0.0091) 0.0544 
Thrombocytopenia 0 1 0.00 0.00 - 235.48"'"'"' 0. 17 (0.6838) 1 .0000 
"' Clinical findings either anecdotally linked to hypoadrenocorticism or with a putative autoimmune etiology; comparison group is all other dogs; there 
were no cases or controls for diabetes mellitus. 
•• Calculated only if an expected cell value is < 5; the preferred p value for this OR. 
"'"'"' Exact confidence limits.128 
•••• Undefined. 
-w -
Table 5. 12. Odds Ratios (OR) for Clinical Findings Associated with Hypoadrenocorticism in Dogs (5 yr :s; Age < 10 yr) from 1994 Survey in the 
United States of Veterinarians Enrolled in Clinical Trial 
i' statistic (p 
value) 
Number of cases Number of controls 95 % confidence Fisher exact 
Clinical finding"' n=307 n=389 OR interval for OR49 Uncorrected40 (2-tailed p value}**162 
Anemia 29 2 20. 19 5.02 - 175.44*** 32. 17 (< 0.0001) 
Arthritis 27 15 2.40 1.20 - 4.84 7.38 (0.0066} 
Crociate ligament rupture 5 5 1 .27 0.29 - 5.58*** 0. 14 (0.7055) 0.7561 
Diabetes mellitus 1 2 0.63 0.01 - 12.21**"' 0.14 (0.7064) 1 .0000 
Hepatitis 16 1 21 .33 3.27 - 896.86*** 17.68 (< 0.0001) 
Hypothyroidism 43 14 4.36 2.26 - 8.55 24.72 ( < 0.0001) 
Keratoconjunctivitis sicca 7 I 9.05 1 . 15 - 409.05*"'"' 6.18 (0.0129) 
Megaesophagus 2 0 ............ ... ......... 2.54 (0. 1 109) 0. 1942 
Myasthenia gravis 2 0 ............ ............ 2.54 (0. 1 109} 0. 1942 
Nephritis 17 2 1 1 .34 2.65 - 101.72*"'* 16.31 (0.0001} 
Thrombocytopenia 5 1 6.42 0.71 - 304.60**"' 3.78 (0.0520) 0.0925 
* Clinical findings either anecdotally linked to bypoadrenocorticism or with a putative autoimmune etiology; comparison group is all other dogs. 
** Calculated only if an expected cell value is < 5; the preferred p value for this OR. 




Table 5.13.  Odds Ratios (OR) for Clinical Findings Associated with Hypoadrenocorticism in Dogs (Age :::: 10 yr) from 1994 SuiVey in the 
United States of Veterinarians Enrolled in Clinical Trial 
x? statistic (p 
value) 
Number of Number of 
cases controls 95% confidence Fisher exact 
Clinical finding* n=249 n=2S4 OR interval for OR411 Uncorrected40 (2-tailed p value)""'ot6l 
Anemia 30 3 1 1 .46 3.48 - 59.27*** 24.22 ( < 0.0001) 
Arthritis 67 53 1 .40 0.9 1 - 2. 15 2.53 (0. 1 120) 
Cruciate ligament rupture 12 6 2.09 0.7 1 - 6.90*** 2.20 (0. 1380) 
Diabetes mellitus 4 2 2.06 0.29 - 22.90*** 0. 72 (0.3976) 0.4462 
Hepatitis 12 4 3 . 16 0.94 - 13.62*** 4.30 (0.0382) 
Hypothyroidism 33 IS 2.43 1 .24 - 4.84 7.86 (0,0050) 
Keratoconjunctivitis sicca 9 8 1 . 15 0.40 - 3.34 0.08 (0.7730) 
Nephritis 19 6 3.41 1 .28 - 10.61••• 7.39 (0.0066) 
Thrombocytopenia 4 1 4.13 0.40 - 204.21"'** 1 .88 (0. 1704) 0.2123 
* Clinical findings either anecdotally linked to hypoadrenocorticism or with a putative autoimmune etiology; comparison group is all other dogs; there 
were no cases or controls for megaesophagus and myasthenia gravis. 
•• Calculated only if an expected cell value is < S; the preferred p value for this OR. 
••• Exact confidence limits. 128 
Logistic Regression 
General 
There were two objectives for the logistic regression: evaluating the 
relationship of age, breed, sex, and body weight with the occurrence of 
hypoadrenocorticism in the dog, and developing models which would predict the 
relative probability of hypoadrenocorticism in dogs. The response variable was 
dichotomous: the dog either had hypoadrenocorticism or did not. Next, unless 
otherwise noted, the word "significant" means that the factor, interaction, test, or 
model being evaluated had a p value less than 0.05. Finally, R2 is 11 the proportion 
of the total uncertainty that is attributed to the model fit. " 178 More specifically, it 
is the negative loglikelihood of the model divided by the negative loglikelihood of 
a model in which no effects were specified. 178 
Factor Evaluation 
Single factor models. A model was fit for each of the individual independent 
variables-age, breed, sex, and body weight-and the response variable. In each of 
these models, the factor and the model itself (the words "factor" and "independent 
variable" are used interchangeably) were significant. The R2 values were very low, 
ranging from 0.02 to 0. 10. 
The models for age and body weight each had significant lack of fit. 
Therefore, the following higher order models were fit: case = age age*age, case 
133 
= age age*age age�ge*age, case = body weight body weight*body weight, and 
case = body weight body weight*body weight body weight*body weight*body 
weight. The model case = age age*age still had a lack of fit problem, although 
only a borderline one (p=0.0423). The lack of fit problem disappeared in the case 
= age age*age age*age*age model (p=O. l605). (However, for the sake of 
parsimony, the cubic term involving age was not used in model development.) The 
lack of fit problem continued for both the higher order models using body weight 
as the independent variable. Detailed results are included in Appendix C l .  
Two factor models with no interactions. A model was fit for each pair of the 
individual independent variables and the response variable. In each model, both 
factors considered singly and the model were significant. The R2 values ranged 
from 0. 07 to 0. 17. Detailed results are included in Appendix C2. 
Two factor models with interactions. A model was fit for each pair of the 
individual independent variables, plus the interaction involving those variables, and 
the response variable. In these models, the factors considered singly may or may 
not have been significant, but in no case was the interaction significant. The 
models were all significant. The R2 values ranged from 0.07 to 0. 18 .  Detailed 
results are included in Appendix C3. 
Three factor models with no interactions. A model was fit for each 
combination of three of the independent variables and the response variable. In 
each of these models, all three factors considered singly and the model itself were 
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significant. The R2 values ranged from 0.12 to 0. 19.  Detailed results are included 
in Appendix C4. 
Three factor models with two-way interactions. A model was fit for each 
combination of three of the independent variables, plus all two-way interactions 
involving those variables, and the response variable. In these models, the factors 
considered singly may or may not have been significant, but no two-way 
interactions except two were significant. The exceptions were the age*sex 
interaction (p=0.0470) in the model case = age breed sex age*breed age*sex 
breed*sex, and the sex*body weight interaction (p=0.0327) in the model case = 
age sex body weight age*sex age*body weight . sex*body weight. The age*sex 
interaction in the first model disappeared if dogs 1 .5 yr old and younger were 
removed from the data set. It also disappeared if sex was categorized as just 
female and male, rather than female-intact, female-spayed, male-intact, and male­
castrated. The models were all significant. The R2 values ranged from 0.13 to 
0.23 . Detailed results are included in Appendix C5. 
Three factor models with two- and three-way interactions. A model was fit 
for each combination of three of the independent variables, plus all two-way 
interactions and the one three-way interaction involving those variables, and the 
response variable. In these models, the factors considered singly were, with two 
exceptions, not significant. The two-way interactions were, with three exceptions, 
similarly not significant. Two of the four three-way interactions were significant; 
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two were not. The models were all significant. The R2 values ranged from 0. 13 
to 0.24. Detailed results are included in Appendix C6. 
Model fitting. The results from more than 100 models were evaluated in 
choosing the two models which are presented below. x The final models were 
chosen to meet four criteria: the model itself had to be significant, each term in 
the model had to be significant, the model lack of fit had to be insignificant, and 
the model had to be reasonably parsimonious. 
The factor evaluation described above provided a starting point for designing 
the two recommended models. First, the single factor models and the two factor 
models (with and without interactions) established that all factors were related to 
the response variable. Adding the quadratic term for age improved the model's fit, 
and, though the cubic term improved the fit more, the cubic term was not included 
because of respect for parsimony. Therefore, the following basic model was 
evaluated: case = age age*age breed sex body weight. This model met all the 
selection criteria listed above. The model was significant (p < 0.0001). Each term 
in the model was significant (each at p < 0.0001). The model lack of fit was not 
significant (p = 0.2692) . And, excepting the quadratic term for age, the model 
was as parsimonious as a model could be and still include all four factors. The R2 
XJ:t should be noted here that four factor-age, breed, sex, and body weight­
models with all two- and three-way interactions included were beyond the 
computer's capability. Thus, they were not considered. 
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value for this model was 0.2418; but large R2 values are rare in categorical 
models. 179 Appendix C7 includes more details about this model. 
This model was then evaluated after the addition, one at a time, of all the 
two-way interactions: age*breed, age*Sex, age*body weight, breed*Sex, 
breed*body weight, and sex*body weight. Four of these six interactions were not 
significant, but two of them were: age*body weight (p = 0.0003) and sex-.body 
weight (p = 0.0368). Based on these results, both of these interactions were added 
to the model above to yield a second useful model: case = age age*age breed sex 
body weight age*body weight sex*body weight. This model also met all the 
selection criteria. The model was significant (p < 0.0001).  Each term in the 
model was significant (each at p < 0.0001,  except sex at p = 0.0046, age*body 
weight at p = 0.0003 ,  and sex*body weight at p = 0.0370). The model lack of 
fit was not significant (p = 0.3833). The R2 value for this model was 0.2516. 
Appendix C7 includes more details about this model. 
Discussion 
Questionnaire Responses and Description of Veterinary Clinics 
This was a large case control study involving questionnaires returned from 
519 veterinarians, 494 separate veterinary clinics, 720 cases, and 1 , 192 controls. 
The response rate was 90.9 % .  The cases sampled probably do not represent the 
average veterinarian in clinical practice, nor veterinarians from veterinary referral 
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hospitals (Chapter 4). They probably represent veterinarians who are more diligent 
than the randomly selected veterinarians surveyed (Chapter 6) since they were 
submitted by private practitioners who went to the trouble of seeking DOCP and 
doing the administrative work associated with enrolling in the clinical trial. 
Figure 5 . 1  reveals that 91 .8% of the responses received were received within 
60 da of the initial mailing. This is useful for planning similar future studies. A 
cutoff of responses at 60 da would seem reasonable. 
The average veterinary clinic had 2.60 full-time veterinarians (Figure 5.2), 
and reported an average estimated number of dogs first diagnosed in 1993 of 1 .23. 
If 2.60 full-time veterinarians see 1 .23 newly diagnosed hypoadrenal dogs per yr, 
this suggested that the average small animal practitioner might see one-half case 
per yr. This probably underestimated the number of cases since one individual in 
each clinic :filled out the questionnaire. This veterinarian, being asked for summary 
data about the entire practice, may not have been aware of all cases seen in the 
practice. Nevertheless, this one-half case per yr per veterinarian probably can 
serve as a useful benchmark. The average number of dogs seen per veterinarian 
per yr (individual dogs, not dog visits) of 1 ,504.7 could serve as a similar 
benchmark. 
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Incidence and Prevalence Estimates 
The incidence estimate of0.34 case/1000 dogs/yr and the prevalence estimate 
of 1 .  7 cases/1 000 dogs suggested an approximate rate at which new cases may be 
acquired, and a rough indicator of how many cases a veterinarian might expect to 
be treating at any one time among all the dogs seen in the practice. 
Ages 
The mean age for hypoadrenal dogs was higher (8 .7 yr) than the mean for 
control dogs (6.2 yr) . Similarly, the average age for live hypoadrenal dogs (8 . 1  
yr) exceeded that for live control dogs (6. 1  yr) . 
Table 5 . 1  shows the ages of hypoadrenal patients which might be expected 
among a veterinarian's patient files. Compared to controls, dogs up to 
approximately 4 yr were less likely to have adrenal insufficiency than other dogs, 
those approximately 4 to 7 yr were about equally likely to be hypoadrenal, and 
those approximately 7 to 14 yr were more likely to have adrenal insufficiency. 
Dogs older than approximately 14 yr were about equally likely to be hypoadrenal 
compared to controls. This might be explained by the earlier death of hypoadrenal 
dogs when compared to controls. 
The estimated average disease duration of 4.9 yr, coupled with the average 
age at death of 9.8 yr, suggested that hypoadrenal dogs can live long lives. 
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Sexes 
The assertion that canine hypoadrenocorticism is more frequent in female 
dogs41•43•93•148•189 was confirmed. Females comprised 54.8 %  of controls, but 69. 1 %  
of cases (Table 5.2). The OR for female dogs compared to males was 1 .84 with 
a 95 % confidence interval of 1 .51  to 2.25 (Table 5.3). 
These data suggested that neutered animals were much more likely to be 
hypoadrenal. The OR for female-spayed dogs compared to female-intact dogs was 
4.06 (95 % confidence interval 2.74 - 6.06), and the OR for male-castrated dogs 
compared to male-intact dogs was 2.20 (95 % confidence interval 1 .56 - 3. 10) 
(Table 5.3). The OR for female-intact dogs compared to all other dogs was 0.35 
(95 % confidence interval 0.24 - 0.51). These results suggested that female-intact 
dogs were less likely to have adrenal insufficiency than other dogs, and, 
specifically, female-spayed dogs. This contradicted another study. 148 The OR for 
female-spayed compared to all other dogs was 2.53 (95 % confidence interval 2.07 
- 3.08), and the OR for male-castrated dogs compared to other dogs was 0.95 
(95 % confidence interval 0.75 - 1 .20) . The OR for neutered dogs of either sex 
compared to intact dogs of either sex was 3 .24 (95 % confidence interval 2.54 -
4. 13) (Table 5 .3). Except for the comparison of male-castrated dogs with all other 
dogs, and this was mitigated by the comparison of male-castrated dogs with male­
intact dogs, the comparisons above led to the conclusion that neutered dogs were 
at greater risk of disease. The possibility existed that other variables, such as age, 
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may have perturbed these data and reduced (or enhanced) the predispositions of 
females and neutered dogs for the disease. To explore the possibility that age was 
affecting these associations, age-stratified analyses were conducted. The results 
generally confirmed the above conclusions. 
That canine hypoadrenocorticism was more frequent in female dogs was 
supported by the data for female dogs 5 yr and older (Tables 5.5-5 .6), but not for 
females less than 5 yr (Table 5.4) . Age-stratified data suggested that neutered dogs 
of either sex were more likely than intact dogs to have adrenal insufficiency 
(Tables 5.4-5.6). 
Overall, there was little evidence from age stratification that age perturbed 
the conclusions about the associations between sex and hypoadrenocorticism in the 
dog. Female or neutered dogs were more likely to be hypoadrenal than their male 
or intact kin. 
Breeds 
Tables 5.7 and 5.8 provide references for veterinarians and dog owners 
interested in whether or not a particular breed was represented among the cases 
or controls or both. Information about less common breeds has until now been 
difficult to come by. Table 5. 8 indicated that, using an OR greater than one and 
a 95 % confidence interval which did not include one as criteria, the following 
breeds were predisposed to hypoadrenocorticism: Airedale Terrier, Basset Hound, 
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Bearded Collie, German Shorthaired Pointer, Great Dane, Poodle, Springer 
Spaniel, and West Highland White Terrier. It indicated that, using the criteria of 
an OR less than one and a confidence interval which did not include one, the 
following breeds were less likely to be hypoadrenal than other breeds: Boxer, 
Cocker Spaniel, Dalmatian, Lhasa Apso, Pit Bull Terrier, Pomeranian, Shetland 
Sheepdog, Shih Tzu, and Yorkshire Terrier. Another study, using the statistical 
criterion of significance at the 0.05 level, found that Great Danes, Standard 
Poodles, and West Highland White Terriers were predisposed to 
hypoadrenocorticism, while Lhasa Apsos and Yorkshire Terriers were less likely 
to be hypoadrenal. 148 Using the more exacting significance level of less than 0.01 
(p value of uncorrected chi-square statistic), the Basset Hound, Bearded Collie, 
Great Dane, Poodle, Springer Spaniel, and West Highland White Terrier were 
predisposed to the disease, while the Cocker Spaniel, Dalmatian, Lhasa Apso, 
Shetland Sheepdog, and Yorkshire Terrier were less likely to be afflicted. Table 
5.  7 suggested that, since there were five Saint Bernards in 714 cases and none in 
1 , 184 controls, Saint Bernards were predisposed to the disease. Though the OR 
for Saint Bernards was undefined, the uncorrected chi-square statistic was 
significant at p < 0.01 (Table 5.8). 
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Body Weights 
The evaluation of body weights must be done with the understanding that 
reported body weights were likely an admixture of exact body weights determined 
by weighing the dogs, and less exact body weights estimated by veterinarians and 
their personnel. The latter should, nevertheless, be reasonably accurate. The 
statistical comparison of average body weight of cases (24.5 kg) with that of 
controls (19.7 kg) showed a difference (p < 0.0005) between these weights. 
The body weight-specific OR (Table 5 .9) suggested that canine 
hypoadrenocorticism was more likely in larger dogs. They suggested that small 
dogs (lighter than about 20 kg) were less likely to be hypoadrenal, that middle­
sized dogs (from about 20 kg to about 50 kg) were neither more nor less likely to 
be hypoadrenal, and that large dogs (heavier than about 50 kg) were more likely 
to be hypoadrenal. The conclusions about small dogs and large dogs were 
supported by the data, while the conclusion about middle-sized dogs was not as 
compelling. Recognizing that this body weight effect might be confounded with 
other variables such as breed, body weight-specific OR were calculated in 10 kg 
increments for Mixed dogs. These OR did not demonstrate a body weight effect 
suggesting that body weight may be confounded with breed. Regarding one 
· specific breed, though the Poodle was clearly predisposed to hypoadrenocorticism, 
it was the large Standard Poodle in which the predisposition has previously been 
reported.11•44•192 
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Though not specifically related to canine hypoadrenocorticism, Figure 5.6 
provided a profile of the body weights of dogs seen in clinical veterinary practice. 
About one dog in five (20.2%) weighed between 5 and 10 kg, and almost half 
(45.2%) weighed 15 kg or less. Only 1 . 1 % were heavier than 50 kg. 
Selected Clinical Findings Associated with Canine Hypoadrenocorticism 
Before age stratification and based on OR and their 95 % confidence intervals 
(fable 5 . 10),  all the clinical findings except diabetes mellitus and megaesophagus 
were associated with hypoadrenocorticism; i.e. , the OR were greater than one, and 
the 95 % confidence interval did not include one. Y After age (yr) stratification, the 
results were for the most part either confirmed or became equivocal, in most of 
the latter cases because the sample sizes dropped to a point that made 
demonstrating statistically significant associations difficult or impossible. 
Anemia was associated with hypoadrenocorticism after age stratification: 0 
< age < 5, OR 19.52, Table 5 . 1 1 ;  5 � age < 10, OR 20. 19, Table 5. 12); and 
age 2: 10, OR 1 1 .46, Table 5 . 13 .  The uncorrected chi-square statistics were 
significant at less than 0.0001 for all these OR. 
YThe OR for myasthenia gravis was undefined, but its uncorrected chi-square 
statistic and its two-tailed Fisher exact computation were each significant at p < 
0.05.  
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Arthritis was associated with hypoadrenocorticism before age stratification. 
Its OR was 2.50, significant at less than 0.0001 (Table 5 . 10) (here, and 
subsequently in this section, the significance levels will, unless otherwise stated, 
be for the uncorrected chi-square statistics). After age stratification, the association 
between hypoadrenocorticism and arthritis became equivocal. The OR were all 
greater than one, but for the age group 0 < age < 5, the 95 % confidence interval 
for the OR of 3 .96 included one even though the ·uncorrected chi-square statistic 
was significant at less than 0.05 (Table 5. 1 1) (this resulted here, and in a few 
other places later in this section, from different statistical techniques used to 
calculate the 95 % confidence interval and the uncorrected chi-square statistic) . For 
the age group 5 < age < 10, the OR was 2.40, the 95 % confidence interval did 
not include one, and the OR was significant at less than 0.01 (Table 5 . 12). For the 
age group age � 10, the OR was 1 .40, the 95 % confidence interval did include 
one, and the significance level was greater than 0.05 (Table 5. 13). Therefore, the 
arthritis results suggested an association between hypoadrenocorticism and 
arthritis, but the association may or may not be perturbed by age. 
Cruciate ligament rupture was not associated with hypoadrenocorticism after 
age stratification (Tables 5. 1 1-5.13) .  Therefore, it was impossible to say whether 
or not the association between hypoadrenocorticism and cruciate ligament rupture 
was affected by age. 
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Although the OR before age stratification for diabetes mellitus was 2. 16, its 
95 % confidence interval included one, and its significance level was greater than 
0.05 (Table 5.10) .  Thus, there was no evidence that diabetes mellitus and canine 
hypoadrenocorticism were associated. 
Hepatitis was associated with hypoadrenocorticism before age stratification. 
Its OR was 7.41 ,  significant at less than 0.0001 (Table 5 . 10) .  For the age group 
0 < age < 5, the OR was 0.00 (Table 5.11).  For the age group 5 < age < 10, 
the OR was 21 .33, the 95 % confidence interval did not include one, and the OR 
was significant at less than 0.0001 (Table 5. 12). For the age group age � 10, the 
OR was 3. 16, the 95 % confidence interval did include one, but the significance 
level was less than 0.05 (Table 5. 13). These results suggested an association 
between hepatitis and hypoadrenocorticism, but whether or not the association was 
affected by age remained unknown. 
Hypothyroidism was associated with hypoadrenocorticism before age 
stratification (Table 5. 10) .  For the age group 0 < age < 5, the OR was 6.45, the 
95 % confidence interval did not include one, and the 2-tailed Fisher exact p value 
was 0.003 1 (Table 5. 1 1) .  For the age group 5 < age < 10, the OR was 4.36, the 
95 % confidence interval did not include one, and the OR was significant at less 
than 0.0001 (Table 5. 12) .  For the age group age > 10, the OR was 2.43, the 
95 % confidence interval did not include one, and the significance level of the OR 
was less than 0.05 (Table 5. 13) . Thus, there was evidence of an association 
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between hypothyroidism and hypoadrenocorticism after age stratification. 
However, hypothyroidism is not unique to hypoadrenocorticism. 
Keratoconjunctivitis sicca was associated with hypoadrenocorticism before 
age stratification (Table 5.10).  For the age group 0 < age < 5, the OR was 
undefined because there were no control dogs with keratoconjunctivitis sicca, but 
the p value for the uncorrected chi-square statistic was less than 0.05 (Table 5. 1 1) .  
For the age group 5 :::;; age < 10, the OR was 9.05, the 95 % confidence interval 
did not include one, and the OR was significant at less than 0.05 (Table 5 . 12). For 
the age group age � 10, the OR was 1 . 15, the 95 % confidence interval did 
include one, and the p value for the uncorrected chi-square statistic exceeded 0.05 
(Table 5. 13) .  These results suggested that keratoconjunctivitis sicca and 
hypoadrenocorticism were associated; the association was affected by age, and the 
effect disappeared as the dogs aged. 
The OR before age stratification for megaesophagus was 5. 19, its 95 % 
confidence interval included one, and its significance level was greater than 0.05 
(Table 5 . 10).  Age stratification yielded no additional useful results (Tables 5. 1 1-
5 .13) . 
Although the OR for myasthenia gravis was undefined, its two-tailed Fisher 
exact p value was less than 0.05 (Table 5. 10).  This suggested an association 
between myasthenia gravis and hypoadrenocorticism. Age stratification yielded no 
useful results because of small sample sizes. 
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Nephritis was associated with hypoadrenocorticism before and after age 
stratification (Tables 5 . 10-5 . 13). 
Thrombocytopenia was associated with adrenal insufficiency before age 
stratification (Table 5 . 10). For the age group 0 < age < 5, the OR was 0.00 
because there were no cases with thrombocytopenia (Table 5 . 1 1).  For the age 
group 5 s; age < 10, the OR was 6.42, its 95 % confidence interval included one, 
and its significance level was greater than 0.05 (Table 5. 12). For the age group 
age ;;::: 10, the OR was 4. 13, the 95 % confidence interval included one, and the 
p value for the uncorrected chi-square statistic was greater than 0.05 (Table 5. 13). 
Therefore, thrombocytopenia was associated with hypoadrenocorticism, but 
whether or not age or other variables were involved was unclear. 
Logistic Regression 
Several things must be understood before discussion of the logistic regression 
begins. The most important understanding is that the specific results in Appendices 
C1-C8 should be examined by the reader. While the discussion below attempts to 
describe and summarize, based on the logistic distribution, the effects of age, 
breed, sex, and body weight on the probability of occurrence of 
hypoadrenocorticism in dogs, the reader must understand that these relationships 
do not lend themselves to simple characterizations. So, while easy clear 
relationships can be sought, they are seldom found with this kind of data. Results 
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are always model-dependent. Conclusions should always be viewed skeptically, 
and a look at the specific results in the appendices is usually appropriate. 
The R1 values in this study were low, never getting above about 0.25. While 
this is expected since categorical models seldom yield high R1 values, 179 it leaves 
many of the factors associated with canine hypoadrenocorticism completely 
undiscovered. 
Next, the logistic regression model, like other models, is imperfect. While 
it is useful in describing biologic systems, and, while a better categorical model 
will seldom provide a better fit, 81 it is an imperfect description of how the world 
works. The reader should keep this in mind. 
The reader should also be aware that the probabilities predicted from the 
models outlined in Appendix C7 are relative, not absolute. Probabilities calculated 
from the use of the estimated coefficients represent probabilities based on the data 
set extant. This data set is, of necessity, not a random one in terms of the number 
of cases vs. the number of controls. At a prevalence rate of 1 .  7 cases/1 000 dogs, 
a data set large enough to include 30 hypoadrenal dogs would have to contain 
about 18,000 randomly selected dogs. This is impractical. Nevertheless, the 
probabilities are still useful. They can be used to compare relative probabilities . 
For example, the estimated probability of hypoadrenocorticism for a 4 yr old, 
female-spayed, 1 1  kg West Highland White Terrier is, using the case = age 
age*age breed sex body weight model, 0.74061 .  The probability for a 1 yr old, 
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male-intact, 30 kg Boxer is, using the same model, 0.00001 .  While these 
probabilities mean nothing in the absolute sense, they say that the West Highland 
White Terrier is relatively much more likely to be diseased than the Boxer. 
And, finally, the reader should remember that not all breeds were included 
in the logistic regression. The data set included 75 breeds, and the use of that 
many breeds in a categorical variable was impractical because of computational 
difficulties. 
Given the above, interpretation of the results was straightforward. The factors 
age, breed, sex, and body weight were each associated with hypoadrenocorticism. z 
The single factor models (Appendix C l), the two factor models with no 
interactions (Appendix C2), and the three factor models with no interactions 
(Appendix C4) were evidence of this. The evidence for whether or not two-way 
interactions existed was muddier. 
The two factor models with interactions (Appendix C3) suggested no 
significant two-way interactions. However, when a third factor was added, a 
significant age*sex interaction appeared in one model, and a significant sex -.body 
weight interaction in another (Appendix C5). The three factor models with two­
and three-way interactions included significant age*sex, breed-.body weight, and 
sex*body weight interactions, again depending on the model specified. There were 
zwhether or not this association constituted causation is discussed in Appendix 
D. 
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significant model-dependent age*breed*sex and breed*sex*body weight 
interactions. Among the dozens of other models considered, there were also many 
which included significant two- and three-way interactions. So were there 
significant two- and three-way interactions? This question was not definitively 
answered. However, the second model selected included age*body weight and 
sex*body·weight interactions because they provided the best fit based on the model 
selection criteria. 
Conclusions 
1 .  Questionnaire Responses and Description of Veterinary Clinics. The 
size (720 cases and 1 , 192 controls) of this study suggested that its results should 
be viewed as reasonably reliable. Over 90% of the questionnaire responses 
received were received within 60 da, indicating that a 60 da cutoff of responses 
would be reasonable for similar studies. In 1993, the veterinary clinics had an 
average 2.60 full-time veterinarians, and initially diagnosed 1 .23 dogs with 
hypoadrenocorticism. A veterinarian in predominantly small animal practice might 
expect to initially diagnose about one-half case of canine hypoadrenocorticism per 
yr. The full-time small animal practitioners in this study saw about 1 ,500 dogs 
(individual dogs, not dog visits) per yr in 1993. 
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2. Incidence and Prevalence Estimates. The incidence (0.34 case/1000 
dogs/yr) and prevalence (1 .7 cases/1000 dogs) estimates for canine 
hypoadrenocorticism were lower than for veterinary referral hospitals (Chapter 4) . 
3 .  Ages. On average, hypoadrenal dogs were older than control dogs, but 
the age at death was similar. This suggested that with proper medical management, 
hypoadrenal dogs may live a normal life span. The estimated average disease 
duration was 4.9 yr. Age-specific OR suggested that the risk of adrenal 
insufficiency increased with age. 
4. Sexes. Females, as previously reported, 41•43•93•148•189 were more likely to 
be hypoadrenal. Female-spayed dogs were more likely to be hypoadrenal than their 
intact counterparts, and male-castrated dogs were more likely to be hypoadrenal 
than intact ones. Thus, neutered dogs of either sex were more likely to have 
adrenal insufficiency than intact dogs. Other variables such as age may have 
perturbed these results. However, results after stratification by age generally 
supported the above conclusions. 
5 .  Breeds .  Using an OR of greater than one and the absence of one in  the 
95% confidence interval as criteria, these breeds were predisposed to adrenal 
insufficiency: Airedale Terrier, Basset Hound, Bearded Collie, German 
Shorthaired Pointer, Great Dane, Poodle, Springer Spaniel, and West Highland 
White Terrier. Using the same criteria, except an OR less than one, these breeds 
were less likely to be hypoadrenal: Boxer, Cocker Spaniel, Dalmatian, Lhasa 
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Apso, Pit Bull Terrier, Pomeranian, Shetland Sheepdog, Shih Tzu, and Yorkshire 
Terrier. Using the more exacting criterion of a significance level of less than 0.01 
(p value of uncorrected chi-square statistic), the Basset Hound, Bearded Collie, 
Great Dane, Poodle, Springer Spaniel, and West Highland White Terrier were 
more likely to have disease, while the Cocker Spaniel, Dalmatian, Lhasa Apso, 
Shetland Sheepdog, and Yorkshire Terrier were less likely. The results suggested 
that Saint Bernards were predisposed to the disease, and that Boston Terriers were 
less likely to be affected. 
6. Body Weights. Small dogs were less likely to be hypoadrenal. Middle­
sized dogs were neither more nor less likely to have adrenal insufficiency. Large 
dogs were more likely to be hypoadrenal. 
7. Selected Clinical Findings Associated with Canine 
Hypoadrenocorticism. Anemia, hypothyroidism, and nephritis were associated with 
hypoadrenocorticism, and the association remained after age stratification. 
Arthritis, cruciate ligament rupture, hepatitis, keratoconjunctivitis sicca, 
myasthenia gravis, and thrombocytopenia were all associated with 
hypoadrenocorticism, but the associations became equivocal after age stratification. 
8.  Logistic Regression. Age, breed, sex, and body weight were 
significantly associated with hypoadrenocorticism in the dog. The probability of 
occurrence of canine hypoadrenocorticism increased with age and body weight, 
was greater in females than males, was greater in neutered than intact dogs, and 
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varied with breed. There was model-dependent evidence of higher order 
interactions; the exact nature of these interactions could not be determined. Models 




CASE CONTROL STUDY USING PATIENTS OF 
RANDOMLY SELECTED VETERINARIANS FROM THE 
AMERICAN VETERINARY MEDICAL ASSOCIATION'S 
LIST OF SMALL ANIMAL PRACTITIONERS 
Introduction 
While the case control study using the patients of veterinarians enrolled in 
the clinical trial (Chapter 5) introduced randomly selected control animals to the 
overall study, this group of veterinarians and their patients might be a biased 
sample. Veterinarians enrolled in the clinical trial had to enroll the dog with its 
attendant signatures, paperwork, restrictions on use of the drug, and other 
inconveniences. Consequently, a case control study of randomly selected 
veterinarians was developed. 
Methods 
The American Veterinary Medical Association (A VMA) maintains a list of 
veterinarians in the United States which includes A VMA members and 
nonmembers. Veterinarians on the list self-classify themselves as to principal 
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occupation within the profession such as small animal practitioners, large animal 
practitioners, practitioners in mixed practice, academics, and military 
veterinarians. From the A VMA list, 1 ,000 veterinarians were randomly selected 
who had classified themselves as either exclusively small animal practitioners or 
as practitioners in mixed practice whose patients were predominantly small 
animals. 
A questionnaire with instructions (Appendices A8 and A9) was designed to 
query these veterinarians about cases of hypoadrenocorticism and controls. The 
cases were hypoadrenal dogs diagnosed by the veterinarians. The control was the 
next dog in the veterinarian's patient record file owned by a different client. 
Whether the control dogs were sick or well was not considered. The method of 
Dillman,35 slightly abbreviated, was used to distribute the questionnaires. A 
reminder letter was sent to the veterinarians approximately one week after the first 
mailing, and another mailing with two more questionnaires and a cover letter was 
made to those not known to have responded approximately four weeks after the 
first mailing. 
The questionnaire requested the number of dogs (not dog visits) seen in the 
veterinary practice in 1993, and the age, breed, sex, body weight, and selected 
clinical findings for cases and controls. These data were used to calculate odds 
ratios (OR). 
Confidence intervals for OR were calculated using Cornfield's 
approximation. 49 If Cornfield confidence limits were inexact, exact confidence 
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limits were calculated. 128 Uncorrected chi-square statistics were reported.40 Fisher 
exact probability calculations for 2x2 contingency tables were calculated when the 
expected value of a cell was less than five. 162 Appendix B contains further details 
regarding these calculations. Body weights for cases and controls were compared 
using a technique for comparing means of unequal variances. 130 
Dogs were frequently reported as simply "Poodle" or "Schnauzer" without 
size specification. Therefore, all Poodles have been combined as one breed, and 
all Schnauzers have been combined as one breed. 
The selected clinical findings were chosen because of their anecdotal 
association with canine hypoadrenocorticism, or their putative autoimmune 
etiology. The list of selected clinical findings is not exhaustive. 
Results 
Questionnaire Responses and Description of Veterinary Clinics 
Five hundred fifty-five (55.5 %) of the 1 ,000 veterinarians returned 
questionnaires which included a total of 151 cases and 141 controls. The first 
response was received 3 da after the first mailing, and the last response was 
received 1 16 da after. Figure 6.1  graphs the number of responses received vs. 
time after the initial mailing. Forty-eight (8 .6%) of the responses were excluded 
because no useful data were received, usually because the veterinarian sa� no dogs 
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Figure 6. 1 .  Time Questionnaires Received After First Mailing from 1994 Survey of Randomly Selected 
Veterinarians in the United States 
Table 6. 1 .  Reasons for Excluding 48 Questionnaires from 1994 Survey of 
Randomly Selected Veterinarians in the United States 
Reason Number Percent 
1994 graduate 3 6.3 
Cats-only practice 6 12.5 
Consultant 3 6.3 
Miscellaneous 6 12.5 
No access to records 7 14.6 
Not in practice 17 35.4 
Referral practice 2 4.2 
Retired 1 2. 1 
University employee 3 6.3 
Total 48 100.2 
159 
Four hundred ninety-five veterinarians reported 1 ,050 full-time veterinarians 
in 495 clinics for an average number of full-time veterinarians per clinic of 2. 1 
(SD 1 .3) (SEMaa 0. 1) (Range 1 .0 - 9.0) . Figure 6.2 plots the number of full-time 
veterinarians in the clinics vs. the percent of individual clinics employing that 
number of full-time veterinarians. 
Four hundred fifty-six of the veterinarians reported the number of dogs 
diagnosed in 1993 and the estimated number of active dog patientsbb seen. The 
estimate of hypoadrenal dogs diagnosed for 1993 was 159 divided by the 456 
veterinary clinics for a mean of 0.35 dogs diagnosed per clinic (SD 0.8) (SEM 
0.04) (Range 0.0 - 10.0). These 456 clinics estimated 1 ,246,229 active dog 
patients during 1993. Four hundred ninety-one veterinarians reported the number 
of dogs diagnosed in 1993 and the number of full-time veterinarians employed in 
their practices. The average number of dogs diagnosed per full-time veterinarian 
was 0. 17 (SD 0.41) (SEM 0.02) (Range 0.00 - 3 .33). Four hundred fifty-one 
veterinarians reported the number of active dog patients in 1993 and the number 
of full-time veterinarians employed. The average number of active dog patients 
seen per full-time veterinarian was 1455.6ce (SD 1 , 156.3) (SEM 54.4) (Range 
25.0 - 1 1 ,000.0). 
aastandard error of the mean (SEM) equals the standard deviation (SD) divided 
by the square root of the sample size. 
bb An active dog patient was a dog seen in the practice in 1993 . Dogs were 
counted only once, even if several visits to the hospital were made in 1993. 
CC'fhis was similar to the estimate of 1 ,600 dogs seen per veterinarian per yr 
obtained on July 29, 1996 from personal communication with Dr. J. Karl Wise, 
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Figure 6.2. Number of Veterinarians Per Clinic from 1994 Survey of Randomly Selected Veterinarians in the United 
States 
Incidence and Prevalence Estimates 
Incidence was estimated at 0. 13 case/1000 dogs/yr by dividing the estimate 
of 159 cases in 1993 by the estimate of the total number of active dog patients of 
1 ,246,229. 
A prevalence estimate of 0.6 case/1000 dogs was obtained by multiplying 
0. 13 case/1000 dogs/yr times the average disease duration estimate of 4.9 yr (see 
Chapter 5) using the formula:3,9&,t20,t23,t68.200.21S.239 
Prevalence = (Incidence) (Average disease duration) 
Ages 
Ages at diagnosis were reported for 149 (98.7%) of the 151 cases. These 
ages are, notably, differently defined from the current age or age at death or age 
when lost to follow-up used in Chapter 5. The mean age was 6.7 yr (SD 3 .7) 
(SEM 0.3) (Range 0.5 - 16.0).  These ages are displayed in Figure 6.3.  Of these 
149 cases, 1 14 (76.5 %) were alive, 27 (1 8 . 1  %) were dead, 6 (4.0%) were lost to 
follow-up, and 2 ( 1 .3 %) were of unknown status. The average age at diagnosis of 
the live dogs was 6.5 yr (SD 3 .8) (SEM 0.4) (Range 0.5 - 16.0).  The average age 
at diagnosis of the dead dogs was 7.9 yr (SD 3.2) (SEM 0.6) (Range 0.5 - 14.0). 
The average age at diagnosis of the dogs lost to follow-up was 4.3 yr (SD 2.4) 
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Figure 6.3. Ages* of 149 Dogs with Hypoadrenocorticism from 1994 Survey of Randomly Selected Veterinarians in 
the United States 
Age was reported for 138 (97.9 %) of the 141 controls. The mean age was 
5.6 yr (SD 3.6) (SEM 0.3) (Range 0.2 - 16.0). These ages are displayed in Figure 
6.4. Of these 138 controls, 130 (94.2%) were alive, 2 (1 .4%) were dead, 4 
(2.9%) were lost to follow-up, and 2 (1 .4%) were of unknown status. The average 
age of live dogs was 5.5 yr (SD 3.6) (SEM 0.3) (Range 0.2 - 15.0) .  The sample 
sizes for dead dogs (two) and dogs lost to follow-up (four) were so small that 
averages for these groups were not meaningful. 
Age-specific OR with relevant statistics are presented in Table 6.2. 
Sexes 
Sex was reported for 147 (97.4%) of the 151 cases, and 139 (98.6%) of the 
141 controls (fable 6.3). Sex-specific OR were calculated with 95 % confidence 
intervals, chi-square statistics, and significance levels (p values) for the chi-square 
statistics (fable 6.4). 
Breeds 
Breeds were reported for 149 (98.7%) of the 151 cases (Table 6.5). The 
seven most frequently reported case breeds with number (%) were: Poodle 22 
(14.8); Mixed 15 (10. 1); German Shepherd 1 1  (7 .4); Labrador Retriever 8 (5.4); 
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Figure 6.4. Ages* of 138 Control Dogs from 1994 Survey of Randomly Selected Veterinarians in the United States 
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Table 6.2. Age*-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 Survey of Randomly Selected Veterinarians in the United States 
Age interval (yr)** 
Number of cases 
n= 149 
Number of controls 
n= l38 OR 
95% confidence 
interval for OR49 
X: statistic (p value) 
Uncorrected40 
0 < age < S 49 6 1  0.62 0.37 - 1 .03 3.88 (0.0488) 
S � age < 10 65 51 1 . 10 0.67 - 1.81  0. 16 (0.6912) 
age � 10 35 20 1 .8 1  0.95 - 3.48 3 .74 (0.0530) 
• Age at diagnosis. 
•• The comparison group is all other dogs. 
Table 6.3.  Sexes of 147 Cases of Canine Hypoadrenocorticism and 139 Controls 
from 1994 Survey of Randomly Selected Veterinarians in the United States 
Cases Controls 
Sexes Number Percent Number Percent 
Female-intact 4 2.7 17 12.2 
Female-spayed 78 53. 1  68 48.9 
All females 82 55.8 85 6 1 .2 
Male-intact 22 15.0 21 15. 1 
Male-castrated 43 29.3 33 23 .7 
All males 65 44.2 54 38.8 





Table 6.4. Sex-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 Survey of Randomly Selected Veterinarians in the United States 
Number of cases Number of controls 
Sex• n= 147 n= 139 
Female-intact 4 17 
Female-spayed 78 68 
Female-spayed** 78 68 
Female (intact and spayed) 82 85 
Male-intact 22 21 
Male-castrated 43 33 
Male-castrated*** 43 33 
Neutered (either sex) 121 101 
"' Except as noted, the comparison group is all other dogs. 
•• Female-spayed compared to female-intact. 
••• Male-castrated compared to male-intact. 
*"'** Exact confidence limits. 128 
OR 
0.20 








interval for OR49 
0.05 - 0.64•••• 
0.72 - 1 .93 
1 .48 - 20.70"'"'"'"' 
0.49 - 1 .32 
0.49 - 1 .99 
0.76 - 2.33 
0.55 - 2.82 
0.96 - 3.20 







1 . 1 1  (0.2917) 
0.33 (0.5686) 
3.83 (0.0503) 
Table 6.5. Breeds of 149 Cases ofHypoadrenocorticism and 140 Controls from 1994 Survey of Randomly 
Selected Veterinarians in the United States* 
Cases Controls 
Breed Nmnber Percent Nmnber Percent 
Akita 3 2.0 0 0.0 
Australian Shepherd 2 1 .3 5 3.6 
Basset Hound 5 3.4 0 0.0 
Beagle 3 2.0 2 1 .4 
Bearded Collie 2 1.3 0 0.0 
Boston Terrier 3 2.0 2 1.4 
Brittany 2 1.3 1 0.7 
Cairn Terrier 2 1.3 0 0.0 
Chihuahua 1 0.7 3 2. 1 
Chow Chow 3 2.0 2 1.4 
Cocker Spaniel 6 4.0 9 6.4 
Dachshund 3 2.0 0 0.0 
Doberman Pinscher 3 2.0 3 2. 1 
German Shepherd 1 1  7.4 13 9.3 
Golden Retriever 4 2.7 8 5.7 
Great Dane 3 2.0 0 0.0 
Great Pyrennes 2 1.3 0 0.0 
Labrador Retriever 8 5.4 15 10.7 
Lhasa Apso 1 0.7 3 2. 1 
Mixed 15 10. 1 28 20.0 
Pomeranian 2 1.3 2 1 .4  
Poodle 22 14.8 13 9.3 
Rottweiler 6 4.0 4 2.9 
Schnauzer 6 4.0 2 1 .4 
Scottish Terrier 3 2.0 0 0.0 
Shetland Sheepdog 1 0.7 2 1 .4 
Shih Tzu 2 1.3 2 1 .4 
Springer Spaniel 5 3.4 2 1.4 
Welsh Corgi 2 1.3 0 0.0 
West Highland White Terrier 3 2.0 0 0.0 
* Breeds are included only if there were at least two cases or two controls of the breed reported in the 
survey. 
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Breeds were reported for 140 (99.3 %) of the 141 controls (Table 6.5).  The 
seven most frequently reported control breeds with number (%) were: Mixed 28 
(20.0); Labrador Retriever 15 (10.7); German Shepherd 13 (9.3);  Poodle 13 (9.3); 
Cocker Spaniel 9 (6.4); Golden Retriever 8 (5.7); and Australian Shepherd 5 (3 .6). 
The number (%) of each of the most frequently reported case breeds among 
controls was (in the same order as listed above for cases) Poodle 13 (9 .3); Mixed 
28 (20.0); German Shepherd 13 (9.3); Labrador Retriever 15 (10.7);  Cocker 
Spaniel 9 (6.4); Rottweiler 4 (2.9); and Schnauzer 2 (1 .4) .  
Breed-specific OR were calculated for all breeds for which there were at least 
five cases or five controls. These OR are reported in Table 6.6. 
Body Weights 
Body weights were reported for 149 (98.7 %) of the 151 cases (Figure 6.5). 
The average body weight (kg) for cases was 20.2 (SD 14. 1) (SEM 1 .2) (Range 1 . 1  
- 63 .6) .  Body weights were reported for 140 (99.3 %) of the 141 controls (Figure 
6.6). The average body weight (kg) for controls was 19.8 (SD 13 .5) (SEM 1 . 1) 
(Range 1 .4 - 74. 1). Body weight-specific OR were calculated for 5 kg body weight 
increments (Table 6.7) . 
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Table 6.6. Breed-Specific Odds Ratios (OR) for Dogs with Hypoadrenocorticism from 1994 SuJVey of Randomly Selected Veterinarians 
in the United States* 
Number of Number of 
cases controls 
Breed** n= 149 n= 140 
Australian Shepherd 2 5 
Basset Hound s 0 
Cocker Spaniel 6 9 
Gennan Shepherd 1 1  13 
Golden Retriever 4 8 
95% confidence 
OR inteJVal for OR49 
0.37 0.03 - 2.30**** 
***** **"'** 
0.61 0. 17 - 1 .98"'"'*"' 
0.78 0.3 1  - 1 .93 
0.46 0. 10 - 1 .75**** 
X: statistic {p value) 
Uncorrected40 
1 .52 (0.2180) 
4. 78 (0.0288) 
0.85 (0.3577) 
0.34 (0.5579) 
1 .66 (0. 1970) 
Fisher exact 
(2-tailed p value)***16l 
0.2698 
0.0609 
� Labrador Retriever 8 IS 0.47 0. 18 - 1 .24 2. 82 (0.0934) 
Mixed 15 28 0.45 0.22 - 0.92 5.62 (0.0177) 
Poodle 22 13 1 .69 0.77 - 3.73 2.04 (0.1536) 
Rottweiler 6 4 1 .43 0.33 - 7.02***"' 0.30 (0.5866) 
Schnauzer 6 2 2.90 0.5 1 - 29.71***"' 1 .81  (0. 1785) 
Springer Spaniel 5 2 2.40 0.38 - 25.48*"'** 1 . 13 (0.2869) 
* Breeds are included only if there were at least five cases or five controls of the breed reported in the survey. 
** The comparison group is all other dogs. 
*** Calculated only if an expected cell value is < 5; the preferred p value for this OR. 
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Figure 6.5. Body Weights of 149 Dogs with Hypoadrenocorticism from 1994 Survey of Randomly Selected 
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Figure 6.6. Body Weights of 140 Control Dogs from 1994 Survey of Randomly Selected Veterinarians in the United 
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• The comparison group is all other dogs. 
Number of 
controls 95% confidence 
n= 140 OR interval for OR49 
18  0.65 0.29 - 1 .46 
25 1 .41 0.77 - 2.61 
23 0.98 o.so - 1 .91 
14 0.65 0.26 - 1 .62 
10 2.25 0.97 - 5.33 
19 0.46 0. 19 - 1 .09 
10 0.94 0.35 - 2.52 
12 0.93 0.38 - 2.32 
s 0.74 0. 14 - 3.54••• 
4 2. 19 0.59 - 9.92••• 
** Calculated only if an expected cell value is < S; the preferred p value for this OR. 
••• Exact confidence limits.128 
r statistic (p value) 
Fisher exact 
Uncorrected40 (2-tailed p value)"'*16l 
1 .29 (0.2566) 
1 .39 (0.2380) 
0.01 (0.941 1) 
1 .03 (0.31 13) 
4.26 (0.0390) 
3. 76 (0.0524) 
0.02 (0.8852) 
0.03 (0.8734) 
0. 19 (0.6645) 0.7435 
1 .70 (0. 1920) 
Selected Clinical Findings Associated with Canine Hypoadrenocorticism 
Odds ratios were calculated for the selected clinical findings, including 95 % 
confidence intervals and uncorrected chi-square statistics with significance levels 
(p values) (Table 6.8) .  
Discussion 
Questionnaire Responses and Description of Veterinary Clinics 
A review of these results must recognize the limitations of sending a 
questionnaire to veterinarians randomly selected from the A VMA's mailing list. 
These include: the list must be accurate; and certain veterinarians, such as 1994 
graduates and those with cats-only practice, did not see any patients in 1993. 
This case control study was large, particularly for an uncommon disease, 
since it obtained 555 responses. The response rate of 55.5% of those initially sent 
questionnaires was satisfactory, though less than ideal. Figure 6. 1 revealed that 
95.9 % of the responses were received within 60 da. This suggested that a cutoff 
of responses after 60 da would be reasonable in similar studies.  
The average veterinary clinic had 2. 10 full-time veterinarians (Figure 6.2), 
and reported an average estimated number of dogs first diagnosed in 1993 of 0.35 
dogs. If 2. 10 full-time veterinarians see 0.35 newly diagnosed hypoadrenal dogs 
per yr, this suggested an average small animal practitioner might expect to see 0.2 
case per yr. This probably understated the number of cases since one veterinarian 
filled out the questionnaire for the entire practice. This veterinarian, being asked 
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Table 6.8. Odds Ratios (OR) for Clinical Findings Associated with Hypoadrenocorticism in Dogs from 1994 Survey of Randomly Selected Veterinarians 
in the United States 
x2 statistic (p value) 
Number of Number of 
cases controls 95% confidence Fisher exact 
Clinical finding* n= l43 n= 140 OR interval for OR49 Uncorrected40 (2-tailed p value)**162 
Anemia 22 1 25.27 3.94 - 1050.33*"'"' 20.39 ( < 0.0001) 
Arthritis 19 1 1  1 .80 0.77 - 4.22 2.20 (0. 1380) 
Cruciate ligament rupture 3 3 0.98 0. 13 - 7.43*"'"' 0.00 (0.9791) 
Diabetes mellitus 8 0 ............ *"'"'"' 8.06 (0.0045) 0.0071 
Hepatitis 17 0 ... ...... "'*"'"' 17.71 (< 0.0001) 
� Hypothyroidism 23 4 6.52 2. 13 - 26.51"'"'"' 14.34 (0.0002) 
Keratoconjunctivitis sicca 8 0 ............ ............ 8.06 (0.0045) 0.0071 
Nephritis 1 1  0 "'"'"'"' "'"'"'"' 1 1 .20 (0.0008) 
Thrombocytopenia 2 1 1 .97 0. 10 - 1 17. 14*"'"' 0.32 (0.5741) 1.0000 
"' Clinical findings either anecdotally linked to hypoadrenocorticism or with a putative autoimmune etiology; comparison group is all other dogs; there 
were no cases or controls for either megaesophagus or myasthenia gravis. 
"'"' Calculated only if an expected cell value is < 5; the preferred p value for this OR. 
"'*"' Exact confidence limits.128 
"'"'"'"' Undefined. 
for summary data about the entire practice, may not have been aware of all cases 
diagnosed. In any event, 0.2 new case per yr might be used as a minimum 
benchmark for the number of cases a small animal practitioner could expect to 
diagnose each yr. Another useful benchmark was that the average full-time 
veterinarian saw 1 ,455.6 dogs (individual dogs, not dog visits) per yr. 
Incidence and Prevalence Estimates 
The incidence estimate of 0.13 case/1 000 dogs/yr and the prevalence estimate 
of 0.6 case/1000 dogs suggested an approximate rate at which new cases may be 
acquired, and a rough indicator of how many cases a veterinarian might expect to 
be treating at any one time. 
Ages 
The mean age of all hypoadrenal dogs was higher (6.7 yr) than the mean age 
for all control dogs (5.6 yr) . This suggested that hypoadrenocorticism tended to 
be present in older dogs. Similarly, the average age for live hypoadrenal dogs (6.5 
yr) exceeded that for live control dogs (5.5 yr) . Since the sample sizes for dead 
and lost to follow-up dogs were so small, no meaningful comparisons could be 
made between cases and controls. 
Age at diagnosis was a poor age definition for this survey. In the survey of 
veterinarians whose patients were enrolled in the clinical trial (Chapter 5), the 
definition of age was current age or age at death or age when lost to follow-up. 
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If a veterinarian or a veterinary assistant looks up the age of a dog in the dog's 
medical record, the age found, assuming that the age has been periodically 
updated, will likely be current age or age at death or age when lost to follow-up. 
If the veterinarian knows the dog is alive, the age will be current age; if the 
veterinarian knows the dog is dead, the age is likely to be the age at or near death; 
and if the veterinarian does not know whether the dog is alive or dead, then the 
recorded age is probably age when lost to follow-up. So the age reported by the 
veterinarian is very likely to fit the current age or age at death or age when lost 
to follow-up definition. Determining age at diagnosis, on the other hand, requires 
some computation. The age listed on the medical record is, unless the dog was 
very recently diagnosed with disease, irrelevant to age at diagnosis. The 
veterinarian would need to know specifically when the diagnosis was made in 
relation to the animal's birth, and some veterinarians may not have gone to the 
trouble of making the necessary computation. Consequently, some of the ages 
reported in this study were probably specious. 
A second reason for making age at diagnosis a poor age definition was that 
age at diagnosis has no meaning in a control dog. Thus, case to control 
comparisons would be specious. 
The age results suggested that they were not reliable. The mean age at 
diagnosis estimate was 6.7 yr, much older than the 4.3 yr estimate reported for the 
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244 literature review cases (Chapter 2), the 4.9 yr estimate reported for the 232 
cases enrolled in the clinical trial (Chapter 3), the 5.4 yr estimate reported for the 
329 cases from the veterinary referral hospitals (Chapter 4), or the 4.9 yr estimate 
obtained by a weighted average of the previous three estimates (Chapter 5).cld 
Therefore, age at diagnosis was a poor way to define age in this survey, and 
is probably a poor way to define it in most case control studies; consequently, the 
age results obtained from this survey, including Figures 6.3 and 6.4, and Table 
6.2, should not be trusted. Future surveys should avoid this error by defining age 
as current age or age at death or age when lost to follow-up. 
Sexes 
The sex data in Table 6.4 can be characterized as equivocal. The 95 % 
confidence intervals for the OR all include one except for female-intact 
(comparison group all other dogs) which had a 95 % confidence interval of 0.05 -
0.64 and a p value for its uncorrected chi-square statistic of 0.0021 , and female-
spayed (comparison group female-intact dogs) which had a 95 % confidence 
interval of 1 .48 - 20.70 and a p value for its uncorrected chi-square statistic of 
ddJ:t is notable that the literature review cases, clinical trial cases, and 
veterinary referral hospital cases all came from studies which focused specifically 
on age at diagnosis.  
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0.0032. This suggested that female-spayed dogs were more likely to be 
hypoadrenal than intact ones, and that female-intact dogs were less likely to be 
hypoadrenal than other dogs. None of the other results, except possibly the one 
discussed below, showed any predilection for or against hypoadrenocorticism. 
The OR for neutered (either sex) was 1 .75 with a 95 % confidence interval 
of 0.96 - 3 .20 (p=0.05 for its uncorrected chi-square statistic). A neutered dog of 
either sex may be more likely to have adrenal insufficiency. 
Breeds 
No OR (Table 6 .6) except one was significant at the 0.05 level. The one 
exception was the Mixed dog which had an OR of0.45, a 95 % confidence interval 
of 0.22 - 0.92, and a p value for the uncorrected chi-square statistic of 0.0177. 
This suggested that a Mixed dog was less likely to be hypoadrenal. Though the OR 
for the Basset Hound was undefined, the p value for the uncorrected chi-square 
statistic was 0.0288, indicating a predisposition for the disease. 
Body Weights 
As with breeds, sample sizes were too small to establish clear body weight 
predilections for or against disease. The statistical comparison of average body 
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weight of cases (20.2 kg) with controls (19.8 kg) revealed no significant 
difference. 
Body weight-specific OR (Table 6.7) revealed little to suggest association 
between body weights and either an increase or decrease in the probability of 
hypoadrenocorticism. There were two possible exceptions. 
First, the 20 kg < weight =:; 25 kg weight range had an OR of 2.25 with a 
95% confidence interval of 0.97 - 5.33 and a p value for the uncorrected chi­
square statistic of 0.0390, suggesting a predilection for hypoadrenocorticism. 
Second, the 25 kg < weight =:; 30 kg weight range had an OR of 0.46 with a 
95 % confidence interval of 0. 19 - 1 .09 and a p value for the uncorrected chi­
square statistic of 0.0524, suggesting they may be less likely to be hypoadrenal. 
These results seemed inconsistent, since it is counterintuitive to conclude dogs in 
the 20 kg < weight =:; 25 kg weight range were predisposed to disease, and dogs 
in the 25 kg < weight < 30 kg weight range were less likely to be diseased. This 
remains unexplained. 
Selected Clinical Findings Associated with Canine Hypoadrenocorticism 
Of the five clinical findings with defined OR displayed in Table 6.8, anemia, 
arthritis, hypothyroidism, and thrombocytopenia had OR which exceeded one. The 
OR for cruciate ligament rupture was less than one. The OR for anemia of 25.27 
and the OR for hypothyroidism of 6.52 were both highly significant (p < 0.001 
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for uncorrected chi-square statistics) . The OR for arthritis, cruciate ligament 
rupture, and thrombocytopenia were not significant at the 0.05 Ievel. Though the 
OR for diabetes mellitus, hepatitis, keratoconjunctivitis sicca, and nephritis were 
undefined, there was evidence that these conditions were associated with 
hypoadrenocorticism (p < 0.01 for their uncorrected chi-square statistics). Sample 
sizes were too small to permit meaningful stratification by age. 
Conclusions 
1 .  Questionnaire Responses and Description of Veterinary Clinics. With 
a response rate of slightly over half (55.5%), all results of this study should be 
considered carefuiiy. Over 90% of the questionnaire responses received were 
·received within 60 da, suggesting a 60 da cutoff would be reasonable in similar 
studies. In 1993 the average veterinary clinic had an estimated 2. 10 full-time 
veterinarians, and initially diagnosed 0.35 dogs. A veterinarian in small animal 
practice might expect to initially diagnose about 0.2 case per yr. This is probably 
an underestimate. The average full-time small animal practitioner saw about 1 ,500 
dogs (individual dogs, not dog visits) in 1993. 
2. Incidence and Prevalence Estimates. Incidence and prevalence estimates 
for canine hypoadrenocorticism were, respectively, 0. 13 case/1000 dogs/yr and 0.6 
case/1000 dogs, which were lower than the estimates obtained from the survey of 
veterinarians enrolled in the clinical trial (Chapter 5) . 
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3 .  Ages. The age results should be disregarded since they were unreliable. 
4. Sexes. Female-intact dogs were less likely to have adrenal insufficiency. 
Female-spayed dogs were more likely. 
5.  Breeds. The Mixed breed dog was less likely than other breeds to be 
hypoadrenal. The Basset Hound may be predisposed to hypoadrenocorticism. 
There were no statistically significant predilections for or against 
hypoadrenocorticism in other breeds; this likely resulted from the relatively small 
sample sizes rather than from a real absence of them. 
6. Body Weights. Body weight data led to no meaningful conclusions. 
7.  Selected Cl inical Findings Associated with Canine 
Hypoadrenocorticism. Anemia, diabetes mellitus, hepatitis, hypothyroidism, 
keratoconjunctivitis sicca, and nephritis were each associated with 
hypoadrenocorticism at a significance level of less than 0.01 . No significant 
associations were found between the other clinical findings and 
hypoadrenocorticism; this was likely the result of small sample sizes rather than 
the real absence of them. 
8 .  General . While this survey augmented the other studies comprising this 
overall study of canine hypoadrenocorticism, it did not in itself provide much 
useful information. It was limited by: the small number of cases reported; the 
uncertainty about the diagnostic method used by responding veterinarians; the 
method of estimation of active dog patients; the definition of age; and the fact that 
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veterinarians have different procedures for removing medical records from their 
files after a dog's death. Thus, a survey of randomly selected veterinarians would 
generally, because of the time and expense required, be a poor vehicle for the 
primary study of an uncommon animal disease. If the disease being studied were 
more common or if larger samples could be obtained at minimal expense, a survey 
of randomly selected veterinarians might nevertheless be appropriate. 
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CHAPfER 7 .  
CONCLUSIONS 
Introduction and Comments Regarding Methodology 
These conclusions are an amalgam of those from the preceding six chapters. 
However, before the conclusions can be presented, a few issues must be discussed 
as background. These include the general strengths and weaknesses of case series, 
case control studies, and mail surveys, particularly as they apply to this work. 
A case series is a .. cross-sectional study with no defined population and no 
comparison group. 11203• The data from the canine literature review (Chapter 2), 
from the microcrystalline desoxycorticosterone pivalate (DOCP) clinical trial 
(Chapter 3) , and from the Veterinary Medical Data Base (VMDB) (Chapter 4) 
were case series. Case series are useful since information is available quickly, and 
they lend themselves to stimulating more definitive research. They are, however, 
prone to overinterpretation, and often provoke II authoritarian (rather than 
authoritative) clinical advice about etiology, prevention, and therapy. 11 174 Case 
series do not prospectively follow patient cohorts, "do not have a time dimension, II 
and 11 suffer from the absence of a comparison group. "52 The use of case series is 
particularly appropriate for rare diseases.51 Data in Chapters 2, 3 ,  and 4 
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represented the first logical step in epidemiology: observe and study those cases 
already available and documented, then develop other studies. Specifically, the 
case series in Chapters 2, 3 ,  and 4 were used as forerunners of the case-control 
studies based on surveys of veterinarians enrolled in the clinical trial of DOCP 
(Chapter 5) and randomly selected veterinarians (Chapter 6) . 
A case-control study is one in which "individuals with a particular condition 
or disease (the cases) are selected for comparison with a series of individuals in 
whom the condition or disease is absent (the controls). Cases and controls are 
compared with respect to existing or past attributes or exposures thought to be 
relevant to the development of the condition or disease under study [Italics in 
original] . " 186 Case control studies are an important way to learn about uncommon 
diseases; they generally are inexpensive and the researcher can obtain results fairly 
quickly. 53 They make use of readily available cases which are often cataloged in 
places like hospitals, disease registries, 187 and veterinary practices.201 This has 
become particularly appealing and useful as these records and registries become 
computerized. 173 Case-control studies are favored for uncommon diseases and those 
with long latency periods, and they enable the researcher to explore large numbers 
of potential risk or causal factors . 202 While case-control studies are useful and 
popular, they suffer from selection bias and measurement bias. 55 The studies using 
cases and controls from the clinical trial of DOCP (Chapter 5), and cases and 
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controls from the randomly selected veterinarians (Chapter 6) were case-control 
studies in which mail survey methodology was used to gather data. These studies 
did no matching of cases and controls since little information already existed about 
factors associated with hypoadrenocorticism. They were inexpensive, assembled 
information from several sources on hundreds of cases of an uncommon disease, 
and explored many factors and their possible association with the disease. 
Selection bias was at work in the printed literature. Many things have to 
come together before a case finds its way into print: an owner willing to seek 
treatment for a sick dog; an observant veterinarian willing to carefully diagnose 
and document the case; a veterinarian willing and able to write the article; a 
compliant editor; and so on. Similarly, specific sets of circumstances are required 
before cases find their way into the files of the VMDB or Ciba Animal Health, 
and still others have to be present before practitioners respond to mail surveys. 
Measurement bias was probably also a� work. There are three kinds of 
measurement bias:S4 
1 .  The presence of the outcome directly affects the exposure. (For 
example, if a dog repeatedly has fleas, the dog's owner will try to keep the dog 
from being infested with fleas.) 
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2. The presence of the outcome affects the subject's recollection of the 
exposure. (For example, a dog's owner is more likely to remember when the dog 
was hit by a car than when the dog had a mild diarrhea.) 
3 .  The presence of the outcome affects the measurement or recording of 
the exposure. (For example, a dog who has suffered a serious illness is more likely 
to have a thoroughly documented medical history than a dog who has received 
only routine wormings and vaccinations.) 
It is unlikely that this study suffered from the first bias listed, but it almost 
certainly did from the second two. It likely occurred with regard to clinical 
findings. A veterinarian or dog owner with a hypoadrenal dog is more likely to 
recall clinical findings in the dog's history than the owner of a control dog. Along 
the same lines, the veterinarian is more likely to inquire about clinical findings in 
a hypoadrenal dog compared to a dog presented for a routine visit or minor illness. 
The veterinarian is also more likely to do more diagnostic testing and, perhaps, to 
record the diagnostic results more carefully when the patient is viewed as "serious" 
(cases) rather than "routine" (controls). 
The advantages and disadvantages of mail survey methodology were also at 
work in these studies . The survey of veterinarians enrolled in the clinical trial of 
DOCP (Chapter 5) and the survey of randomly selected veterinarians (Chapter 6) 
were both mail surveys. Low response rate is an important problem with mail 
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surveys. A prominent text in the field states, "Surveys by mail typically elicited 
extremely low response rates, even with short questionnaires, and ·high response 
to relatively long questionnaires was very rare indeed . . . . "30 Another problem 
is nonresponse to particular items on questionnaires among those questionnaires 
actually received. 33 Another shortcoming of mail questionnaires is that they are 
often far shorter than needed to elicit the necessary research data. 32 The survey of 
randomly selected veterinarians may have suffered from all these problems, though 
particularly from the last. 
The need for a high response rate stems from the idea that selection bias is 
introduced when some people respond and some do not. If responders and 
nonresponders have different characteristics, then the study is biased by these 
differences. This problem becomes less important as the response rate increases. 
This "unknown bias from refusals"34 is difficult or impossible to quantify, since 
it is by definition "unknown. "  The mail survey of veterinarians enrolled by Ciba 
Animal Health in the clinical trial of DOCP (Chapter 5) was probably not greatly 
affected by a response rate problem since the rate was 90.9 % compared to the 
survey of randomly selected veterinarians with a rate of 55.5 % .  Though no 
definitive minimum response rate can be established, one source suggests by 
implication that a 50% response rate may be a useful working minimum. 31 By that 
standard, the response rate for both surveys was satisfactory. 
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Specific item nonresponse may have been a small problem. The DOCP 
clinical trial veterinarians (Chapter 5) were asked for two controls for each of their 
cases . They provided 1 .66 controls per case, ages for 92.6 % of cases and 97.6% 
of controls, and sexes for 98.9% of cases and 96.6 %  of controls . The randomly 
selected veterinarians (Chapter 6) were asked for one control per case. They 
provided 0.93 controls per case, ages for 98.7 % of cases and 97.9% of controls, 
and sexes for 97.4% of cases and 98.6% of controls. There were some 
nonresponses for other variables as well, which leads to the question of whether 
or not these nonresponses perturbed the results. The answer is no, for two reasons. 
First, the samples for these variables were quite large. Given these large samples, 
a responder/nonresponder bias, even if present, would have to be overwhelming 
before it could materially change the results. Second, it is almost impossible to 
postulate how a responder/noriresponder bias could occur which would have 
affected the results. Responding veterinarians might have less busy practices than 
nonresponders who, having busier practices, have less time to fill out 
questionnaires. However, no plausible scenario could systematically change the 
characteristics of the case of canine hypoadrenocorticism in a veterinarian's 
medical records or the characteristics of the control dog which followed. 
Therefore, nonresponses were not viewed as a problem. 
The most significant problem with mail surveys is the compromise between 
response rate and length of questionnaire. If the questionnaire is long and 
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complicated, the response rate will go down. Conversely, if the questionnaire is 
short and simple, the response rate will go up, and responder/nonresponder bias 
will be less troublesome. These questionnaires were deliberately written to be 
brief. The result was good response rates, but lots of unanswered questions. For 
example, lots of dogs had anemia, but what kind of anemia? A more detailed 
questionnaire might have inquired about the specific nature of each anemia. But 
then it might not have been returned. Consequently, shortening the questionnaire 
was an undesirable, though unavoidable, part of the mail surveys. 
Finally, the estimates of active dog patients reported by the DOCP clinical 
trial veterinarians (Chapter 5) and the randomly selected veterinarians (Chapter 6) 
may have introduced error in the incidence and prevalence estimates. How this 
error may have affected the results is unknown. Some veterinarians probably 
guessed at the number of active dog patients; others likely obtained it from 
computerized medical records. The method used for these studies did not 
determine how the veterinarians arrived at the number of active dog patients. 
Future studies should address this issue. In this regard, the numbers of active dog 
patients seen per full-time veterinarian were virtually identical for the DOCP 
clinical trial veterinarians (1504. 7) and the randomly selected veterinarians 
(1455.6) .= This suggested that this study flaw was, if present, minimal. 
COJ'hese were similar to the estimate of 1600 dogs seen per veterinarian per yr 
obtained on July 29, 1996 from personal communication with Dr. J. Karl Wise, 
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Overall, the mail survey served a purpose. Assembling a credible group of 
several hundred cases with controls of a disease as uncommon as canine 
hypoadrenocorticism was useful and the mail survey methodology was the only 
practical way to obtain this information. 
Recognizing the advantages and disadvantages of case series, case-control 
studies, and mail survey questionnaires, the following conclusions are presented. 
They are a composite and comparison of the conclusions drawn in Chapters 2 
through 6. 
Incidence and Prevalence Estimates 
The incidence and prevalence estimates appear in Table 7 . 1 .  The incidence 
was highest for the veterinary referral hospitals; next for the Ciba Animal Health 
veterinarians, who might be considered more motivated than the randomly selected 
veterinarians since they went to the trouble of enrolling in the clinical trial; and 
last for the randomly selected veterinarians. These results suggested that 0.36 
case/1000 dogs/yr (a simple mean of the three incidences) can be used as a point 
estimate of incidence. Similarly, 1 . 8  cases/1000 dogs can be used as a point 
estimate for prevalence. These point estimates can be used by veterinary clinicians. 
Center for Information Management, American Veterinary Medical Association. 
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Table 7 . 1 .  Incidence and Prevalence Estimates Determined in Three Epidemiologic 
Studies of Naturally Occurring and Iatrogenically Produced Canine 
Hypoadrenocorticism 
Study 
Case series: veterinary 
referral hospitals 
Case control: survey of 
veterinarians enrolled in 
clinical trial 














*Each estimate differs significantly from each other estimate (p < 0.0001). 
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Ages 
The average age at diagnosis (SD) (SEMff) (Range) in yr for dogs with 
adrenal insufficiency was 4.3 (") (hh) (0.2-12.0) for dogs included in the 
literature review (Chapter 2),ii 4.9 (3 .0) (0.2) (0.3-13 .0) for dogs in the Ciba 
Animal Health clinical trial of DOCP (Chapter 3), and 5.4 (3.2) (0.2) (0. 1-15.0) 
for the dogs diagnosed in veterinary referral hospitals (Chapter 4) . A simple mean 
of these three results was 4.9 yr, a result consistent with estimates provided in two 
well-known veterinary references. 41•43 The results demonstrated that the disease can 
be diagnosed in very young and very old dogs. 
The ages reported in the survey of veterinarians enrolled by Ciba Animal 
Health in the clinical trial of DOCP (Chapter 5) were current age or age at death 
or age when lost to follow-up. The mean age (SD) (SEM) (Range) for cases in yr 
was for live dogs 8 . 1  (3 .0) (0. 1) (1 .5-18 .0), for dead dogs 9.8 (3 .4) (0.2) (1 .0-
17.2), and for dogs lost to follow-up 8 .6 (3 . 1) (0.7) (4.0-13 .0) .  It was for controls 
6. 1 (3 .9) (0. 1) (0. 1-19.0) for live dogs, 10.2 (5.2) (0.8) (0.3-17.0) for dead dogs, 
and 5.7 (4.3) (0.4) (0.2-16.0) for dogs lost to follow-up. Average disease duration 
ffStandard error of the mean (SEM) equals the standard deviation (SD) divided 
by the square root of the sample size. 
"Not reported for all cases. 
hhNot reported for all cases. 
iiThis assumes that the articles reviewed actually reported "age at diagnosis" ; 
in fact, they reported "age. " 
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was estimated at 4.9 yr (Chapter 5) . This suggested that hypoadrenal dogs tended 
to be older than control dogs. Age-specific odds ratios (OR) suggested that the risk 
of hypoadrenocorticism increased with age. The ages reported in the survey of 
randomly selected veterinarians (Chapter 6) should be disregarded because they 
were unreliable. 
Sexes 
The sexes for hypoadrenal dogs were 16. 8 %  female-intact, 47. 8 %  female­
spayed, 22.3 % male-intact, and 13 .0% male-castrated in the literature review 
(Chapter 2); 6. 1 ,  61 .8,  13 .0, and 19. 1 (percentages ordered female-intact, female­
spayed, male-intact, and male-castrated) for the clinical trial of DOCP (Chapter 
3); 14.0, 53 .8,  13 . 1 ,  and 19. 1 for veterinary referral hospitals (Chapter 4); 5 .2, 
63.9, 10.3, and 20.7 for the mail survey of Ciba Animal Health veterinarians 
(Chapter 5); and 2.7, 53 . 1 ,  15.0, and 29.3 for the mail survey of randomly 
selected veterinarians (Chapter 6). These were remarkably similar, and taken 
together using simple averages, suggested that hypoadrenal dogs were 9 %  female­
intact, 56 % female-spayed, 15 % male-intact, and 20% male-castrated. This was 
consistent with previous assertions that canine hypoadrenocorticism is primarily 
a disease of the female dog.41.43.93.14B.IB9 
Sex-specific OR and sex-specific incidence estimates calculated from 
veterinary referral hospitals (Chapter 4), from the mail survey of Ciba Animal 
195 
Health veterinarians (Chapter 5), and from the mail survey of randomly selected 
veterinarians (Chapter 6) supported the conclusion that females were more likely 
to be hypoadrenal, but also suggested that female-spayeds were more likely than 
female-intacts, that male-castrateds were more likely than male-intacts, and that 
neutered dogs were more likely than intact ones. This contradicted one study 
which reported that female-intacts had an increased probability of disease 
compared to female-spayeds. 148 These associations between neutering and 
hypoadrenocorticism could be influenced by the age at which dogs were neutered. 
Though these studies did not address this possibility, future studies might do so. 
Table 7.2 summarizes the sex-specific OR. These data can be used by veterinary 
clinicians when evaluating potential cases of hypoadrenocorticism. 
Breeds 
The data demonstrated that canine hypoadrenocorticism was widespread 
among breeds. Several breeds were at increased risk of disease and several at 
decreased risk. The results from veterinary referral hospitals (Chapter 4), the 
survey of veterinarians enrolled by Ciba Animal Health in the clinical trial of 
DOCP (Chapter 5), and the survey of randomly selected veterinarians (Chapter 6) 
were consistent (Table 7.3). 
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Table 7.2. Sex-Specific Risks of Canine Hypoadrenocorticism Based on Three Epidemiologic Studies 
Sex-specific 95% confidence interval Uncorrected 
Study Sexes• odds ratio (OR) for OR411 X: statistic (p valuer' 
Case series: veterinary 
referral hospitals 
Female-intact 0.56 0.40 - 0.78 13.05 (0.0003) 
Female-spayed 2.88 2.28 - 3.64 90.60 ( < 0.0001) 
Female-spayed** 3.02 2. 13 - 4.30 45.75 ( < 0.0001) 
Female (intact and spayed) 1.97 1.53 - 2.53 30. 81 ( <  0.0001) 
Male-intact 0.32 0.23 - 0.45 49.81 ( < 0.0001) 
Male-castrated 1 .25 0.92 - 1 .69 2.21 (0. 1371) 
-
\C) Male-castrated••• 2.92 1 .91  - 4.47 29. 16 ( < 0.0001) -...l 
Neutered (either sex) 3.29 2.53 - 4.27 94.99 ( < 0.0001) 
Case control: survey of 
veterinarians enrolled 
in clinical trial 
Female-intact 0.62 0.23 - 1 .68 1 .05 (0.3061) 
Female-spayed 2.40 1 .54 - 3.74 16.94 ( < 0.0001) 
Female-spayed** 2. 16 0.79 - 6.03 2. 75 (0.0974) 
Female (intact and spayed) 2.3 1 1 .46 - 3.66 14.31 (0.0002) 
Male-intact 0.35 0. 18 - 0.69 1 1 .08 (0.0009) 
Male-castrated 0.65 0.38 - 1 . 12 2. 70 (0. 1 002) 
Male-castrated*** 1 .71 0.78 - 4.07 2. 19 (0. 1387) 




Table 7.2 continued 
Study 











Neutered (either sex) 
* Except as noted, the comparison group is all other dogs. 
** Female-spayed compared to female-intact. 
*** Male-castrated compared to male·intact. 
**** Exact confidence limits. 128 
Sex-specific 
odds ratio (OR) 
0.20 







95% confidence interval 
for OR49 
0.05 • 0.64**** 
0.72 . 1 .93 
1 .48 - 20. 70**** 
0.49 - 1 .32 
0.49 - 1 .99 
0.76 - 2.33 
o.ss - 2.82 
0.96 - 3.20 
Uncorrected 






1 . 1 1  (0.2917) 
0.33 (0.5686) 
3.83 (0.0503) 
Table 7 .3. Breeds at Increased or Decreased Risk of Canine Hypoadrenocorticism Based on Three Epidemiologic Studies• 
Uncorrected Fisher exact 
Breed-speci fie 95% confidence interval x.2 statistic (p (2-tailed p 
Study Breed odds mtio (OR) for OR49 value)40 value)"'"'162 
Case series: veterinary 
referml hospitals 
Poodle 3.17 2. 18 - 4.58 44.65 ( < 0.0001) 
Labrador Retriever 0.49 0.24 - 0.98 4.61 (0.0317) 
Great Dane 4.56 2.28 - 8.83 26.48 ( < 0.0001) 0.0001 
West Highland White 7.33 
Terrier 
3.90 - 13.46 61 .83 ( < 0.0001) < 0.0001 
-
1.0 1.0 
Case control: survey of 
veterinarians enrolled 
in clinical trial 
Airedale Terrier 2.6 1 1 .06 - 6.56 5.36 (0.0206) 
Basset Hound 3.38 1 .50 - 7.79 10.96 (0.0009) 
Bearded Collie 4. 19 1 .20 - 1 8.36*** 6.87 (0.0088) 
Boxer 0. 12 0.00 - 0.77*** 6 . 17 (0.0130) 
Cocker Spaniel 0.5 1  0.30 - 0.85 7.44 (0.0064) 
Dalmatian 0.00 0.00 - 0.50*** 8.51 (0.0035) 
German Shorthaired 2.52 1 .06 - 6.06 5.41 (0.0200) 
Pointer 
Great Dane 7.63 2.50 - 31 .09*** 18.53 ( < 0.0001) 
Lhasa Apso 0.22 0.04 - 0. 75**"' 7.09 (0.0078) 
Pit Bull Terrier 0.00 0.00 - 0.84*** 5.45 (0.0195) 0.0165 
Pomeranian 0. 12 0.00 - 0. 77**"' 6. 17 (0.0130) 
Poodle 3.55 2.55 - 4.93 67.44 (< 0.0001) 
Table 7.3 continued 
Breed-specific 95% confidence interval 
Study Breed odds ratio (OR) 
Shetland Sheepdog 0. 15 
Shih Tzu 0.25 
Springer Spaniel 2.54 
West Highland White 
Terrier 
5.93 
Yorkshire Terrier 0. 14 




* Breeds are included if the 95% confidence interval did not contain one. 
** Calculated only if an expected cell value is < 5; the preferred p value for this OR. 
*** Exact confidence limits. 128 
for OR49 
0.03 - 0.47*** 
0.05 - 0. 83*** 
1 .29 - 5.04 
2.69 - 13.46 
0.02 - 0.58*** 
0.22 - 0.92 
Uncorrected Fisher exact 





27.69 ( < 0.0001) 
9.47 (0.0021) 
5.62 (0.0177) 
These results were remarkably consistent in that in no case was a breed found 
to be at increased risk in one study and at decreased risk in another. Three of the 
breeds reported at increased risk were also reported by another study148 as being 
predisposed to hypoadrenocorticism. These were Great Danes, Poodles (the 
previously published study reported only Standard Poodles), and West Highland 
White Terriers. Portuguese Water Dogs, Rottweilers, and Wheaten Terriers have 
been reported to be predisposed to hypoadrenocorticism. 148 This was not confirmed 
by this study. A decreased risk among Golden Retrievers, Lhasa Apsos, and 
Yorkshire Terriers has been reported. 148 This study did not find a decreased risk 
among Golden Retrievers, but it did among the other two breeds. One textbook 
reported that Labrador Retrievers might be predisposed to adrenal insufficiency. 69 
This is in conflict with the results of this study, which showed Labrador Retrievers 
at decreased risk. This is viewed as a minor discrepancy since the textbook stated 
that the predisposition was a possibility, not a certainty. These data can be used 
by veterinary clinicians when evaluating potential cases of hypoadrenocorticism. 
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Body Weights 
The average body weight (SD) (SEM) (Range) in kg for dogs enrolled in the 
clinical trial ofDOCP (Chapter 3) was 23.4 (13.6) (0.8) (2.7-72.7). For cases and 
controls, respectively, the results based on the survey of veterinarians enrolled by 
Ciba Animal Health in the clinical trial of DOCP (Chapter 5) were 24.5 (14.5) 
(0.6) (2.3-81 .8) and 19.7 (12.7) (0.4) (1 .4-68.2). For cases and controls, 
respectively, the results based on the survey of randomly selected veterinarians 
(Chapter 6) were 20.2 (14. 1) (1 .2) (1 . 1-63 .6) and 19.8 (13.5) ( 1 . 1) (1 .4-74. 1).  
Body weight specific OR were calculated in both surveys, Chapters 5 and 6, and 
are tabulated in Tables 5.9 and 6.7, respectively. 
A simple average of the averages from the three studies above was 22.5 kg; 
a weighted average of the averages was 23.6 kg. These were comparable to the 
median weight of 20.0 kg reported for 225 hypoadrenal dogs in another study, 148 
and suggested that the average dog with hypoadrenocorticism weighs over 20 kg. 
Data from the survey of veterinarians enrolled in the clinical trial of DOCP 
(Chapter 5) provided evidence that the probability of hypoadrenocorticism 
increased with body weight. The average body weight of24.5 kg for cases differed 
significantly (p < 0.0005) from the 19.7 kg for controls. Body weight-specific OR 
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(Table 5.9) suggested that the probability of hypoadrenocorticism increased with 
body weight. Data from the survey of randomly selected veterinarians (Chapter 6) 
did not support this conclusion. The average body weight of20.2 kg for cases was 
not significantly greater than the 19.8 kg for controls. Body weight-specific OR 
(Table 6. 7) failed to demonstrate a relationship between body weight and disease. 
Table 7.4 summarizes the body weight-specific risks of hypoadrenocorticism. A 
few comments are appropriate here. 
First, though the survey of randomly selected veterinarians did not confirm 
the proposition that the probability of canine hypoadrenocorticism varied directly 
with body weight, neither did it refute it. Second, the survey of randomly selected 
veterinarians was much smaller than the survey of veterinarians enrolled in the 
clinical trial, and thus should not be given as much weight. The counter-argument 
is that, though the survey of randomly selected veterinarians was much smaller, 
it was still much too large (149 cases and 140 controls for body weight) to ignore. 
Third, the possibility existed that the ostensible body weight effect is really an 
effect from some confounding variable such as breed. 
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Table 7.4. Body Weight-Specific Risks of Canine Hypoadrenocorticism Based on Two Epidemiologic Studies 
Uncorrected Fisher exact 
Body weight-specific 95% confidence interval 'Jf statistic (p (2-tailed p 
Study Body weight (kg)* odds ratio (OR) for OR•9 value)40 value)"'"'162 
Case control: survey of 
veterinarians enrolled 
in clinical trial 
0 < weight � 5 0.37 0.24 - 0.58 22.79 (< 0.0001) 
5 < weight � 10 0.88 0.68 - 1 . 13 1 . 1 1  (0.2923) 
10 < weight � 15 0.57 0.41 - 0.80 1 1 .57 (0.0007) 
IS < weight � 20 0.69 0.49 - 0.98 4.62 (0.03 15) 
� 20 < weight � 2S 1 .70 1 .27 - 2.28 13 .70 {0.0002) 
2S < weight � 30 1 . 1 1  0.80 - 1 .S2 0.41 (O.S236) 
30 < weight � 35 1 . 17 0.84 - 1 .61  0.94 (0.3327) 
35 < weight � 40 1 .6S 1 . 13 - 2.40 7.51 (0.0061) 
40 < weight � 4S 1 .29 0.78 - 2. 13 1 . 12 (0.2906) 
4S < weight � SO 1 . 1 1  O.S7 - 2. 14 0. 1 1  (0. 7443) 
SO < weight � SS 3 . 14 1 .06 - 10.37••• 5.58 (0.0182) 
weight > S5 5.72 2.36 - 15.86*"'"' 20.40 ( < 0.0001) 
� 
Table 7.4 continued 
Study 
Case control: survey of 
randomly selected 
veterinarians 
Body weight (kg)* 
0 < weight :!5: S 
S < weight :!5: 10 
10 < weight s 15 
IS < weight :!5: 20 
20 < weight :!5: 2S 
25 < weight :!5: 30 
30 < weight :!5: 35 
35 < weight :!5: 40 
40 < weight :!5: 45 
weight > 45 
• The comparison group is all other dogs. 
Body weight-specific 











95% confidence interval 
for OR4� 
0.29 - 1 .46 
0.77 - 2.61 
0.50 - 1.91 
0.26 - 1.62 
0.97 - 5.33 
0. 19 - 1 .09 
0.35 - 2.52 
0.38 - 2.32 
0.14 - 3.54••• 
0.59 - 9.92••• 
•• Calculated only if an expected cell value is < S_; the preferred p value for this OR. 
••• Exact confidence limits.128 
Uncorrected 
x2 statistic (p 
value)40 
1 .29 (0.2566) 
1 . 39 (0.2380) 
0.01 (0.94 1 1) 
1 .03 (0.31 13) 
4.26 (0.0390) 
3 .76 (0.0524) 
0.02 (0.8852) 
0.03 (0.8734) 
0. 19 (0.6645) 





Serum Sodium and Potassium Concentrations 
The average serum sodium and potassium concentration (SD) (SEM) (Range) 
in meq/L for hypoadrenal dogs in the literature review (Chapter 2) were, 
respectively, 129.4 (.D) � (1 14.0-150.0) and 7.2 (11) (mm) (4.6-10.8) .  The 
ratio of serum sodium to potassium concentrations was 18 .0. The corresponding 
values, in the same order, for the DOCP clinical trial (Chapter 4) and veterinary 
referral hospitals (Chapter 5), respectively, were: 13 1 .8 (9.4) (0.6) (104.0-174.0), 
6 .8  (1 .3) (0. 1) (3 .2-12.8), 20.2 (4.8) (0.3) (10.5-38.8); and 135.2 (10.6) (0.7) 
(97.0-160.0) ,  5.9 (1 .7) (0. 1) (2.9-1 1 .7), 25.2 (8 .3) (0.5) (1 1 . 1-46.6) .  Simple 
means of these results yielded 132. 1 for sodium, 6.6 for potassium, and 21 . 1  for 
the sodium to potassium ratio. These values supported the propositions that dogs 
with adrenal insufficiency are hyponatremic and hyperkalemic, 41•43 and that their 
sodium to potassium ratios are under 25 .0129 or 27 .0 .41 •43•189 
Electrolyte results from the clinical trial of DOCP (Chapter 3) established 
that hypoadrenocorticism did occur in dogs with normal values for serum sodium, 
potassium, and sodium to potassium ratio--specifically, about one case in 20 had 
.UN ot reported for all cases. 
� ot reported for all cases. 
11Not reported for all cases . 
mmN ot reported for all cases. 
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normal values for all three diagnostic indicators. The results from the veterinary 
referral hospitals (Chapter 4) were that no case was normal for all three diagnostic 
indicators. This suggested that a veterinarian with a patient normal for these three 
diagnostic indicators should, in most cases, provisionally remove adrenal 
insufficiency from the list of differential diagnoses, thereby avoiding the time and 
cost of the adrenocorticotropic hormone (ACTH) stimulation test. 
Clinical Findings 
Clinical findings included: anorexia; vomiting; depression; weakness; weight 
loss; azotemia; diarrhea; cardiac anomalies such as microcardia, bradycardia, and 
arrhythmias; skin and hair problems; gastroenteric difficulties such as 
gastroenteritis and abdominal pain; polyuria or polydipsia; limb stiffness; muscle 
atrophy; shock or collapse; and shaking or trembling. This comprehensive list 
mirrors the clinical findings reported elsewhere. 44 
The following results should be viewed skeptically. The clinical findings were 
selected because of their anecdotal association with canine hypoadrenocorticism or 
their putative autoimmune etiology. These included anemia, arthritis, cruciate 
ligament rupture, diabetes mellitus, hepatitis, hypothyroidism, keratoconjunctivitis 
sicca, megaesophagus, myasthenia gravis, nephritis, and thrombocytopenia. 
Ostensible associations between some of these clinical findings, notably anemia and 
nephritis, and hypoadrenocorticism may have resulted from the fact that the 
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clinical finding can be associated with any chronic disease, not specifically with 
hypoadrenocorticism. For example, dogs with normal kidneys presented with 
hypoadrenocorticism often appear to have nephritis because of shock and renal 
failure produced by poor renal perfusion. This is a normal part of the 
pathophysiology of hypoadrenocorticism and should not be confused with true 
nephritis, a separate disease. Also, comparisons between cases and controls 
probably included measurement bias. The health of cases was probably explored 
more thoroughly because of their illness than the health of controls. Thus, it was 
more likely that clinical findings were discovered for cases than controls. It is 
impossible to determine the extent of this measurement bias. 
Anemia, arthritis, cruciate ligament rupture, diabetes mellitus, hepatitis, 
hypothyroidism, keratoconjunctivitis sicca, myasthenia gravis, nephritis, and 
thrombocytopenia were all associated with hypoadrenocorticism in at least one 
study. This is all the selected clinical findings except megaesophagus. This may 
be testament to the wisdom of the selection process for clinical findings, or could 
be due to measurement bias. Which, if either, of these interpretations has merit 
will remain a mystery. These ostensible associations should be explored with 
further studies, particularly studies which control measurement bias . Table 7.5 
summarizes the clinical finding-specific risks of hypoadrenocorticism. 
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Table 7.5. Clinical Finding-Specific Risks of Canine Hypoadrenocorticism Based on Two Epidemiologic Studies 
Clinical finding- Uncorrected Fisher exact 
specific 95% confidence interval X: statistic (p (2-tailed p 
Study Clinical finding* odds ratio (OR) for OR49 value).., value)''"'1162 
Case control: survey of 
veterinarians enrolled 
in clinical trial 
Anemia 18.52 8.43 - 48.03*''"" 97.92 ( < 0.0001) 
Arthritis 2.50 1 .81  - 3.44 35.54 ( < 0.0001) 
Cruciate ligament rupture 2.28 1 .05 - 5.02 5.21 (0.0224) 
Diabetes mellitus 2. 16 0.46 - 10.93••• 1 .38 (0.2403) 0.3023 
N Hepatitis 7.41 3 . 15 - 20. 14 30.35 ( < 0.0001) 0 \0 
Hypothyroidism 4.65 3.04 - 7. 12 64.29 ( < 0.0001) 
Keratoconjunctivitis sicca 3.51 1 .49 - 8.49 10.57 (0.0012) 
Megaesophagus 5.19 0.41 - 272.46••• 2.53 (0. 1 120) 0. 1434 
Myasthenia gravis .... . .... . 5. 18 (0.0229) 0.0494 
Nephritis 6.77 3.33 - 14.08 40.85 (<0.0001) 
Thrombocytopenia 5.22 1.30 - 30.07••• 7.61 (0.0058) 0.01 19 
N ....... 
0 
Table 7.5 continued 
Study 

























95% confidence interval 
for OR49 
3.94 - 1050.33"'"'"' 
0.77 - 4.22 
0. 13 - 7.43••• 
• ••• 
• ••• 
2. 13  - 26.51"'"'"' 
• ••• 
• ••• 
0. 10 - 1 17. 14"'"'"' 
Uncorrected 
X: statistic (p 
value)40 
20.39 ( < 0.0001) 
2.20 (0. 1380) 
0.00 (0.9791) 
8.06 (0.0045) 
17.7 1 ( <  0.0001) 
14.34 (0.0002) 
8.06 (0.0045) 








• Clinical findings either anecdotally linked to hypoadrenocorticism or with a putative autoimmune etiology; comparison group is all other dogs. 
•• Calculated only if an expected cell value is < 5; the preferred p value for this OR. 
••• Exact confidence limits. 122 
•••• Undefined. 
••••• There were no cases or controls for either megaesophagus or myasthenia gravis. 
Case Definition in Epidemiologic 
Studies of Canine Hypoadrenocorticism 
Detailed analyses of the data from the clinical trail of DOCP (Chapter 3) 
demonstrated that epidemiologic studies of canine hypoadrenocorticism may be 
conducted using a case definition less restrictive than one requiring an ACTH 
stimulation test. Data indicated that the population diagnosed using the ACTH 
stimulation test was virtually identical to the population diagnosed without it. Thus, 
while the ACTH stimulation test is desirable in establishing the diagnosis for an 
individual patient, requiring it in epidemiologic studies is unnecessarily restrictive. 
Consequently, epidemiologic studies can benefit from the salutary effects .of greater 
case numbers, less complexity, more convenience, and less cost afforded by the 
less restrictive case definition that, if the veterinarian says the dog has 
hypoadrenocorticism, then, by definition, it does. 
Logistic Regression 
Age, breed, sex, and body weight were significantly associated with the 
occurrence of hypoadrenocorticism in the dog. Specifically, the probability of 
occurrence of canine hypoadrenocorticism increased with age and body weight, 
was greater in females than males, was greater in neutered than intact dogs, and 
varied with breed. There was model-dependent evidence of higher order 
interactions, but the exact nature of these interactions could not be determined. 
2 1 1  
Models were prepared which could, recognizing that many factors other than age, 
breed, sex, and body weight are involved in the occurrence of adrenal 
insufficiency, predict the relative probability of this disease in different dogs. 
Methodology 
Data from the veterinary literature, VMDB, clinical trial of DOCP, and mail 
survey of veterinarians enrolled in the clinical trial were all useful. The survey of 
veterinarians selected from the American Veterinary Medical Association's list of 
veterinarians suggested that mail survey methodology was a poor vehicle for 
obtaining data about an uncommon disease from randomly selected veterinarians; 
this limitation could be mitigated by substantially increasing the sample size and 
questionnaire response rate. Mail survey methodology can be useful for studying 
other diseases and obtaining basic descriptive data about veterinarians and their 
patients. Survey responses may be cut off 60 da after mailing. 
Future Studies 
The incidence and prevalence estimates presented in Table 7.1 ,  while 
different statistically, were the same order of magnitude, and, thus, can be 
considered useful overall estimates. Future studies could focus on incidence and 
prevalence estimates for particular ages, breeds, sexes, or body weights. 
212 
Mail smveys which request data on clinical findings should, if possible, 
precisely define the clinical findings. For example, what exactly constitutes 
" anemia" or "nephritis"? This must be done without making the survey so onerous 
or complicated that veterinarians do not respond at all. 
Matched case-control studies of hypoadrenal dogs would be a logical next 
step for those sexes and breeds already identified as associated with the disease. 
Matching on sex or breed or both would effectively remove these variables from 
the analyses, and permit focus on other variables such as age and body weight, the 
influence of which have been less well defined. This would require large data 
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Al . Case Data Abstract Form (VMDB Participants) (front) 
UNIVERSITY OF TENNESSEE 
COLLEGE OF VETERINARY MEDICINE 
CANINE HYPOADRENOCORTICISM STUDY 
CASE DATA ABSTRACT FORM 
PLEASE COMPLETE A SEPARATE FORM FOR EACH CASE . 
1 .  INSTITUTION CODE : __ 2 .  PATIENT ID NUMBER: _______ _ 
3 .  DATE OF DISCHARGE: ---��-�-�'------
4 .  OWNER ZIP CODE : 
month day year 
5 .  LABORATORY TEST RESULTS USED TO MAQ THE DIAGNOSIS : 
( These results should come from laboratory reports dated during 
this episode of care . Copies of laboratory reports may be sent 
in lieu of completing the information below . ) 
A .  ACTH STXMULATION TEST ( See attached sample for possible 
documentation type ) : 
PRE-STXMULATION ( BASELINE OR RESTING ) CORTISOL, ______ _ 
POST-STIMULATION CORTISOL�-------
B .  PLASMA OR SERUM ELECTROLYTE CONCENTRATIONS : 
DATE OF � SODIUM TEST DORING THIS EPISODE OF CARE 
month year 
SODIUM ( Na+ ) LEVEL ----------
DATE OF E1BS% POTASSIUM TEST DORING THIS EPISODE OF CARE 
month year 
POTASSIUM ( K+ )  LEVEL -----------
PLEASE COIIPLE'l'E THE BACK OF '1'BB PORM ALSO .  
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A2. Case Data Abstract Form (VMDB Participants) (back) 
6 .  TREATMENT: 
A. HAS THIS DOG BEEN TREATED WITH FLORINEF 
( FLUDROCORTISONE ) ?  YES NO 
B • HAS THIS DOG BEEN TREATED WITH PERCORTEN 
( DESOXYCORTICOSTERONE PIVALATE ) ?  YES NO 
7 .  OTHER DIAGNOSES ( Please list all diagnoses from the initial 
visit to the present ) :  
DIAGNOSIS DATE OF DIAGNOSIS 
THANK YOU . 
PLEASE RETURN THE FORMS TO DR. WILLIAM J. KELCH , DEPARTMENT OF 
ENVIRONMENTAL PRACTICE , BOX 1071 , KNOXVILLE , TN 37901-1071 . 
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A3 . Population Data Abstract Form (front) 
CANINE HYPOADRENOCORTICISH S'l'tJDY 
POPULATION DATA ABSTRACT FORM 
PLEASE COMPLETE ONE OF TRESE FORMS PER INSTU'OTION/PACIU'l'Y . 




THE FOLLOWING INFORMATION IS OPTIONAL BtJ'l' WOULD BE VERY HELPFUL IF 
IT IS AVAILABLE . 
2 . NtJHBER OF DOGS SEEN* DURING 





MALES ,  UNlCNOWN 
SEX tJIIlQfOWN 
B. 0 TO 2 WEEKS OLD 
2 WKS TO 2 KOS OLD 
2 TO 6 KOS OLD 
6 TO 12 KOS OLD 
1 TO 2 YEARS OLD 
2 TO 4 YEARS OLD 
4 TO 7 YEARS OLD 
7 TO 10 YEARS OLD 
10 TO 15 YEARS OLD 
15 YEARS AND OLDER 
1989 : 1990 : 1991 : 
C .  IF THE FREQUENCY OF DIFFERENT BREEDS CAN BE DETERKIHED FOR 
THE DOGS SEEN DURING 1989 THROUGH 1991 , PLEASE ATTACH A UST 
OF BREED FREQUENCY . 
*NOT THE NUMBER OF DOG VISITS : A DOG CAN BE COUNTED ONLY ONCE 
DURING THE 'l'HREE YEARS . FOR EXAMPLE , A DOG SEEN FIRST IN 1989 
WOULD BE COUNTED ONCE IN 1989 AND WOULD HOT BE COUNTED AGAIN EVEN 
IF IT WAS SEEN AGAIN IN 1990 AND/OR 1991 . 
PLEASE COMPLETE THE BACJ( OF THE FORM ALSO. 
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A4. Population Data Abstract Form (back) 
PLEASE INDICATE A PERSON (USUALLY THE PERSON ABSTRACTING THE 
INFORMATION ) WHO COULD BE CONTACTED IF THERE ARE QUESTIONS ABOUT 
THE INFORMATION ON THE FORMS . 
NAME : _____________________________ PHONE : -------------
BEST TIMES TO CALL : _______________________________ _ 
NAME OF INSTITUTION OR FACILITY =----------------------
PLEASE RETURN THE INFORMATION IN THE ENVELOPE PROVIDED . 
THANK YOU VERY MUCH FOR YOUR ASSISTANCE . 
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A5. Case Data Abstract Form (VMDB Non-Participants) (front) 
CANINE HYPOADRENOCORTICISM STUDY 
CASE DATA ABSTRACT FORM 
PLEASE COMPLETE A SEPARATE FORM FOR EACH CASE . KEY WORDS OTHER 
THAN CANINE HYPOADRENOCORTICISM THAT MAY BE HELPFUL IN LOCATING 
CASES ARE ADRENAL CORTICAL HYPOFUNCTION , ADDISON ' S  DISEASE , AND 
ADRENAL INSUFFICIENCY . 
1 .  INSTITUTION CODE : _____ 2 .  PATIENT ID NUMBER: ______ _ 
3 .  OWNER ZIP CODE : 
4 .  DATE OF FIRST DIAGNOSIS : 
month day year 
5 .  AGE WHEN FIRST DIAGNOSED : BIRTH DATE : 
OR 
years months 
6 •. SEX : ( Please mark one category only) 
Intact female __ 
Spayed female __ 
Female , unknown __ 
Intact male __ 
Neutered male ___ 
Male , unknown 
7 .  BREED : 
8 .  TEST RESULTS USED TO MAKE THE DIAGNOSIS : 
year month 
( These results should come from laboratory reports dated very 
near the same date as the DATE OF FIRST DIAGNOSIS .  Copies 
of laboratory reports are desired and can be attached to 
this abstract form . If copies of lab reports are attached , 
the blanks below do not need to be filled in . )  
ACTH STIMULATION TEST : 
DATE OF TEST ---,..­
month day year 
RESTING CORTISOL. ___ ____ _ 
POST-STIMULATION CORTISOL�-------
PLEASE COMPLETE THE BACK OF THE FORM ALSO . 
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A6. Case Data Abstract Form (VMDB Non-Participants) (back) 
9 .  TREATMENT : 
A . HAS THIS DOG BEEN TREATED WITH FLORINEF 
( FLUDROCORTISONE ) ?  YES NO 
B .  HAS THIS DOG BEEN TREATED WITH PERCORTEN 
( DESOXYCORTICOSTERONE PIVALATE ) ?  YES NO 
10 . OTHER DIAGNOSES : 
( If a summary of other diagnoses is included in the record , 
please attach a copy . If only a few other diaqnoses are 
listed , please record the information below . ) 
DIAGNOSIS DATE OF DIAGNOSIS 
THANK YOU . 
PLEASE RETURN THE FORMS ALONG WITH THE POPULATION DATA ABSTRACT 
FORM IN THE ENVELOPE PROVIDED OR MAIL TO DR . JOHN C .  NEW , JR .  1 
DEPARTMENT OF ENVIRONMENTAL PRACTICE , BOX 1071 , KNOXVILLE , TN ,  
3 7901-1071 . 
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A 7. Case Control Study of Canine Hypoadrenocorticism (Survey Form for 
Veterinarians Enrolled in Clinical Trial) (front) 
CASE CONTROL STUDY OF CANINE HYPOADRENOCORTICISM 
Investigator Name: ___________ _ Date._· ------
Cllnic Name: ----------------------
Dog's Name: Owner's Name· 
Age' (yr):_ WL (Ib):_ Breed: Sex: M MC F )FS (Cin:ll one 
Health Status: (Circle one) Alive Dead Lost to follow-up 
Cause of Hypoadrenocorticism: (Circle one) Lysodren AdrenalectOmy Unknown 
Other Diseases: (CMck aD that eppty) 
Anemia" Keratoconjunctivitis sicca Arthritis" �-Cruciate tigament rupture 
Diabetes mellitus �hritis� gtaVIS 
Hepatitis. Thrombocytopenia 
Hypothyroidism None of the above 
Dog's Name· Owner's Name· 
Age' (yr): _ WL (lb):_ Breed· Sex: M MC F FS (Cft:ll OM) 
Health Status: (Cft:ll one) Alive Dead Lost to foiJa.v-up 
Other Diseases: (CIIIclc 111 that apply) 
HYPothyroidism Anemia" Arthritis' Kitratoconjunctiviti sicca 
Cruciate ligament rupture �us Diabetes meUitus �gravis Hepatitis. '" 
Hypoadrenocorticism 
None of the above Thiomboc:ytopen 
Dog'S NamA· Owner's Name· 
Age' (yr):__ Wt. (lb):_ Bteecl: Sex: M MC F FS (Cft:ll one) 
Health Status: (Cft:llone) Alive Dead Lost to follow-up 
Other Diseases: (CIIIclc all that apply) 
Anemia" HYPotflyroidism 
Arthritis" Kei'atoconjunctivitis slcca Cruciate ligament rupiUre Megaesophagus Diabetes mellitus Myasthenia gravis 
Hepatitis• 1\lephritis" 
Hypoadrenocorticism Thrombocytopenia 
None of the above 
In your practice how many d� were diagnosed with hypoadrenocorticism between January 1 ,  
1993 and December 31 , 1 993  
Approximately how many active dog patients do you have in your practice?' 
How many full-time veterinarians work in your practice? 
Print the name of person filling out case report form 
Footnotes on Reverse 
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AS. Case Control Study of Canine Hypoadrenocorticism (Survey Form for 
Veterinarians Enrolled in Clinical Trial) (back) 
Footnotes 
1 Current age gr age at death m last known age (If lost to follow-up) 
2 Anemia from any cause 
3 Any inflammatory disease of the joints 
4 Any inflammatory disease of the liver 
5 Any inflammatory disease of the kidney 
6 All cases diagnosed regardless of whether they lived or died or how they were treated. 
7 Active dog patients is the number of dogs that have visited your practice in the last year 
(January 1 ,  1993 to December 31 , 1993). 
Note: H you have any questions, contact Phyfis HIDing, LVT, Susan Owen or Randy Lynn, 
DVM at 1-80D-637-o281 . 
Return to: Ciba Animal Health 
Post Office Box 18300 
Greensboro, NC 2741s.8300 
246 
A9. Instructions for Filling Out the Case Report Form-Case Control Study of 
Canine Hypoadrenocorticism (Instructions for Suxvey Form for Veterinarians 
Enrolled in Clinical Trial) (front) 
INSTRUCTJONS FOR FIWNG OUT THE CASE REPORT FORM 
case Control Study of Canine Hypoadrenocortlcism 
1 .  FiD in the date you are preparing the fonn i n  the upper right comer. 
2. For the hypgadrena! dgg: 
a. The investigator's name, clinic's name, dog's name, and owner's name have 
already been filled in. 
b. Please record the dog's
.
current age if alive m age at death m last known age 
if "lost to follow-up. • 
If you are not certain whether the dog is alive or dead, please contact the 
owner and find out. "Lost to follow-up" should include a dogs where it Is 
impossible to detennine whether the dog is alive or dead. In this case, record 
the dog's age at the time it was last known to be alive. 
· c. Record the dog's health status and presumed cause of hypoadrenocorticism 
[lysodren therapy, adrenalectomy or unknown]. 
d. Check which "Other Diseases• have been diagnosed in this dog at any time 
during its life. [Simply check those that apply.) 
3. For Cpntrpl Qog No 1: 
[Your "file" of patients may be a paper file or a computer file: "next" In the file 
means next alphabetically.) 
a. The next record (alphabetically) in your file after the record of the hypoadre­
nal patient will serve as Control Dog No. 1 provided it has a glfferent owner 
and is a dog. If the next record belongs to the same owner or is not a dog, 
go to the next record until a stag owned by a different owner is found. (Note: 
dogs which live in the same household will be considered to have the same 
owner.) 
(continued on reverse) 
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AlO. Instructions for Filling Out the Case Report Form-Case Control Study of 
Canine Hypoadrenocorticism (Instructions for Survey Form for Veterinarians 
Enrolled in Clinical Trial) (back) 
b. Fill in the information for Control Dog No. 1 .  It is self-explanatory. 
c. Record age the same way as for the hypoadrenal dog. 
4.  For Cgntml Pas� Ng. 2: 
a. Go to the fiflll record after the record for Control Dog No. 1 and use it as 
Control Dog No. 2, again prpvlded it has a different owner and is a .dog. If 
not, go to the sixth record, seventh record, etc., until you come to a .dog with 
a different owner. 
b. Fill in the information for Control Dog No. 2. It is again self-explanatory. 
c. Record age the same way as for the hypoadrenal dog. 
s. For Practice Qata: 
a. Record the total number of cases of canine hypoadrenocorticism diagnosed 
in your practice between January 1 ,  1 993 and December 31 , 1 993. 
This includes all cases diagnosed regardless of whether they were treated, 
how they were treated, or whether they lived or died. 
b. Record the total number of dogs seen in your practice (active dog patients) 
between January 1 ,  1993 and December 31, 1993. This is om the number of 
dog visits, it is the number of dogs. For example, if an individual dog was 
seen fwe times during the year, that dog is counted only .PDC§. 
c. Record the number of veterinarians who work full-time in your practice. If you 
have part-time veterinarians, estimate their total work load. For example, two 
veterinarians working half-time equals one full-time veterinarian. 
6. .friDt the name of the person filling out the Case Report Form at the end of the 
form. 
7. Please mail the Case Report Form(s) in the enclosed postage-paid envelope. 
Thanks a Jot! 
- 2 -
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A l l .  Case Contrql Study of Canine H:YPoadrenocorticism (Survey Form for 
Randomly Selected Veterinarians) 
Investigator's Name ---------
CASE CONTROL STUDY OF CANINE HYPOADRENOCORTICISM 
(Footnotes/Instructions on Reverse) 
Approximately how many active dog patients' did you see in 1993?·---------­
How many full-time veterinarians work In your practice? ------
In your practice how many dogs were initially diagnosed with hypoadrenocorticism between 
January 1 ,  1993 and December 31 , 1993'?2 ------
If your answer to the last question was greater than zero, please complete the following for all 
hypoadrenal dog.s diagnosed in 1993 and a control dog for each (please cali 1-8D0-447-2391 for 
additional fonns if you need them). 
HYPOAORENAL DOG 
Age (yr): Wt. (lb): _ Breed: ----- Sex: M MC F FS (Cin:lo one) (at time of diagnosis) 
Health Status:3 (Circle one) Alive Dead 
Cause of Hypoadrenocorticism: (Circle one) 
Other Diseases: (CIIeck all thBI apply) 
Anemia" 
Arthritis5 




Lost to follow-up 
Lysodren Adrenalectomy Unknown 






None of the above ----
CONTROL DOG8 
Age (yr): Wt. (lb): _ Breed: -----
(at last visit in 1993) 
Health Status:3 (Circle one) Alive Dead Lost to foUow-up 
Other Diseases: (Check all thBI apply) 













None of the above ----
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A12. Instructions for Filling Out the Case Report Form-Case Co
ntrol Study of 




1 Record the total number of dogs seen in your praclice (active dog patients) between January 1 ,  
1993 and December 31 , 1993. This J:i DQ1 th e  number of dog visits, it is th e  number of dogs. For 
example, H an  individual dog was seen five times during the year, that dog is counted only mu��. 
2 Record the total number of cases of canine hypoadrenocorticism diagnosed in your practice 
between January 1 ,  1993 and December 31, 1993. This Includes all cases diagnosed regardless 
of whether they were treated, how they were treated, or whether they lived or died. 
3Lost to follow-up means it Is Impossible to �etermine whether the dog Is now alive or dead. 
4 Anemia is a packed cell volume less than 30% from any cause. 
5 Any inflammatory disease of the joints. 
6 Any inflammatory disease of the liver. 
7 Any inflammatory disease of the kidney. 
8 The next record (alphabetically) in your file after the record of the hypoadrenal patient will serve 
as the Control Dog pmyjded It was seen in 1993, has a djfferent mmw: and is a dgg which does 
om have hypoadrenocorticism� If the next record belongs to the same owner or is not a dog seen 
In 1993 or has hypoadrenocorticism, go to the next record until a ggg IUD m .1993 is found 
which does om have hypoadrenocorticism and is owned by a different owner. (Note: dogs which 
live in the same household will be considered to have the same owner.) 
Note: If you have any questions, contact Phylis Hilling, L VT or Randy Lynn, DVM at 
1-&0o-447-2391 . 
Retum to: Ciba Animal Health 
Post Office Box 18300 
Greensboro, NC 27419-8300 
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APPENDIX B 
COMPUTATION OF em-SQUARE STATISTICS 
Variable B 
General 2 x 2 Contingency Table 
Variable A 
Category 1 Category 2 
Category 1 a b a + b 
Category 2 c d c + d  
a + c  b + d  N = a + b + c + d  
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C 1 .  Evaluation of Logistic Regression Models for Presence or Absence of Canine 
Hypoadrenocorticism Using Age, Breed, Sex, and Body Weight as 
Independent Variables: All Single Factor Models 
Model 







































































0. 1 176 
0. 1234 
Factor Chance Model 
Wald chi probability LOF**** 
Model square of Wald chi chi square 
• •• Factor (dt)***" square (df) , 
Case = 466.80 
(372) 
Body weight 2.52(1) 0. 1 124 
Body weight• 
Body weight 0.30(1) 0.5870 
Case = 460.62 
(371) 
Body weight 5.20(1) 0.0226 
Body weight• 
Body weight 2.65(1) 0. 1037 
Body weight• 2.82(1) 0.0933 
Body weight• 
Body weight 
• Case = presence or absence of hypoadrenocorticism in dog. 
Age = dog's age in yr. 
Breed = dog's breed. 
Chance 
probability 
of LOF chi 
square R2 1110 
0.0006 0.0221 
0.0010 0.0248 
Sex = dog's sex classified as female-intact, female-spayed, male-intact, or male-castrated. 
•• All models were significant at p < 0.0001 .  
*** Wald chi square with associated degrees of  freedom in  parentheses. 
•••• Lack of fit chi square with associated degrees of freedom in parentheses. 
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C2. Evaluation of Logistic Regression Models for Presence or Absence of Canine 
Hypoadrenocorticism Using Age, Breed, Sex, and Body Weight as 
Independent Variables: All Two Factor Models with No Interactions 
Factor Chance Model Chance 
Wald chi probability LOF**** probability 
Model square of Wald chi chi square of LOF chi 
• •• Factor (df)***" square (df) square R:: 1so ' 
Case =  440.04 0.0006 0.1673 
(348) 
Age 140.96(1) < 0.0001 
Breed 170.93(17) < 0.0001 
Case =  338.52 < 0.0001 0.0973 
(21 8) 
Age 103.51(1) < 0.0001 
Sex 60.51(3) < 0.0001 
Case =  1627.57 < 0.0001 0.0958 
(1313) 
Age 147.05(1) < 0.0001 
Body weight 71.72(1) < 0.0001 
Case =  66.04 0.0526 0. 1359 
(49) 
Breed 162. 13(17) < 0.0001 
Sex 90.27(3) < 0.0001 
Case =  688.29 0.0908 0. 1244 
(640) 
Breed 173.42(17) < 0.0001 
Body weight 47.21(1) < 0.0001 
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Factor Chance Model 
Wald chi probability LOF**** 
Model square of Wald chi chi square 
• •• Factor (df)***" square (df) ' 
Case =  784.49 
(655) 
Sex 104.99(3) < 0.0001 
Body weight 48.93(1) < 0.0001 
• Case = presence or absence of bypoadrenocorticism in dog. 
Age = dog's age in yr. 
Breed = dog's breed. 
Chance 
probability 
of LOF chi 
square Rl iSO 
0.0004 0.0715 
Sex = dog's sex classified as female-intact, female-spayed, male-intact, or male-castrated. 
•• All models were significant at p < 0.0001. 
••• Wald chi square with associated degrees of freedom in parentheses. 
•••• Lack of fit chi square with associated degrees of freedom in parentheses. 
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C3. Evaluation of Logistic Regression Models for Presence or Absence of Canine 
Hypoadrenocorticism Using Age, Breed, Sex, and Body Weight as 
Independent Variables: All Two Factor Models with Interactions 
Model 
















































































Factor Chance Model 
Wald chi probability LOF**** 
Model square of Wald chi chi square 
• •• Factor (dt)***" square (dt) , 
Case = 777.86 
(652) 
Sex 33.35(3) < 0.0001 
Body weight 17.97(1) < 0.0001 
Sex*Body 
weight 6.40(3) 0.0935 
• Case = presence or absence of hypoadrenocorticism in dog. 
Age = dog's age in yr. 
Breed = dog's breed. 
Chance 
probability 
of LOF chi 
square R2 tao 
0.0005 0.0744 
Sex = dog's sex classified as female-intact, female-spayed, male-intact, or male-castrated. 
•• All models were significant at p < 0.0001.  
••• Wald chi square with associated degrees of freedom in parentheses. 
**** Lack of fit chi square with associated degrees of freedom in parentheses. 
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C4. Evaluation of Logistic Regression Models for Presence or Absence of Canine 
Hypoadrenocorticism Using Age, Breed, Sex, and Body Weight as 
Independent Variables: All Three Factor Models with No Interactions 
Model 
• •• ' 
Case =  
Case =  
Case =  


























































• Case = presence or absence of hypoadrenocorticism in dog. 
Age = dog's age in yr. 
Breed = dog's breed. 
Chance 
probability 










Sex = dog's sex classified as female-intact, female-spayed, male-intact, or male-castrated. 
** All models were significant at p < 0.0001. 
••• Wald chi square with associated degrees of freedom in parentheses. 
**** Lack of fit chi square with associated degrees of freedom in parentheses. 
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CS. Evaluation of Logistic Regression Models for Presence or Absence of Canine 
Hypoadrenocorticism Using Age, Breed, Sex, and Body Weight as 
Independent Variables: All Three Factor Models with Two-Way Interactions 
Factor Chance Model Chance 
Wald chi probability LOF**** probability 
Model square of Wald chi chi square of LOF chi 
• •• Factor (elf)***" square (elf) square RZ 180 ' 
Case = 494.22 0.4132 0.2270 
(488) 
Age 0.07(1) 0.7940 
Breed 17.47(17) 0.4227 
Sex 0.03(3) 0.9984 
Age•Breed 7.76(17) 0.9715 
Age• Sex 7.95(3) 0.0470 
Breed•Sex 13. 75(49) 1 .0000 
Case = 1542.30 0.0072 0.2171 
(1409) 
Age 0.04(1) 0.8491 
Breed 6.99(17) 0.9837 
Body weight 0. 14(1) 0.7076 
Age• Breed 14.71(17) 0.6163 
Age• Body 0. 1 1(1) 0.7383 
weight 
Breed•Body 17.51(17) 0.4202 
weight 
Case = 1769.60 < 0.0001 0. 1286 
(1512) 
Age 45.84(1) < 0.0001 
Sex 1 1 .42(3) 0.0097 
Body weight 13. 1 1(1) 0.0003 
Age•Sex 3.72(3) 0.2933 
Age• Body 1 .51(1) 0.2184 
weight 
Sex•Body 8.76(3) 0.0327 
weight 
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Factor Chance Model 
Wald chi probability LOF**** 
Model square of Wald chi chi square 
• •• Factor (dO***" square (dO ' 
Case =  919.26 
(883) 
Breed 13.39(17) 0.7095 
Sex 3.43(3) 0.3303 
Body weight 0.09(1) 0.7678 
Breed*Sex 12.02(49) 1.0000 
Breed*Body 15.63(17) 0.5502 
weight 
Sex*Body 6.88(3) 0.0758 
weight 
* Case = presence or absence of hypoadrenocorticism in dog. 
Age = dog's age in yr. 
Breed = dog's breed. 
Chance 
probability 
of LOF chi 
square R2 ISO 
0.1929 0.2051 
Sex = dog's sex classified as female-intact, female-spayed, male-intact, or male-castrated. 
*"' All models were significant at p < 0.0001. 
*** Wald chi square with associated degrees of freedom in parentheses. 
**** Lack of fit chi square with associated degrees of freedom in parentheses. 
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C6. Evaluation of Logistic Regression Models for Presence or Absence of Canine 
Hypoadrenocorticism Using Age, Breed, Sex, and Body Weight as 
Independent Variables: All Three Factor Models with Two- and Three-Way 
Interactions 
Model 
• •• ' 
Case =  
Case =  


































































































< 0.0001 0. 1292 
Factor Chance Model 
Wald chi probability LOF**** 
Model square of Wald chi chi square 
• •• Factor (df)***" square (df) ' 
Case = 895.30 
(832) 
Breed 7.96(17) 0.9675 
Sex 0. 15(3) 0.9857 
Body weight < 0.01(1) 0.9969 
Breed*Sex 17. 19(49) 1.0000 
Breed*Body 2260.49 < 0.0001 
weight (17) 
Sex*Body 74. 17(3) < 0.0001 
weight 
Breed*Sex* 8226.35 < 0.0001 
Body weight (42) 
* Case = presence or absence of hypoadrenocorticism in dog. 
Age = dog's age in yr. 
Breed == dog's breed. 
Chance 
probability 
of LOF chi 
square Rz 1110 
0.0630 0.2155 
Sex = dog's sex classified as female-intact, female-spayed, male-intact, or male-castrated. 
** All models were significant at p < 0.0001. 
*** Wald chi square with associated degrees of freedom in parentheses. 
**** Lack of fit chi square with associated degrees of freedom in parentheses. 
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C7. Two Logistic Regression Models Fit for Presence or Absence of Canine 
Hypoadrenocorticism Using Age, Breed, Sex, and Body Weight as 
Independent Variables 
Factor Chance Model Chance 
Wald chi probability LOF*••• probability 
Model square of Wald chi chi square of LOF chi 
• •• Factor (dt)***" square (dt) square R2 1so ' 
Case =  1612. 14 0.2692 0.2418 
(1578) 
Age 82.51(1) < 0.0001 
Age• Age 51.96(1) < 0.0001 
Breed 148. 12(17) < 0.0001 
Sex 40.27(3) < 0.0001 








Airedale Terrier 1 .37241 
Basset Hound 2.72231 
Bearded Collie 2.26271 
Boxer -6.86806 
Cocker Spaniel 0.68076 
Dalmatian -7. 15408 
German Shorthaired Pointer 1 .72756 
Great Dane 3 . 18304 
Lhasa Apso -0.95415 
Pit Bull Terrier -7. 18512 
Pomeranian -0.01 101 
Poodle 2.54412 
Shetland Sheepdog -0.43610 
Shih Tzu 0.48986 
Springer Spaniel 2.62266 
West Highland White Terrier 3.60843 







Body weight 0.03585 
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Factor Chance Model Chance 
Wald chi probability LOF**** probability 
Model s�uare of Wald chi chi smuare of LOF chi • •• Factor (d ***" square square R2 tso ' (d 
Case =  1590.04 0.3833 0.2516 
(1574) 
Age 80.25(1) < 0.0001 
AgHAge 60. 18(1) < 0.0001 
Breed 143.08(17) < 0.0001 
Sex 13.03(3) 0.0046 
Body weight 25.84(1) < 0.0001 
Age• Body 12.85{1) 0.0003 
weight 









Airedale Terrier 1.35685 
Basset Hound 2.80167 
Bearded Collie 2.29040 
Boxer -6.80605 
Cocker Spaniel 0.73518  
Dalmatian -7.01512 
German Shorthaired Pointer 1 .87936 
Great Dane 2.57387 
Lhasa A�so -0.96808 
Pit Bull errier -7.07281 
Pomeranian -0. 1 1475 
Poodle 2.54819 
Shetland Sheepdog -0.55209 
Shih Tzu 0.47 1 10 
Springer �aniel 2.67659 
West Hig and White Terrier 3.80993 







Body weight 0.06772 
Age•Body weight -0.00527 
Female-intact•Body weight -0.03871 
Female-spayed•Body weight 0.01 1 12 
Male-intact•Bod� weight 0.0063 1 
Male-castrated• ody weight 0.00000 
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* Case = presence or absence of bypoadrenocorticism in dog. 
Age = dog's age in yr. 
Bieed = dog's breed. 
Sex = dog's sex classified a5 female-intact, female-spayed, male-intact, or male-astrated. 
** Both models were significant at p < 0.0001. 
*** Wald chi square with associated degrees of freedom in parentheses. 
**"'* Lack of fit chi square with associated degrees of freedom in parentheses. 
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APPENDIX D 
CAUSALITY: A COMPLEX ISSUE 
Melissa called her husband George at his office at three o'clock in the 
afternoon. Their six-month-old son Jason had a terrible case of diaper rash, and 
her last can of medicated diaper powder had become thoroughly soaked and 
useless when a pipe above the bathroom medicine cabinet leaked. Would George 
stop by the store on the way home and pick up some more powder? George, good 
husband and father he, said he would. 
George-after a long delay in his usual five o'clock departure because he was 
forced to listen as his boss bloviated endlessly about a myriad of hopelessly inane 
topics-left his office, got in his car, and drove toward the store. About a mile 
before the store, George heard a thumping noise from the right rear of the car. 
Recognizing that he had a flat tire, George pulled over, threw open the door, and 
stepped out of the car directly into the path of an oncoming truck. George was 
killed instantly. Question: What caused George's death? 
The issue of causality is a complex one which philosophers and scientists 
have been struggling with for centuries. Epidemiologists are often inclined to 
quickly and, as it turns out, facilely dismiss the issue as simple and self-evident. 
For example, asked the question posed in Chapter 5 whether age, breed, sex, and 
body weight cause canine hypoadrenocorticism, many epidemiologists would 
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condescendingly respond assertively in the negative. Age, breed, sex, and body 
weight may be associated with canine hypoadrenocorticism, they would say, but 
to speak of causation would be naive. This appendix demonstrates that, while these 
epidemiologists may or may not be correct, questions of causality are definitely not 
answered simply. Put by another: 
. . .  it is apparent that some of the main philosophical problems of causation 
do not yield to any easy solution. The idea of a necessary connection 
between cause and effect may be, as Hume thought, an esoteric and 
metaphysical one, but it is doubtful whether anyone can render an adequate 
analysis of the causal relation without it [Italics added] . 221 
The author will, risking nihilism, assert that, given the present state of human 
knowledge and understanding, assertions that such and such is or is not the cause 
of something else are virtually always naive. This will be based on the premise 
that such assertions are usually at variance with human understanding of the 
physical universe. 
This discussion of causality in epidemiology must be preceded by the 
disclaimer that it does not pretend to be comprehensive, and its author 
acknowledges up-front that he is a rookie philosopher of the rawest sort. 
Nevertheless, as appropriate in an interdisciplinary endeavor like the Comparative 
and Experimental Medicine Program, the author attempts in his probably 
hopelessly puerile way to, in the spirit of the first Ph.D. granted in "General" by 
The University of Tennessee in 1886 (see Preface), grapple with this thorny issue. 
His purpose is not to settle the issue of what is and what is not a cause, but to 
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establish that the issue is a complex one not given to flip, pat pronouncements. 
The fact that a well-known and respected epidemiologist has seen fit to devote an 
entire section in his epidemiology text to causation, 165 and to edit another entire 
book on the subject,l69 testifies to the issue's complexity. Indeed, he says, "We 
know from Hume, Popper, and others that causal inference is at best tentative and 
is still a subjective process. " 170 In addition, his book on causation says the 
following about whether or not the epidemiologist, as a scientist, is obliged to 
consider the philosophic complexity of this issue: 
Thus it is in good conscience that one may recommend to the empirical 
scientist to stand back occasionally and engage in philosophical reflection 
upon the ultimate nature and significance of his enterprise. He should find 
it worthwhile to study philosophical literature, for it contains matters of 
substance that may provide insight and intellectual satisfaction. tas 
Finally, if Aristotle, David Hume, John Stuart Mill, Immanuel Kant, Isaac 
Newton, and Bertrand Russell cannot sort out the causality issue, only an act of 
incredible hubris would lay claim to having done so. The author makes no such 
claim. 
Western culture and thought about the physical universe have gone through 
three major eras: Aristotle's rationalism, Locke's and Newton's empiricism and 
determinism, and Planck's and Einstein's quantum and relativity theory. Each of 
these eras was characterized by a different view of cause (and, of course, some 
individuals in each of these eras naively asserted the absolute 11rightness" of these 
different views). 
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Aristotle, whose thought about causes prevailed until the Renaissance, 
defined four kinds of causes, 18•n and, most important, he felt that rational thought 
rather than empiricism was the most reliable method for obtaining truth. The 
doctrine of rationalism held that "scientific knowledge accumulated through reason 
and intuition rather than by empirical observation. " 164 Indeed, Aristotle's ontology 
suggested that reason was "far more real and trustworthy . . .  than the fleeting and 
undependable experience of the senses. "204 Aristotle, for example, might well have 
asserted the superiority of his rationally-reasoned belief that a large rock falls 
faster than a small one even, had the results been available to him, in the face of 
Galileo's empirical experiment.204 In other words, rational thought was supreme. 
A corollary of rationalism was the preeminence of mathematics as the "highest 
form of knowledge. "  164 
John Locke rejected Aristotelian rationalism in favor of empiricism. He 
claimed that the human mind was a tabula rasa (blank tablet) at birth and that 
experience dictated knowledge.205 Locke's philosophic position led naturally to the 
empiricism and determinism of the scientific method and the new physics of Isaac 
Newton. Rationalism and reason were not entirely rejected, of course, but they 
were accepted only within the "well-defined activities of calculation and logic. "205 
Put more succinctly: 
With Newton, the world was not only thought of as a machine, but was 
exhibited in detail as a function of mechanical laws-a system of the world. 
All matters of celestial and terrestrial mechanics, scattered and disconnected 
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in Kepler, Copernicus, Huygens, Halley, Wren, Hook, and Galileo, were 
unified into a grand system of mathematical-mechanical laws [Italics 
added] . IID,B4 
According to this view, the world was a giant machine, the components of which, 
having already been set in motion, would interact in wholly predictable ways in 
accordance with the "laws" of physics. Newton's universal law of gravity and his 
laws of thermodynamics exemplified these laws, and science has, since the time 
of Newton, been largely engaged in finding and refining these laws-all the while, 
of course, assuming that such laws existed, and that they could be systematically 
described, principally using mathematics. 00 This belief in definable physical laws 
has been described as follows: 
Nonetheless, the notion arose in the eighteenth century that "all sufficiently 
smooth Newtonian systems were exactly and meaningfully solvable. In 
consequence, one no longer spoke of unsolvable systems, only those not yet 
solved [Italics added] . "56 
In other words, everything can be explained by the new physics, and, if something 
appears not to be explainable, it is not because there is no mechanistic explanation, 
the mechanism simply has not yet been discovered and defined.PP (This, arguably, 
IIDJt is a paradox that, while rejecting Aristotelian rationalism, Newtonian 
physics heavily emphasized mathematics, a discipline which, as mentioned above, 
was, according to the rationalists, the "highest form of knowledge. "220 
00Newton, in fact, had to specifically develop differential calculus in order to 
explain this new physics. 
PPJ'his view of the universe led naturally to the deistic theologic assertion by 
the French philosophes (and Thomas Jefferson) that the universe was like a giant 
clock which had been wound up by God, and then abandoned by Him to tick on 
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could be described as the ultimate in human hubris: the assertion that the human 
mind was capable of comprehending everything which goes on in the universe.) 
This worldview largely underpins late twentieth-century science, and, within the 
scientific community at least, remains, rightly or wrongly, largely unchallenged. 
The late nineteenth- and early twentieth-century thought of men like Max Planck 
and Albert Einstein challenged some of the tenets of this worldview. 
What will be called here "modern physics" (emphatically recognizing that 
Newtonian physics is very much alive today in all sorts of real-world applications) 
includes quantum mechanics which began with Max Planck's quantum theory in 
1900,248 relativity theory which began with Albert Einstein's special theory of 
relativity in 1905,248 and chaos theory which began with men like Mitchell 
Feigenbaum in the 1970s.qq·63 Each of these (quantum mechanics, relativity, and 
in perpetuity. This view, mirrored to some extent by the fatalism of Calvinism, led 
inevitably (and sadly) to a determinism which denied human volition. 
This view similarly led to much of the conflict over the centuries between the 
religious and scientific communities-dating from the house arrest of Galileo in the 
seventeenth century, including the Scopes " monkey trial'' in Dayton, Tennessee in 
1925, and (amazingly!) also including the current debate in the Tennessee 
legislature (this is written on 7 March 1996) about the teaching of evolution in 
schools. 
q"The author acknowledges here that the lumping together of quantum theory, 
relativity, and chaos into "modern physics" is wholly arbitrary and is done for two 
reasons: convenience, and the author's nearly overwhelming ignorance of these 
fields . The author recognizes that these are three different kinds of physics as 
explained in the following: "The most passionate advocates of the new science 
[chaos theory] go so far as to say that twentieth-century science will be 
remembered for just three things: relativity, quantum mechanics, and chaos. 
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chaos) challenges the Newtonian mechanistic view of the universe. An example of 
each challenge follows. 
Newtonian physics says that, given the position and momentum of an object 
moving in space, it is simple to compute the position and momentum of the object 
at a future time. Quantum mechanics, on the other hand, has demonstrated that 
sub-atomic particles do not behave in this way. Not only can the future position 
and momentum of a sub-atomic particle not be predicted from its present position 
and momentum, it is impossible to accurately measure both the present position 
and momentum of the sub-atomic particle in the first place. The particle's position 
or its momentum can be accurately measured, but not both. This is Heisenberg's 
uncertainty principle, and it has been empirically verified by many experiments. 
Since both the particle's position and momentum cannot be determined, quantum 
mechanics, in contrast to Newtonian physics, cannot predict specifically where the 
particle will be at some future instant, but can predict the probability that the 
particle will be at a particular position with a particular momentum.249 This 
illustrates one of the essential differences between the Newtonian and quantum 
mechanical worldviews: the Newtonian world is precisely predictable--always 
Chaos, they contend, has become the century's third great revolution in the 
physical sciences. Like the first two revolutions, chaos cuts away at the tenets of 
Newton's physics . As one physicist put it: 'Relativity eliminated the Newtonian 
illusion of absolute space and time; quantum theory eliminated the Newtonian 
dream of a controllable measurement process; and chaos eliminates the Laplacian 
fantasy of deterministic predictability. '  "64 
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measurable and certain; the quantum mechanical world is probabilistically 
predictable--often immeasurable and uncertain. rr So the Newtonian world view is 
imperfect. 
Relativity also challenges Newtonian physics. Indeed, Einstein's "proof' that 
light is composed of photons (recognizing that no theory of physics has 
satisfactorily explained the wave-particle duality of light), coupled with Thomas 
Young's double-slit experiment conducted in the early nineteenth century, leads 
to the strong, but very unsettling, possibility that light has consciousness. 250 
Indeed, to quote from a book on physics: "We have little ·choice but to 
acknowledge that photons, which are energy, do appear to process information and 
to act accordingly [Italics added] . "251 Ironically, Einstein himself would probably 
have totally rejected this possibility. He is quoted as saying: 
. . . I should not want to be forced into abandoning strict causality without 
defending it more strongly than I have so far. I find the idea quite intolerable 
that an electron exposed to radiation should choose of its own free will, not 
only its moment to jump off, but also its direction. In that case, I would 
rather be a cobbler, or even an employee in a gaming house, than a physicist 
[Italics in original] . 38 
Nevertheless, photons of light and electrons may be conscious. 
Relativity, as is well-known (tritely so, perhaps), says that time itself is 
relative; e.g. , a cigarette smoked by an astronaut moving through space bums 
rrone philosopher tries to reconcile this conflict between precise and 
probabilistic predictability. 240 
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longer (literally!) than a cigarette smoked by an earthbound astronaut.252 This 
relativity of time has been empirically verified by flying atomic clocks around the 
world.".2S3 The strange nature of relativity can be described as follows: 
The physical theories of Einstein, and the variants developed by others, 
which have each been called the "theory of relativity" are so named because 
they have relativized some of the attributes and relations (spatial distance, 
time interval, mass) which the Newtonian theory had asserted to be invariant 
(absolute). 67 
Finally, chaos theory has been defined as "the qualitative study of unstable 
aperiodic behavior in deterministic nonlinear dynamical systems. "90 It is 
schizophrenic in that it at once confirms that chaotic systems11 are in principle 
predictable, but that they are, due to "sensitive dependence on initial conditions, "  
almost wholly unpredictable as a practical matter. 88 In other words, specifying 
initial conditions is well nigh impossible, and the ability to compute results does 
not exist even if the initial conditions were known. For example, what does 
watching two bits of foam floating side by side at the bottom of a waterfall tell 
about where they were at the top? "Nothing. As far as standard physics [is] 
"It is an interesting conundrum that, although belief in things like "conscious 
photons"  and "relative time" seems intuitively based more in faith and spirituality 
than in science, the "proof' of these beliefs still, to be satisfying, must rest on 
empirical evidence. This may be a measure of just how powerfully the Newtonian 
way of thinking has been hammered into our twentieth-century brains. 
nwhich "can appear in the context of exceedingly simple and entirely 
Newtonian equations of motion "88; i.e. , chaotic systems are easily and everywhere 
to be found. 
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concerned, God might just as well have taken all those water molecules under the 
table and shuffled them personally. "65 This leads to the humbling paradox that the 
universe is at the same time deterministic, but not deterministic in the sense of a 
Newtonian timepiece. This has been better said: 
The curious nature of chaotic unpredictability also raises questions about 
scientific determinism. These systems with sensitive dependence on initial 
conditions produce random or chancy behavior, the opposite of what we 
would expect from a picture of the universe as strictly determined clockwork. 
Yet chaos theorists consistently describe their models as "deterministic."  . .  
. Not only does chaos theory suggest that predictability should be considered 
separately from determinism, but in conjunction with quantum-mechanical 
considerations it raises serious doubts about the viability of the doctrine of 
determinism in the context of modem physics [Italics added]. uu,s9 
This alludes to the conundrum of "causation without determinism,"  a seemingly 
oxymoronic phrase which philosophers have, in light of modem physics, recently 
been grappling with. 146 It may also allude to problems sometimes introduced into 
philosophic arguments "as a consequence of customary linguistic usage. "220 In 
other words, there is a point at which these arguments become moot because they 
depend on the limited ability of humans to communicate with words. At that point, 
and it is impossible to determine precisely where that point is, further argument 
becomes meaningless. 
uuln other words, "predictability .. and 11determinism" are separate ideas. What? 
(The author confesses that he is now at or beyond the edge of his intellectual 
capability.) 
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Finally, contemporary scientific training emphasizes an epistemology which 
at best ignores and at worst is openly hostile to the apparently disorderly conduct 
of chaotic nonlinear systems. In other words, though we live in a decidedly 
nonlinear world (as defined by Aristotle or Newton or Einstein), the contemporary 
training of and practice by scientists tries to force the world to be linear. This bias 
against the nonlinear has been succinctly described: 
. . . the professional training of scientists . . . diverted attention away from 
areas where chaos might have been discovered and studied. By training 
students to disregard apparently disordered behavior, to focus attention on 
linear models, and to seek simple exact solutions, scientific education 
screened off chaos . . . .  Education in the natural sciences created the 
impression that linear and solvable systems were the only ones (or at least 
the only important ones)-an impression that came very close to being a 
prejudice in favor of systems as regular and predictable as clockwork. . . . 
Professional instruction rendered chaos less visible in two ways: on the one 
hand, students were indirectly steered away from nonlinear systems (the only 
systems in which chaos is possible) by being taught that they were 
uninteresting or exceptional cases. On the other hand, when apparently 
bizarre or even chaotic behavior was found in these nonlinear systems, it was 
dismissed as mere noise or experimental error . . . 91 
In other words, scientists are taught to shun results which they cannot understand 
in favor of those which fit their (often preconceived) idea of how the world ought 
to work. wntis is a very unscientific attitude! 
VVJiow many times have you heard a scientist say, "The experiment did not 
work"? Amazing! According to Newtonian thought, which shapes most 
contemporary scientific thought, experiments always work; i.e. , the molecules 
always do what they are supposed to. The problem is human understanding, not 
molecular incompetence. 
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So, what does all this have to do with the question of whether or not age, 
breed, sex, and body weight cause canine hypoadrenocorticism? The answer is, 
recognizing the possibly just accusation of nihilism, unknown and unknowable 
given contemporary human understanding of how the world works. ww How can 
causality be conclusively determined if the physical world is as yet ill-defined? It 
cannot. Assertions to the contrary are naive and symptomatic of contemporary 
hubris among scientists. 
So, back to Melissa and George: What caused George's death? The answer 
is unknown and unknowable. On the macro-, non-scientific level, one could argue 
that the causes were the plumbing problem at George's house; the baby Jason's 
diaper rash; Melissa's call to George; George's delay leaving work while his boss 
blathered on; the manufacturer of George's tires; the person who dropped the 
object on the road which punctured George's tire; George's carelessness in getting 
out of his car; and so on. On the micro-, scientific level, one could argue that the 
causes were being hit by a truck (the forensic pathologist's view); the sudden 
collapse of the cranium with its incumbent near-instantaneous cessation of all 
ordered neural activity in the brain (the neuropathologist's view); a failure to 
WW'fhe question could, trivially, be answered yes.4•19•100•121•124•137• 145• 166•167 (Each 
of these nine references--with specific page numbers cited--is a work of either 
philosophy or epidemiology in which the definition of causality leads to the answer 
yes. The author recognizes that other references could be found in which the 
definition of causality leads to the answer no.) 
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breathe accompanied by sudden, irrevocable cardiovascular collapse (the 
cardiologist's view); the necrosis of tissues and cells due to massive hemorrhage 
and near-complete interruption of blood supply (the histopathologist's view); the 
necrosis of tissues and cells due to profound alterations in their cellular milieu 
(oxygen tension, pH, electrolyte concentrations, etc.) (the biochemist's view); and 
so on.xx Therefore, the question of causality remains puzzling in even seemingly 
simple situations. 
So, what is the point? It is that the epidemiologist should neither fall prey to 
the post hoc ergo propter hoc fallacy nor be too quick to cavalierly dismiss factors 
associated with diseases as surely not causally related. The epidemiologist should, 
recognizing just how complex the causality issue is, avoid both errors-in most 
cases by recognizing that what causes something is usually unknown and 
unknowable. 
Finally, a spiritual, mystical element has crept into this discussion. This was 
deliberate, and while some scientists dismiss appeals to the supernatural as 
primitive superstition, some of the world's best scientific thinkers do not. So, lest 
the author's thoughts about science generally and causality specifically-and their 
possible relationship to the spiritual--be casually dismissed, the reader is referred 
to the words of Stephen Hawking, a mathematician and physicist who has (unlike 
:antis reasoning parallels almost exactly that used in a well-known textbook 
of epidemiology. 99 
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the author) thoroughly understood Aristotelian rationalism, Newtonian physics, and 
modern physics; who has in fact filled the same professor's position at Cambridge 
University once filled by Isaac Newton; and who has been described175 as a 
"legend" and a "worthy successor" of Newton by Carl Sagan: 
However, if we do discover a complete theory [of the universe] it should in 
time be understandable in broad principle by everyone, not just a few 
scientists. Then we shall all, philosophers, scientists, and just ordinary 
people, be able to take part in the discussion of the question of why it is that 
we and the universe exist. If we find the answer to that, it would be the 
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